Tracker · 410 regulatory documents · 553 clinical-trial registrations

Regulatory & Clinical Tracker

FDA and DEA documents from the Federal Register on mental health and controlled substances, and clinical-trial registrations from ClinicalTrials.gov. Documents are dated by publication and registrations by the day ClinicalTrials.gov first posted them.

Latest regulatory coverage

REGULATION · ANALYSIS

Nine in ten public comments on FDA's five most-commented reviews favor approval. The outcomes did not follow.

A Johns Hopkins team coded 600 public comments from the five most-commented FDA reviews of 2020 to 2024 and found 90.2 percent supported approval. Its own appendix of 44 advisory committee reviews shows comment volume tracking committee votes in no consistent way. In the five cases, FDA's documents point to other grounds, among them inspections, manufacturing comparability, durability data, post hoc analyses and one Center Director override of his own reviewers.

More regulatory coverage (11) →
REGULATION · ANALYSIS

Japan designated three new drugs on October 27. The local bans that took effect first are built to lapse.

A nitazene opioid, a methoxy tryptamine and a cocaine-like tropane were designated the same day by two different systems: nationally under the Pharmaceuticals and Medical Devices Act, in force November 6, and by at least five prefectures under their own ordinances, in force October 28. The prefectural layer is a bridge. Aichi has designated 250 substances since 2012, every one has lapsed into the national list, and its current roster is these three.

REGULATION · ANALYSIS

A lab bought 46 products labeled cat's claw. All 46 contained undeclared kratom alkaloids, including eight that promised none.

A preprint from the University of Mississippi's natural products center bought 46 chewable products labeled as cat's claw and found undeclared kratom alkaloids in every one. Thirty-nine contained one or both of two compounds the DEA placed in Schedule I in August; the third scheduled compound was not in the laboratory's analyte panel. Eight products that promised no kratom and no 7-OH contained both. FDA's own public page on these compounds, current to October 12, does not mention cat's claw.

REGULATION · ANALYSIS

DEA is redrawing its kratom line before the first one took effect

DEA is replacing the 7-hydroxymitragynine threshold it proposed in July with a two-part test: more than 1 mg per gram, or less than 100 parts mitragynine to one part of the potent alkaloids. The proposal is not a final order, and none had issued as of October 27. On the arithmetic, the new test can be looser or tighter than the old one, depending on a product's alkaloid mix. DEA says it has made no finding that anything below the line is safe.

REGULATION

Drugmakers behind most U.S. branded drug sales now have pricing deals nobody voted on. Which psychiatric drugs they cover is not public.

The White House added nine more drugmakers to its most-favored-nation pricing program, bringing the total to 26 companies covering an estimated 89 percent of the branded drug market. None of the new nine build their business around psychiatric drugs. That's beside the point: the company that makes esketamine signed on months ago, and the whole arrangement is voluntary, unenforced by law, and largely undisclosed to Congress.

REGULATION

Puerto Rico opens a research-policy review on psychedelics and ibogaine. It has not approved any clinical use.

Executive Order 2026-037 creates a scientific advisory committee to study whether Puerto Rico should build a pilot clinical research program for emerging therapies, including psilocybin, MDMA, and ibogaine, with veterans named as a priority population. The order states that it does not authorize offering these therapies as part of routine clinical practice, and any future research would still need separate regulatory authorization, a distinction worth stating plainly before the headline runs ahead of it.

REGULATION

Medicare's 2027 physician-rate cut landed deeper than proposed. Behavioral health is one of the few specialties partly shielded from why.

CMS's CY 2027 physician fee schedule cuts both Medicare conversion factors, a system-wide reimbursement headwind. But the same rule extends Medicare's telehealth mental health flexibility through 2027, and last year's most contested pay cut specifically exempted the time-based codes psychiatry and psychotherapy mostly bill under. The rule is a mixed signal, not a uniform one, and the mix matters more than the headline number.

REGULATION

DEA moves to schedule tianeptine, the other 'gas station' compound quietly building a mortality record

A federal Schedule I proposal would close the retail loophole that has let tianeptine, an atypical antidepressant abroad and an opioid-like supplement in unregulated US retail, spread through the same gas-station-and-smoke-shop channel as kratom's concentrated derivatives. It is the third distinct DEA scheduling action against this retail category in two weeks.

Regulatory & Clinical Tracker

  • Regulatory documents: Federal Register publications from Nov 10, 2024 to Nov 17, 2026.
  • Clinical-trial registrations: first posted from Aug 12, 2026 to Nov 17, 2026.

Showing 410 regulatory documents and 553 clinical-trial registrations for all available history.

Regulatory documents

410

FDA and DEA documents published in the Federal Register. The date shown is the publication date.

Published November 12, 2026
DEA
Schedules of Controlled Substances: Placement of Oveporexton in Schedule IV
Interim final rule · Effective Nov 12, 2026 · Comments due Dec 14, 2026
scheduling

On August 5, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Orzeyful (oveporexton) for the treatment of narcolepsy type 1 in adults. The Department of Health and Human Services (HHS) provided the Drug Enforcement Administration…

Federal Register document 2026-23075

View on Federal Register
DEA
Importer of Controlled Substances Application: NSI Lab Solutions LLC
Notice · Comments due Dec 14, 2026
scheduling

NSI Lab Solutions LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-23006

View on Federal Register
Published November 10, 2026
DEA
Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2027
Notice
scheduling

The Drug Enforcement Administration (DEA) proposes to establish the 2027 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA) and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine…

Federal Register document 2026-22843

View on Federal Register
DEA
Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sale) Pursuant to 21 U.S.C. 826(h)
Final order · Effective Nov 10, 2026
scheduling

The Drug Enforcement Administration (DEA) is adjusting the 2026 aggregate production quota for the schedule II controlled substances d,l-amphetamine, d-amphetamine (for sale), hydromorphone, and methylphenidate (for sale). In making this determination, DEA has considered the…

Federal Register document 2026-22842

View on Federal Register
Published November 6, 2026
DEA
Specific Listing for 3-Chloromethcathinone, A Currently Controlled Schedule I Substance
Final rule · Effective Nov 6, 2026
scheduling

The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Controlled Substances Code Number (drug code) for 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3- chloromethcathinone; 3-CMC) in schedule I of the Controlled Substances Act (CSA). Although…

Federal Register document 2026-22717

View on Federal Register
Published November 5, 2026
DEA
Routine DEA registration application notices · 3
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Navinta LLC
Notice · Comments due Jan 4, 2027
scheduling

Navinta LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-22556

View on Federal Register
DEA
Importer of Controlled Substances Application: Diamond Animal Health, Inc.
Notice · Comments due Dec 7, 2026
scheduling

Diamond Animal Health, Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-22555

View on Federal Register
DEA
Importer of Controlled Substances Application: Noramco
Notice · Comments due Dec 7, 2026
scheduling

Noramco has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-22553

View on Federal Register
Published November 2, 2026
DEA
Routine DEA registration application notices · 2
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: AJNA Biosciences
Notice · Comments due Jan 4, 2027
scheduling

AJNA Biosciences has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-22289

View on Federal Register
DEA
Importer of Controlled Substances Application: Globyz Pharma LLC
Notice · Comments due Dec 2, 2026
scheduling

Globyz Pharma LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-22288

View on Federal Register
DEA
Conforming Amendment Regarding the Criminal Law Technical Amendments Act of 2002
Final rule · Effective Nov 2, 2026
scheduling

The Criminal Law Technical Amendments Act of 2002 ("Technical Amendments Act") became law on November 2, 2002, as part of the 21st Century Department of Justice Appropriations Authorization Act. The Technical Amendments Act amended sections 401(d), 402(c), and 403 of the…

Federal Register document 2026-22285

View on Federal Register
Published October 30, 2026
DEA
Schedules of Controlled Substances: Placement of Centanafadine in Schedule III
Interim final rule · Effective Oct 30, 2026 · Comments due Nov 30, 2026
scheduling

On July 24, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder in adults and pediatric patients aged 6 years and older, weighing at least 20 kg. …

Federal Register document 2026-22208

View on Federal Register
Published October 29, 2026
DEA
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc.
Notice · Comments due Dec 28, 2026
scheduling

Sigma Aldrich Research Biochemicals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-22048

View on Federal Register
Published October 19, 2026
DEA
Routine DEA registration application notices · 10
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Organic Standards Solutions International, LLC
Notice · Comments due Nov 18, 2026
scheduling

Organic Standards Solutions International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-21370

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals, Inc.
Notice · Comments due Dec 18, 2026
scheduling

Janssen Pharmaceuticals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-21369

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Groff Health Inc
Notice · Comments due Dec 18, 2026
scheduling

Groff Health Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-21368

View on Federal Register
DEA
Importer of Controlled Substances Application: Groff NA Hemplex LLC
Notice · Comments due Nov 18, 2026
scheduling

Groff NA Hemplex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-21367

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
Notice · Comments due Dec 18, 2026
scheduling

Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-21360

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: National Center for Natural Products Research University of Mississippi/NCNPR
Notice · Comments due Dec 18, 2026
scheduling

National Center for Natural Products Research University of Mississippi/NCNPR has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-21359

View on Federal Register
DEA
Importer of Controlled Substances Application: National Center for Natural Products Research
Notice · Comments due Nov 18, 2026
scheduling

National Center for Natural Products Research has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-21358

View on Federal Register
DEA
Importer of Controlled Substances Application: Groff Health Inc.
Notice · Comments due Nov 18, 2026
scheduling

Groff Health Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-21355

View on Federal Register
DEA
Importer of Controlled Substances Application: DMS Pharmaceutical Group
Notice · Comments due Nov 18, 2026
scheduling

DMS Pharmaceutical Group has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-21354

View on Federal Register
DEA
Importer of Controlled Substances Application: Halo Pharmaceutical Inc.
Notice · Comments due Nov 18, 2026
scheduling

Halo Pharmaceutical Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-21353

View on Federal Register
Published October 14, 2026
DEA
Schedules of Controlled Substances: Temporary Placement of 7- Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I
Notice of intent
scheduling

The Administrator of the Drug Enforcement Administration (DEA) is issuing this notice of intent to publish a temporary order to schedule 7-hydroxymitragynine and mitragynine pseudoindoxyl (including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers…

Federal Register document 2026-20943

View on Federal Register
DEA
Schedules of Controlled Substances: Temporary Placement of MGM-15 and MGM-16 in Schedule I
Notice of intent
scheduling

The Drug Enforcement Administration (DEA) is issuing this notice of intent to publish a temporary order to schedule two 7- hydroxymitragynine-related substances (MGM-15 and MGM-16), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers…

Federal Register document 2026-20942

View on Federal Register
Published October 9, 2026
DEA
Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products
Final determination · Effective Nov 9, 2026
scheduling

The Drug Enforcement Administration (DEA) is revoking the exempted status for certain nonnarcotic prescription products that are currently on DEA's Table of Exempted Prescription Products, but whose National Drug Codes (NDC) are inactive because they are no longer available…

Federal Register document 2026-20757

View on Federal Register
DEA
Schedules of Controlled Substances: Placement of O-Desmethyltramadol in Schedule I; Correction
Correction · Correction effective Oct 9, 2026
scheduling

On August 12, 2026, the Drug Enforcement Administration (DEA) published a temporary order placing O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its salts, isomers, and salts of isomers…

Federal Register document 2026-20748

View on Federal Register
Published October 6, 2026
FDA
Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for Information
Notice · Comments due Nov 20, 2026
psychedelics

The Food and Drug Administration (FDA or the Agency) is describing the approaches it is considering for the design of early- phase clinical trials of ibogaine drug products and is opening a public docket to receive comments. The Department of Health and Human Services (HHS) is…

Federal Register document 2026-20427

View on Federal Register
Published October 1, 2026
DEA
Extension of Reexportation Period.
Proposed rule · Comments due Nov 30, 2026
scheduling

This proposed rule would amend the regulations of the Drug Enforcement Administration (DEA) to extend the time allowed for reexports of controlled substances outside of the European Economic Area from 180 days from the date of original release from U.S. Customs and Border…

Federal Register document 2026-20084

View on Federal Register
Published September 28, 2026
DEA
Routine DEA registration application notices · 3
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Irvine Labs, Inc.
Notice · Comments due Nov 27, 2026
scheduling

Irvine Labs, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-19803

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Cargill, Incorporated
Notice · Comments due Nov 27, 2026
scheduling

Cargill, Incorporated has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-19795

View on Federal Register
DEA
Importer of Controlled Substances Application: Benuvia Operations, LLC
Notice · Comments due Oct 28, 2026
scheduling

Benuvia Operations, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-19792

View on Federal Register
Published September 24, 2026
DEA
Routine DEA registration application notices · 5
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company
Notice · Comments due Nov 23, 2026
scheduling

Cayman Chemical Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-19542

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories
Notice · Comments due Nov 23, 2026
scheduling

Eli-Elsohly Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-19541

View on Federal Register
DEA
Importer of Controlled Substances Application: Fisher Clinical Services, Inc. (I)
Notice · Comments due Oct 26, 2026
scheduling

Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-19540

View on Federal Register
DEA
Importer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.
Notice · Comments due Oct 26, 2026
scheduling

Cambridge Isotope Laboratories, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-19539

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.
Notice · Comments due Dec 23, 2026
scheduling

Cambridge Isotope Laboratories, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-19538

View on Federal Register
Published September 23, 2026
DEA
Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I
Proposed rule · Comments due Oct 23, 2026
scheduling

The Drug Enforcement Administration proposes placing five tryptamine hallucinogens, 4-hydroxy-N,N-diisopropyltryptamine (other names: 4-OH-DiPT; 3-(2-(diisopropylamino)ethyl)-1H-indol-4- ol), 5-methoxy-alpha-methyltryptamine (other names: 5-MeO-AMT; 1-(5…

Federal Register document 2026-19400

View on Federal Register
Published September 21, 2026
DEA
Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
Final rule · Effective Oct 21, 2026
scheduling

With the issuance of this final rule, the Drug Enforcement Administration places the substance diphenidine (1-(1,2- diphenylethyl)piperidine), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in…

Federal Register document 2026-19231

View on Federal Register
Published September 14, 2026
DEA
Routine DEA registration application notices · 2
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Irvine Labs, Inc.
Notice · Comments due Oct 14, 2026
scheduling

Irvine Labs, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-18757

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.
Notice · Comments due Nov 13, 2026
scheduling

Cambrex High Point, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-18753

View on Federal Register
Published September 8, 2026
DEA
Routine DEA registration application notices · 5
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Irvine Labs, Inc.
Notice · Comments due Nov 9, 2026
scheduling

Irvine Labs, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-18204

View on Federal Register
DEA
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Notice · Comments due Oct 8, 2026
scheduling

Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-18203

View on Federal Register
DEA
Importer of Controlled Substances Application: Cambrex High Point, Inc.
Notice · Comments due Oct 8, 2026
scheduling

Cambrex High Point, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-18202

View on Federal Register
DEA
Importer of Controlled Substances Application: Fresenius Kabi USA, LLC
Notice · Comments due Oct 8, 2026
scheduling

Fresenius Kabi USA, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-18201

View on Federal Register
DEA
Importer of Controlled Substances Application: AndersonBrecon, Inc DBA PCI Pharma Services
Notice · Comments due Oct 8, 2026
scheduling

AndersonBrecon, Inc DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-18199

View on Federal Register
Published August 27, 2026
DEA
Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV
Interim final rule · Effective Aug 27, 2026 · Comments due Sep 28, 2026
scheduling

On May 29, 2026, the United States Food and Drug Administration (FDA) approved a new drug application for Cypsedo (cipepofol) for induction of general anesthesia in adults undergoing surgery. The Department of Health and Human Services provided the Drug Enforcement…

Federal Register document 2026-17536

View on Federal Register
DEA
Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
Temporary scheduling order · Effective Aug 27, 2026
scheduling

The Drug Enforcement Administration (DEA) issues this temporary order to schedule 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4- yl)-5,6-dichloro-1,3-dihydro-2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro brorphine or SR-14968); 5,6-dichloro-1-(1-(4…

Federal Register document 2026-17531

View on Federal Register
Published August 26, 2026
DEA
Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
Temporary scheduling order · Effective Aug 26, 2026
scheduling

The Drug Enforcement Administration (DEA) is issuing this temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16), including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers…

Federal Register document 2026-17429

View on Federal Register
DEA
Routine DEA registration application notices · 5
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Curia New York Inc.
Notice · Comments due Sep 25, 2026
scheduling

Curia New York Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-17388

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City
Notice · Comments due Oct 26, 2026
scheduling

Cambrex Charles City has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-17387

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
Notice · Comments due Oct 26, 2026
scheduling

Chemtos, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-17386

View on Federal Register
DEA
Importer of Controlled Substances Application: Experic LLC
Notice · Comments due Sep 25, 2026
scheduling

Experic LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-17385

View on Federal Register
DEA
Importer of Controlled Substances Application: Cambrex Charles City
Notice · Comments due Sep 25, 2026
scheduling

Cambrex Charles City has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-17383

View on Federal Register
FDA
International Drug Scheduling; Single Convention on Narcotic Drugs; Convention on Psychotropic Substances; Clobromazolam (Phenazolam); Cychlorphine (N-Propionitrile Chlorphine); Desalkylgidazepam (Bromonordiazepam); Ethylbromazolam; Etomethazene (5-Methyl Etodesnitazene); Spirochlorphine (R6980); Etomidate; Medetomidine; Request for Comments
Notice · Comments due Sep 3, 2026
scheduling

The Food and Drug Administration (FDA or Agency) is providing interested persons with the opportunity to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of eight drug…

Federal Register document 2026-17380

View on Federal Register
Published August 25, 2026
DEA
Routine DEA registration application notices · 11
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC
Notice · Comments due Oct 26, 2026
scheduling

Kinetochem LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-17288

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals
Notice · Comments due Oct 26, 2026
scheduling

Chattem Chemicals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-17287

View on Federal Register
DEA
Importer of Controlled Substances Application: Chattem Chemicals
Notice · Comments due Sep 24, 2026
scheduling

Chattem Chemicals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-17286

View on Federal Register
DEA
Importer of Controlled Substances Application: Prof Compounding CTS of Ameri
Notice · Comments due Sep 24, 2026
scheduling

Prof Compounding CTS of Ameri has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-17285

View on Federal Register
DEA
Importer of Controlled Substances Application: Galephar Pharmaceutical Research Inc.
Notice · Comments due Sep 24, 2026
scheduling

Galephar Pharmaceutical Research Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-17284

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute SRI Montana Satellite Laboratory
Notice · Comments due Oct 26, 2026
scheduling

Scottsdale Research Institute SRI Montana Satellite Laboratory has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-17282

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Curia Missouri Inc.
Notice · Comments due Oct 26, 2026
scheduling

Curia Missouri Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-17280

View on Federal Register
DEA
Importer of Controlled Substances Application: Vici Health Sciences, LLC
Notice · Comments due Sep 24, 2026
scheduling

Vici Health Sciences, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-17277

View on Federal Register
DEA
Importer of Controlled Substances Application: Biopharmaceutical Research Company
Notice · Comments due Sep 24, 2026
scheduling

Biopharmaceutical Research Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-17276

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Curia New York Inc
Notice · Comments due Oct 26, 2026
scheduling

Curia New York Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-17274

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Biopharmaceutical Research Company
Notice · Comments due Oct 26, 2026
scheduling

Biopharmaceutical Research Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-17273

View on Federal Register
Published August 14, 2026
DEA
Exempt Chemical Preparations Under the Controlled Substances Act
Notice · Comments due Oct 13, 2026
scheduling

The applications for exempt chemical preparations received by the Drug Enforcement Administration between March 1, 2026, and June 30, 2026, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations through…

Federal Register document 2026-16665

View on Federal Register
Published August 12, 2026
DEA
Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
Temporary scheduling order · Effective Aug 12, 2026
scheduling

The Drug Enforcement Administration issues this temporary order to schedule O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its isomers, esters, ethers, salts, and salts of isomers, esters and…

Federal Register document 2026-16413

View on Federal Register
Published August 11, 2026
DEA
Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V
Proposed rule · Comments due Sep 10, 2026
scheduling

The Drug Enforcement Administration proposes to transfer suvorexant ([(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4- diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone), lemborexant ((1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)…

Federal Register document 2026-16375

View on Federal Register
Published August 3, 2026
DEA
Amendment to 3,4-MDP-2-P Methyl Glycidic Acid, a List I Chemical
Proposed rule · Comments due Sep 2, 2026
scheduling

The Drug Enforcement Administration is proposing to modify the listing of the list I chemical 3,4-MDP-2-P methyl glycidic acid (also known as PMK glycidic acid) to include esters of 3,4-MDP-2-P methyl glycidic acid, not listed elsewhere in the Controlled Substances Act (CSA)…

Federal Register document 2026-15624

View on Federal Register
Published July 23, 2026
DEA
Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem
Notice · Comments due Sep 21, 2026
scheduling

American Radiolabeled Chem has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-14915

View on Federal Register
Published July 22, 2026
DEA
Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation
Notice · Comments due Sep 21, 2026
scheduling

Cerilliant Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to supplementary information listed below for further drug information.

Federal Register document 2026-14704

View on Federal Register
Published July 16, 2026
DEA
Routine DEA registration application notices · 4
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Catalent Greenville, Inc.
Notice · Comments due Aug 17, 2026
scheduling

Catalent Greenville, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-14286

View on Federal Register
DEA
Importer of Controlled Substances Application: Unither Manufacturing LLC
Notice · Comments due Aug 17, 2026
scheduling

Unither Manufacturing LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-14285

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: AMPAC Fine Chemicals LLC
Notice · Comments due Sep 14, 2026
scheduling

AMPAC Fine Chemicals LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-14284

View on Federal Register
DEA
Importer of Controlled Substances Application: Catalent CTS, LLC
Notice · Comments due Aug 17, 2026
scheduling

Catalent CTS, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-14280

View on Federal Register
Published July 14, 2026
FDA
Psychedelic Drugs: Considerations for Clinical Investigations; Guidance for Industry; Availability
Notice
psychedelics

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry titled "Psychedelic Drugs: Considerations for Clinical Investigations." Because interest in the therapeutic potential of psychedelic drugs has been increasing and…

Federal Register document 2026-14158

View on Federal Register
FDA
Considerations for Potential Future Therapeutic Use of Psychedelic Drugs; Public Hearing; Request for Comments
Notice
psychedelics

The Food and Drug Administration (FDA, the Agency, or we) is announcing a public hearing on the potential future therapeutic use of psychedelic drugs. In collaboration with federal partners, FDA is holding this public hearing to obtain feedback and perspectives on issues…

Federal Register document 2026-14155

View on Federal Register
Published July 9, 2026
DEA
Designation of Phenethyl Halides as List I Chemicals
Proposed rule · Comments due Aug 10, 2026
scheduling

The Drug Enforcement Administration is proposing the control of phenethyl halides as list I chemicals under the Controlled Substances Act (CSA). Phenethyl halides are important to the illicit manufacture of fentanyl, as well as fentanyl analogues, and fentanyl- related…

Federal Register document 2026-13825

View on Federal Register
Published July 8, 2026
DEA
Schedules of Controlled Substances: Placement of Tianeptine in Schedule I
Proposed rule · Comments due Aug 7, 2026
scheduling

The Drug Enforcement Administration proposes placing the substance tianeptine (7-[(3-chloro-6,11-dihydro-6-methyl-5,5- dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever…

Federal Register document 2026-13821

View on Federal Register
Published July 7, 2026
DEA
Importer of Controlled Substances Application: Benuvia Operations, LLC.
Notice · Comments due Aug 6, 2026
scheduling

Benuvia Operations, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-13705

View on Federal Register
Published July 6, 2026
DEA
Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I
Notice of intent
scheduling

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule three 7-hydroxymitragynine-related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16), including their isomers, esters, ethers, salts, and…

Federal Register document 2026-13581

View on Federal Register
DEA
Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I
Notice of intent
scheduling

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 7-hydroxymitragynine above a specified threshold, including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever…

Federal Register document 2026-13580

View on Federal Register
Published July 1, 2026
DEA
Schedules of Controlled Substances: Temporary Placement of 5,6- Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
Notice of intent
scheduling

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1,3-dihydro- 2H-benzo[d]imidazol-2-one (commonly known as 5,6-dichloro brorphine or…

Federal Register document 2026-13364

View on Federal Register
Published June 30, 2026
DEA
Routine DEA registration application notices · 5
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: United States Pharmacopeial Convention
Notice · Comments due Jul 30, 2026
scheduling

United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-13164

View on Federal Register
DEA
Importer of Controlled Substances Application: Veterans Pharmaceuticals, Inc.
Notice · Comments due Jul 30, 2026
scheduling

Veterans Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-13148

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Aug 31, 2026
scheduling

Veranova, L.P. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-13147

View on Federal Register
DEA
Importer of Controlled Substances Application: Almac Clinical Services Incorp. (ACSI)
Notice · Comments due Jul 30, 2026
scheduling

Almac Clinical Services Incorp. (ACSI) has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-13145

View on Federal Register
DEA
Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Notice · Comments due Jul 30, 2026
scheduling

Catalent Pharma Solutions, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-13144

View on Federal Register
FDA
Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of Oxygenation
Final order · Effective Jun 30, 2026

The Food and Drug Administration (FDA) is classifying the monitor for opioid induced impairment of oxygenation into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for…

Federal Register document 2026-13140

View on Federal Register
Published June 24, 2026
DEA
Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I
Notice of intent
scheduling

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2- [(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol), including its isomers…

Federal Register document 2026-12654

View on Federal Register
DEA
Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction
Correction · Correction effective Jun 24, 2026
scheduling

On March 16, 2026, the Drug Enforcement Administration published a temporary order placing 8-bromo-1-methyl-6-phenyl-4H- benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of…

Federal Register document 2026-12653

View on Federal Register
Published June 17, 2026
DEA
Routine DEA registration application notices · 7
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Wedgewood Pharmacy LLC
Notice · Comments due Jul 17, 2026
scheduling

Wedgewood Pharmacy LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-12144

View on Federal Register
DEA
Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
Notice · Comments due Jul 17, 2026
scheduling

AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-12143

View on Federal Register
DEA
Importer of Controlled Substances Application: Aphena Pharma Solutions MD, LLC
Notice · Comments due Jul 17, 2026
scheduling

Aphena Pharma Solutions MD, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-12142

View on Federal Register
DEA
Importer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Jul 17, 2026
scheduling

Veranova, L.P. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-12141

View on Federal Register
DEA
Importer of Controlled Substances Application: Scottsdale Research Institute
Notice · Comments due Jul 17, 2026
scheduling

Scottsdale Research Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-12140

View on Federal Register
DEA
Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
Notice · Comments due Jul 17, 2026
scheduling

AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-12138

View on Federal Register
DEA
Importer of Controlled Substances Application: Arizona Department of Corrections
Notice · Comments due Jul 17, 2026
scheduling

Arizona Department of Corrections has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-12137

View on Federal Register
Published June 15, 2026
DEA
Routine DEA registration application notices · 3
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: VHG Labs DBA LGC Standards
Notice · Comments due Jul 15, 2026
scheduling

VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-11911

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Aug 14, 2026
scheduling

Veranova, L.P., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-11910

View on Federal Register
DEA
Importer of Controlled Substances Application: Cerilliant Corporation
Notice · Comments due Jul 15, 2026
scheduling

Cerilliant Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-11909

View on Federal Register
Published June 9, 2026
DEA
Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Final rule · Effective Jul 9, 2026
scheduling

The "Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 (the SUPPORT Act)," which became law on October 24, 2018, amended the Controlled Substances Act to expand the conditions a practitioner must meet to…

Federal Register document 2026-11526

View on Federal Register
Published June 8, 2026
DEA
Importer of Controlled Substances Application: CalCog Inc.
Notice · Comments due Jul 8, 2026
scheduling

CalCog Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-11416

View on Federal Register
Published May 26, 2026
DEA
Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
Proposed rule · Comments due Jun 25, 2026
scheduling

The Drug Enforcement Administration proposes placing diphenidine (1-(1,2-diphenylethyl)piperidine), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act.

Federal Register document 2026-10380

View on Federal Register
DEA
Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products
Proposed rule · Comments due Jun 25, 2026
scheduling

The Drug Enforcement Administration (DEA) proposes to revoke the exempted status for certain nonnarcotic prescription products that are currently on DEA's Table of Exempted Prescription Products list but whose National Drug Code (NDC) is inactive because they are no longer…

Federal Register document 2026-10379

View on Federal Register
Published May 22, 2026
DEA
Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
Temporary scheduling order · Effective May 22, 2026
pharma · scheduling

The Drug Enforcement Administration (DEA) issues this temporary order to schedule 2-(2-fluorophenyl)-2- (methylamino)cyclohexan-1-one (commonly known as 2- fluorodeschloroketamine or 2-FDCK), including its salts, isomers, and salts of isomers whenever the existence of such…

Federal Register document 2026-10253

View on Federal Register
Published May 20, 2026
DEA
Revision of Applications for Manufacturing and Procurement Quotas
Proposed rule · Comments due Jul 20, 2026
scheduling

The Drug Enforcement Administration (DEA) proposes to revise existing regulations relating to the management of quotas for schedule I and II controlled substances and the list I chemicals, ephedrine, pseudoephedrine, and phenylpropanolamine, to be utilized by DEA- registered…

Federal Register document 2026-10128

View on Federal Register
DEA
Exempt Chemical Preparations Under the Controlled Substances Act
Notice · Comments due Jul 20, 2026
scheduling

The applications for exempt chemical preparations received by the Drug Enforcement Administration between July 1, 2025, and March 31, 2026, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations through…

Federal Register document 2026-10090

View on Federal Register
DEA
Routine DEA registration application notices · 2
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Amneal Pharmaceuticals, LLC
Notice · Comments due Jun 22, 2026
scheduling

Amneal Pharmaceuticals, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-10089

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Organix Chemistry Solutions LLC
Notice · Comments due Jul 20, 2026
scheduling

Organix Chemistry Solutions, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-10087

View on Federal Register
Published May 18, 2026
DEA
Bulk Manufacturer of Controlled Substances Application: Benuvia Operations, LLC
Notice · Comments due Jul 17, 2026
scheduling

Benuvia Operations, LLC. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-09930

View on Federal Register
Published May 13, 2026
DEA
Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
Final rule · Effective May 13, 2026
scheduling

With the issuance of this final rule, the Drug Enforcement Administration places 5-pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3- b]indol-1-one (other names: CUMYL-PEGACLONE; SGT-151), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers…

Federal Register document 2026-09566

View on Federal Register
Published May 4, 2026
DEA
Specific Listing for Hexahydrocannabinol, A Currently Controlled Schedule I Substance
Final rule · Effective May 4, 2026
scheduling

The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Controlled Substances Code Number (drug code) for 6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H- benzo[c]chromen-1-ol (also known as hexahydrocannabinol, and HHC) in schedule I of the…

Federal Register document 2026-08595

View on Federal Register
DEA
Routine DEA registration application notices · 4
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.
Notice · Comments due Jul 6, 2026
scheduling

Patheon API Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-08588

View on Federal Register
DEA
Importer of Controlled Substances Application: ANI Pharmaceuticals Inc.
Notice · Comments due Jun 3, 2026
scheduling

ANI Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-08587

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: ANI Pharmaceuticals Inc.
Notice · Comments due Jul 6, 2026
scheduling

ANI Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-08586

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals Inc.
Notice · Comments due Jul 6, 2026
scheduling

Patheon Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-08585

View on Federal Register
Published May 1, 2026
DEA
Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
Final rule · Effective May 1, 2026
scheduling

With the issuance of this final rule, the Drug Enforcement Administration places methyl 2-[[1-(4-fluorobutyl)indole-3- carbonyl]amino]-3,3-dimethyl-butanoate (other names: 4F-MDMB-BUTICA; 4F-MDMB-BICA), N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1…

Federal Register document 2026-08517

View on Federal Register
Published April 28, 2026
DEA
Schedules of Controlled Substances: Rescheduling of Marijuana; Withdrawal
Proposed rule
cannabis · scheduling

The Department of Justice published a notice of proposed rulemaking in the Federal Register on May 21, 2024, which proposed to transfer marijuana from schedule I of the Controlled Substances Act to schedule III. The Drug Enforcement Administration ("DEA") published a notice of…

Federal Register document 2026-08178

View on Federal Register
DEA
Schedules of Controlled Substances: Rescheduling of Marijuana
Proposed rule
cannabis · scheduling

This is notice that the Drug Enforcement Administration ("DEA") will hold a hearing with respect to the proposed rescheduling of marijuana into schedule III of the Controlled Substances Act beginning June 29, 2026. The proposed rescheduling of marijuana was initially proposed…

Federal Register document 2026-08177

View on Federal Register
DEA
Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements
Final rule · Effective Apr 28, 2026
cannabis · scheduling

With the issuance of this final rule, which constitutes a final order, the Acting Attorney General of the U.S. Department of Justice places drug products containing marijuana that have been approved by the Food and Drug Administration (FDA) in schedule III of the Controlled…

Federal Register document 2026-08176

View on Federal Register
Published April 24, 2026
DEA
Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
Final rule · Effective Apr 27, 2026
scheduling

With the issuance of this final rule, the Drug Enforcement Administration places methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H- indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA), including its salts, isomers, and salts of isomers whenever the existence of such…

Federal Register document 2026-08104

View on Federal Register
Published April 21, 2026
DEA
Routine DEA registration application notices · 3
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: AJNA Biosciences
Notice · Comments due Jun 22, 2026
scheduling

AJNA Biosciences has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-07698

View on Federal Register
DEA
Importer of Controlled Substances Application: VA Cooperative Studies Program
Notice · Comments due May 21, 2026
scheduling

VA Cooperative Studies Program has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-07697

View on Federal Register
DEA
Importer of Controlled Substances Application: Leading Pharma LLC
Notice · Comments due May 21, 2026
scheduling

Leading Pharma LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-07696

View on Federal Register
Published April 17, 2026
DEA
Routine DEA registration application notices · 4
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Usona Institute, Inc.
Notice · Comments due Jun 16, 2026
scheduling

Usona Institute, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-07562

View on Federal Register
DEA
Importer of Controlled Substances Application: Royal Emerald Pharmaceuticals
Notice · Comments due May 18, 2026
scheduling

Royal Emerald Pharmaceuticals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-07561

View on Federal Register
DEA
Importer of Controlled Substances Application: Quagen Pharmaceuticals LLC
Notice · Comments due May 18, 2026
scheduling

Quagen Pharmaceuticals LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-07559

View on Federal Register
DEA
Importer of Controlled Substances Application: LTS Therapy Systems, LLC
Notice · Comments due May 18, 2026
scheduling

LTS Therapy Systems, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-07558

View on Federal Register
Published April 3, 2026
DEA
Routine DEA registration application notices · 4
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Purisys, LLC
Notice · Comments due Jun 2, 2026
scheduling

Purisys, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-06524

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute
Notice · Comments due Jun 2, 2026
scheduling

Research Triangle Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-06522

View on Federal Register
DEA
Importer of Controlled Substances Application: Lipomed/LGC Standards
Notice · Comments due May 4, 2026
scheduling

Lipomed/LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-06521

View on Federal Register
DEA
Importer of Controlled Substances Application: Blue Rabbit Veterinary LLC
Notice · Comments due May 4, 2026
scheduling

Blue Rabbit Veterinary LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-06520

View on Federal Register
DEA
Designation of P2P Methyl Glycidic Acid as a List I Chemical
Final rule · Effective May 4, 2026
scheduling

The Drug Enforcement Administration is finalizing the control of 2-methyl-3-phenyloxirane-2-carboxylic acid (also known as P2P methyl glycidic acid and BMK glycidic acid) and its esters, its optical and geometric isomers, its salts, salts of its optical and geometric isomers…

Federal Register document 2026-06523

View on Federal Register
Published April 1, 2026
DEA
Routine DEA registration application notices · 7
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Research Triangle Institute
Notice · Comments due May 1, 2026
scheduling

Research Triangle Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-06311

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC
Notice · Comments due Jun 1, 2026
scheduling

Pharmaron Manufacturing Services (US) LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-06261

View on Federal Register
DEA
Importer of Controlled Substances Application: Sterling Wisconsin, LLC
Notice · Comments due May 1, 2026
scheduling

Sterling Wisconsin, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-06260

View on Federal Register
DEA
Importer of Controlled Substances Application: Indivior Manufacturing LLC
Notice · Comments due May 1, 2026
scheduling

Indivior Manufacturing LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-06259

View on Federal Register
DEA
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Notice · Comments due May 1, 2026
scheduling

Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-06258

View on Federal Register
DEA
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Notice · Comments due May 1, 2026
scheduling

Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-06257

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Royal Emerald Pharmaceuticals
Notice · Comments due Jun 1, 2026
scheduling

Royal Emerald Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-06256

View on Federal Register
Published March 30, 2026
DEA
Routine DEA registration application notices · 3
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC
Notice · Comments due Apr 29, 2026
scheduling

Pharmaron Manufacturing Services (US) LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-06053

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
Notice · Comments due May 29, 2026
scheduling

Chemtos, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-06052

View on Federal Register
DEA
Importer of Controlled Substances Application: Usona Institute
Notice · Comments due Apr 29, 2026
scheduling

Usona Institute. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-06051

View on Federal Register
Published March 26, 2026
DEA
Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
Notice · Comments due May 26, 2026
scheduling

SpecGx LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-05912

View on Federal Register
Published March 23, 2026
DEA
Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
Final rule · Effective Apr 22, 2026
scheduling

With the issuance of this final rule, the Drug Enforcement Administration places substance 3-methoxyphencyclidine (1-(1-(3- methoxyphenyl)cyclohexyl)piperidine; 3-MeO-PCP), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This…

Federal Register document 2026-05618

View on Federal Register
Published March 20, 2026
DEA
Exempt Chemical Preparations Under the Controlled Substances Act
Notice · Comments due May 19, 2026
scheduling

The applications for exempt chemical preparations received by the Drug Enforcement Administration between September 1, 2024, and December 31, 2025, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations…

Federal Register document 2026-05486

View on Federal Register
DEA
Ordering Schedule I and II Controlled Substances Using DEA Form 222; Technical Amendments
Final rule · Effective Mar 20, 2026
scheduling

On September 30, 2019, the Drug Enforcement Administration (DEA) published the final rule, New Single-Sheet Format for U.S. Official Order Form for Schedule I and II Controlled Substances (DEA Form 222). The final rule implemented a new single sheet format for DEA Form 222 and…

Federal Register document 2026-05482

View on Federal Register
Published March 19, 2026
DEA
Routine DEA registration application notices · 7
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Pisgah Laboratories Inc
Notice · Comments due Apr 20, 2026
scheduling

Pisgah Laboratories Inc has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-05360

View on Federal Register
DEA
Importer of Controlled Substances Application: United States Pharmacopeial Convention
Notice · Comments due Apr 20, 2026
scheduling

United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-05359

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Siegfried Grafton, Inc.
Notice · Comments due May 18, 2026
scheduling

Siegfried Grafton, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-05358

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Sterling Wisconsin, LLC
Notice · Comments due May 18, 2026
scheduling

Sterling Wisconsin, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-05357

View on Federal Register
DEA
Importer of Controlled Substances Application: Siegfried Grafton, Inc.
Notice · Comments due Apr 20, 2026
scheduling

Siegfried Grafton, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-05356

View on Federal Register
DEA
Importer of Controlled Substances Application: Patheon API Services, Inc.
Notice · Comments due Apr 20, 2026
scheduling

Patheon API Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-05355

View on Federal Register
DEA
Importer of Controlled Substances Application: SpecGx LLC
Notice · Comments due Apr 20, 2026
scheduling

SpecGx LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-05353

View on Federal Register
Published March 16, 2026
DEA
Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I
Temporary scheduling order · Effective Mar 16, 2026
scheduling

The Drug Enforcement Administration issues this temporary order to schedule 8-bromo-1-methyl-6-phenyl-4H- benzo[f][1,2,4]triazolo[4,3-a][l, 4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of such salts…

Federal Register document 2026-05064

View on Federal Register
Published March 13, 2026
DEA
Routine DEA registration application notices · 5
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Patheon API Services Inc
Notice · Comments due May 12, 2026
scheduling

Patheon API Services Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-04973

View on Federal Register
DEA
Importer of Controlled Substances Application: Lonza Tampa, LLC
Notice · Comments due Apr 13, 2026
scheduling

Lonza Tampa, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-04972

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Pisgah Laboratories Inc
Notice · Comments due May 12, 2026
scheduling

Pisgah Laboratories Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-04971

View on Federal Register
DEA
Importer of Controlled Substances Application: Purisys, LLC
Notice · Comments due Apr 13, 2026
scheduling

Purisys, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-04970

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Stepan Company
Notice · Comments due May 12, 2026
scheduling

Stepan Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-04969

View on Federal Register
Published March 10, 2026
DEA
Designation of Propionyl Chloride as a List I Chemical
Final rule · Effective Apr 9, 2026
scheduling

The Drug Enforcement Administration is finalizing the control of propionyl chloride as a list I chemical under the Controlled Substances Act (CSA). Propionyl chloride is used in the illicit manufacture of the controlled substances fentanyl, fentanyl analogues, and…

Federal Register document 2026-04657

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals Inc.
Notice · Comments due May 11, 2026
scheduling

Sigma Aldrich Research Biochemicals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-04655

View on Federal Register
Published March 6, 2026
FDA
Developing Specifications for In-Home Disposal Systems for Opioid Analgesics Dispensed in an Outpatient Setting; Establishment of a Public Docket; Request for Comments
Notice · Comments due Apr 6, 2026

The Food and Drug Administration (FDA, the Agency, or we) is announcing the establishment of a docket to solicit public comment on what specifications for in-home disposal systems, if application holders are required to make them available under the Opioid Analgesic Risk…

Federal Register document 2026-04479

View on Federal Register
Published March 4, 2026
DEA
Routine DEA registration application notices · 8
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Parexel International, LLC
Notice · Comments due Apr 3, 2026
scheduling

Parexel International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-04308

View on Federal Register
DEA
Importer of Controlled Substances Application: Maridose LLC
Notice · Comments due Apr 3, 2026
scheduling

Maridose LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-04307

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Restek Corporation
Notice · Comments due May 4, 2026
scheduling

Restek Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-04306

View on Federal Register
DEA
Importer of Controlled Substances Application: Patheon API Inc.
Notice · Comments due Apr 3, 2026
scheduling

Patheon API Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-04305

View on Federal Register
DEA
Importer of Controlled Substances Application: Stepan Company
Notice · Comments due Apr 3, 2026
scheduling

Stepan Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-04303

View on Federal Register
DEA
Importer of Controlled Substances Application: Restek Corporation
Notice · Comments due Apr 3, 2026
scheduling

Restek Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-04299

View on Federal Register
DEA
Importer of Controlled Substances Application: Catalent Greenville, Inc.
Notice · Comments due Apr 3, 2026
scheduling

Catalent Greenville, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-04296

View on Federal Register
DEA
Importer of Controlled Substances Application: Amneal Pharmaceuticals, LLC
Notice · Comments due Apr 3, 2026
scheduling

Amneal Pharmaceuticals, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-04289

View on Federal Register
Published March 2, 2026
DEA
Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
Final rule · Effective Apr 1, 2026
scheduling

With the issuance of this final rule, the Drug Enforcement Administration places clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam and their salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible…

Federal Register document 2026-04112

View on Federal Register
Published February 27, 2026
FDA
International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; Scheduling Recommendations; N-Pyrrolidino Isotonitazene; N-Desethyl Etonitazene; Coca Leaf; MDMB-FUBINACA; Request for Comments
Notice · Comments due Mar 5, 2026
scheduling

The Food and Drug Administration (FDA or Agency) is providing interested persons with the opportunity to submit written comments concerning recommendations to impose international manufacturing and distributing restrictions on certain drug substances, under international drug…

Federal Register document 2026-03914

View on Federal Register
Published February 13, 2026
DEA
Routine DEA registration application notices · 4
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: S&B Pharma LLC DBA Norac Pharma
Notice · Comments due Mar 16, 2026
scheduling

S&B Pharma LLC DBA Norac Pharma has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-02914

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics, Inc.
Notice · Comments due Apr 14, 2026
scheduling

Siemens Healthcare Diagnostics, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-02911

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
Notice · Comments due Apr 14, 2026
scheduling

Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-02909

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
Notice · Comments due Apr 14, 2026
scheduling

Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-02908

View on Federal Register
Published February 5, 2026
DEA
Registering Emergency Medical Services Agencies Under the Protecting Patient Access to Emergency Medications Act of 2017
Final rule · Effective Mar 9, 2026
scheduling

The "Protecting Patient Access to Emergency Medications Act of 2017," (the Act) which became law on November 17, 2017, amended the Controlled Substances Act (CSA) to allow for a new registration category for emergency medical services agencies that handle controlled substances. …

Federal Register document 2026-02288

View on Federal Register
Published February 4, 2026
DEA
Routine DEA registration application notices · 2
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: S & B Pharma LLC DBA Norac Pharma
Notice · Comments due Apr 6, 2026
scheduling

S & B Pharma LLC DBA Norac Pharma has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-02232

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Sterling Pharma USA LLC
Notice · Comments due Apr 6, 2026
scheduling

Sterling Pharma USA LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-02230

View on Federal Register
Published February 2, 2026
DEA
Routine DEA registration application notices · 4
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Mylan Inc.
Notice · Comments due Mar 4, 2026
scheduling

Mylan Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-01947

View on Federal Register
DEA
Importer of Controlled Substances Application: Medi-Physics Inc. DBA GE Healthcare
Notice · Comments due Mar 4, 2026
scheduling

Medi-Physics Inc. DBA GE Healthcare has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-01946

View on Federal Register
DEA
Importer of Controlled Substances Application: Sharp Clinical Services, LLC
Notice · Comments due Mar 4, 2026
scheduling

Sharp Clinical Services, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-01944

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Promega Corporation
Notice · Comments due Apr 3, 2026
scheduling

Promega Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-01940

View on Federal Register
Published January 23, 2026
DEA
Routine DEA registration application notices · 2
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Organic Consultants LLC DBA Cascade Chemistry
Notice · Comments due Mar 24, 2026
scheduling

Organic Consultants, LLC DBA Cascade Chemistry has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-01305

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Maridose LLC
Notice · Comments due Mar 24, 2026
scheduling

Maridose LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-01298

View on Federal Register
Published January 22, 2026
DEA
Importer of Controlled Substances Application: Siegfried USA, LLC
Notice · Comments due Feb 23, 2026
scheduling

Siegfried USA, LLC has applied to be registered as an importer of basic class(es) of controlled substances(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2026-01194

View on Federal Register
Published January 21, 2026
DEA
Importer of Controlled Substances Application: Mylan Pharmaceuticals Inc.
Notice · Comments due Feb 20, 2026
scheduling

Mylan Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-01072

View on Federal Register
Published January 20, 2026
DEA
Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
Notice of intent
pharma · scheduling

The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one (commonly known as 2-fluorodeschloroketamine or 2-FDCK), including its salts, isomers, and salts…

Federal Register document 2026-00954

View on Federal Register
DEA
Definition of “Cannabimimetic Agents” and Assignment of an Administration Controlled Substances Code Number for All “Cannabimimetic Agents”
Final rule · Effective Feb 19, 2026
scheduling

The Drug Enforcement Administration is publishing this final rule to amend its regulations related to "cannabimimetic agents" by including the term's definition, identifying 18 additional substances that meet the definition, and consolidating most existing administration…

Federal Register document 2026-00907

View on Federal Register
Published January 16, 2026
DEA
Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC
Notice · Comments due Mar 17, 2026
scheduling

Siegfried USA, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-00833

View on Federal Register
Published January 15, 2026
DEA
Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I
Final rule · Effective Feb 17, 2026
scheduling

With the issuance of this final rule, the Drug Enforcement Administration places 4-fluoroamphetamine (4-FA; 1-(4- fluorophenyl)propan-2-amine; para-fluoroamphetamine), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This…

Federal Register document 2026-00633

View on Federal Register
Published January 12, 2026
DEA
Schedules of Controlled Substances: Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I
Final order · Effective Feb 11, 2026
scheduling

With the issuance of this final order, the Administrator of the Drug Enforcement Administration is permanently placing 2-(4- methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (other names: N-pyrrolidino metonitazene or metonitazepyne) and 5…

Federal Register document 2026-00362

View on Federal Register
Published January 8, 2026
DEA
Routine DEA registration application notices · 4
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Mylan Technologies Inc.
Notice · Comments due Feb 9, 2026
scheduling

Mylan Technologies Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-00130

View on Federal Register
DEA
Importer of Controlled Substances Application: Curium US LLC
Notice · Comments due Feb 9, 2026
scheduling

Curium US LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-00129

View on Federal Register
DEA
Importer of Controlled Substances Application: Janssen Pharmaceuticals Inc.
Notice · Comments due Feb 9, 2026
scheduling

Janssen Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-00128

View on Federal Register
DEA
Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
Notice · Comments due Feb 9, 2026
scheduling

AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2026-00127

View on Federal Register
Published January 5, 2026
DEA
Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2026
Final order · Effective Jan 5, 2026
scheduling

This final order establishes the initial 2026 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.

Federal Register document 2025-24277

View on Federal Register
Published December 23, 2025
DEA
Schedules of Controlled Substances: Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I
Final order · Effective Jan 22, 2026
scheduling

With the issuance of this final order, the Administrator of the Drug Enforcement Administration is permanently placing N-ethyl-2- (2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (other name: N-desethyl isotonitazene) and 2-(4-ethoxybenzyl)-5-nitro…

Federal Register document 2025-23717

View on Federal Register
Published December 22, 2025
DEA
Routine DEA registration application notices · 4
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: IsoSciences, LLC
Notice · Comments due Feb 20, 2026
scheduling

IsoSciences LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-23621

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Navinta LLC
Notice · Comments due Feb 20, 2026
scheduling

Navinta LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-23620

View on Federal Register
DEA
Importer of Controlled Substances Application: Myonex LLC
Notice · Comments due Jan 21, 2026
scheduling

Myonex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-23619

View on Federal Register
DEA
Importer of Controlled Substances Application: National Center for Natural Products Research
Notice · Comments due Jan 21, 2026
scheduling

National Center for Natural Products Research has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-23503

View on Federal Register
Published December 19, 2025
DEA
Routine DEA registration application notices · 4
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Aveva Drug Delivery Systems, Inc.
Notice · Comments due Jan 20, 2026
scheduling

Aveva Drug Delivery Systems, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-23469

View on Federal Register
DEA
Importer of Controlled Substances Application: Bright Green Corporation
Notice · Comments due Jan 20, 2026
scheduling

Bright Green Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-23468

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals, Inc.
Notice · Comments due Feb 17, 2026
scheduling

Janssen Pharmaceuticals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-23467

View on Federal Register
DEA
Importer of Controlled Substances Application: Groff Health Inc.
Notice · Comments due Jan 20, 2026
scheduling

Groff Health Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-23466

View on Federal Register
Published December 16, 2025
DEA
Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I
Proposed rule · Comments due Jan 15, 2026
scheduling

The Drug Enforcement Administration proposes placing methyl 2- [[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethylbutanoate (other names: 4F-MDMB-BUTICA; 4F-MDMB-BICA), N-(1-amino-3,3-dimethyl-1- oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide (other name…

Federal Register document 2025-22963

View on Federal Register
DEA
Schedules of Controlled Substances: Extension of Temporary Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act
Temporary scheduling order · Effective Dec 12, 2025
scheduling

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to extend the temporary schedule I status of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA. The schedule I status of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA…

Federal Register document 2025-22960

View on Federal Register
Published December 15, 2025
DEA
Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I
Notice of intent
scheduling

The Administrator of the Drug Enforcement Administration is issuing this notification of intent to publish a temporary order to schedule 8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][l, 4]diazepine (commonly known as bromazolam), including its salts, isomers, and…

Federal Register document 2025-22763

View on Federal Register
Published December 11, 2025
DEA
Schedules of Controlled Substances: Extension of Temporary Placement of MDMB-4en-PINACA in Schedule I of the Controlled Substances Act
Temporary scheduling order · Effective Dec 12, 2025
scheduling

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to extend the temporary schedule I status of MDMB-4en-PINACA. The schedule I status of MDMB- 4en-PINACA is in effect through December 12, 2025. This temporary order will extend…

Federal Register document 2025-22540

View on Federal Register
DEA
Schedules of Controlled Substances: Extension of Temporary Placement of CUMYL-PEGACLONE in Schedule I of the Controlled Substances Act
Temporary scheduling order · Effective Dec 12, 2025
scheduling

The Administrator of the Drug Enforcement Administration (DEA) is issuing this temporary scheduling order to extend the temporary schedule I status of CUMYL-PEGACLONE. In an order dated December 12, 2023, DEA temporarily placed CUMYL-PEGACLONE in schedule I of the Controlled…

Federal Register document 2025-22496

View on Federal Register
DEA
Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I
Proposed rule · Comments due Jan 12, 2026
scheduling

The Drug Enforcement Administration proposes placing the substance CUMYL-PEGACLONE (SGT-151; 5-pentyl-2-(2-phenylpropan-2- yl)pyrido[4,3-b]indol-1-one), including its salts, isomers (including optical, positional, and geometric isomers), and salts of isomers, in schedule I of…

Federal Register document 2025-22495

View on Federal Register
Published December 3, 2025
DEA
Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC
Notice · Comments due Feb 2, 2026
scheduling

Kinetochem LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-21790

View on Federal Register
Published December 1, 2025
DEA
Routine DEA registration application notices · 3
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Invizyne Technologies, Inc.
Notice · Comments due Jan 30, 2026
scheduling

Invizyne Technologies, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-21724

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Benuvia Operations, LLC
Notice · Comments due Jan 30, 2026
scheduling

Benuvia Operations, LLC. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-21720

View on Federal Register
DEA
Importer of Controlled Substances Application: Blue Rabbit Veterinary LLC
Notice · Comments due Dec 31, 2025
scheduling

Blue Rabbit Veterinary LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-21719

View on Federal Register
Published November 28, 2025
DEA
Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2026
Notice
scheduling

The Drug Enforcement Administration (DEA) proposes to establish the 2026 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA) and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine…

Federal Register document 2025-21509

View on Federal Register
Published November 26, 2025
DEA
Routine DEA registration application notices · 19
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Noramco
Notice · Comments due Jan 26, 2026
scheduling

Noramco has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-21192

View on Federal Register
DEA
Importer of Controlled Substances Application: Noramco
Notice · Comments due Dec 26, 2025
scheduling

Noramco has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-21191

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: National Center for Natural Products Research
Notice · Comments due Jan 26, 2026
scheduling

National Center for Natural Products Research has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-21190

View on Federal Register
DEA
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Notice · Comments due Dec 26, 2025
scheduling

Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-21189

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Irvine Labs Inc.
Notice · Comments due Jan 26, 2026
scheduling

Irvine Labs Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-21187

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Organix Chemistry Solutions, LLC
Notice · Comments due Jan 26, 2026
scheduling

Organix Chemistry Solutions, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-21186

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Siegfried Grafton, Inc.
Notice · Comments due Jan 26, 2026
scheduling

Siegfried Grafton, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-21185

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories
Notice · Comments due Jan 26, 2026
scheduling

Eli-Elsohly Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-21184

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company
Notice · Comments due Jan 26, 2026
scheduling

Cayman Chemical Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-21183

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Groff NA Hemplex LLC
Notice · Comments due Jan 26, 2026
scheduling

Groff NA Hemplex LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-21182

View on Federal Register
DEA
Importer of Controlled Substances Application: VHG Labs DBA LGC Standards
Notice · Comments due Dec 26, 2025
scheduling

VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-21181

View on Federal Register
DEA
Importer of Controlled Substances Application: NSI Lab Solutions, LLC.
Notice · Comments due Dec 26, 2025
scheduling

NSI Lab Solutions, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-21180

View on Federal Register
DEA
Importer of Controlled Substances Application: Caligor Coghlan Pharma Services
Notice · Comments due Dec 26, 2025
scheduling

Caligor Coghlan Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-21179

View on Federal Register
DEA
Importer of Controlled Substances Application: Siegfried Grafton, Inc.
Notice · Comments due Dec 26, 2025
scheduling

Siegfried Grafton, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-21178

View on Federal Register
DEA
Importer of Controlled Substances Application: Halo Pharmaceutical Inc.
Notice · Comments due Dec 26, 2025
scheduling

Halo Pharmaceutical Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-21177

View on Federal Register
DEA
Importer of Controlled Substances Application: Organic Standards Solutions International, LLC
Notice · Comments due Dec 26, 2025
scheduling

Organic Standards Solutions International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-21176

View on Federal Register
DEA
Importer of Controlled Substances Application: Irvine Labs, Inc.
Notice · Comments due Dec 26, 2025
scheduling

Irvine Labs, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-21175

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Irvine Labs, Inc.
Notice · Comments due Jan 26, 2026
scheduling

Irvine Labs, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-21174

View on Federal Register
DEA
Importer of Controlled Substances Application: Benuvia Operations, LLC
Notice · Comments due Dec 26, 2025
scheduling

Benuvia Operations, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-21173

View on Federal Register
Published November 17, 2025
DEA
Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I
Final rule · Effective Dec 17, 2025
scheduling

With the issuance of this final rule, the Drug Enforcement Administration places 4-chloromethcathinone (4-CMC, 1-(4-chlorophenyl)- 2-(methylamino)propan-1-one), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is…

Federal Register document 2025-20004

View on Federal Register
Published October 15, 2025
DEA
Schedules of Controlled Substances: Temporary Placement of Ethyleneoxynitazene, Methylenedioxynitazene, 5-Methyl Etodesnitazene, N-Desethyl Etonitazene, N-Desethyl Protonitazene, N,N-Dimethylamino Etonitazene, and N-Pyrrolidino Isotonitazene in Schedule I
Temporary scheduling order · Effective Oct 15, 2025
scheduling

The Drug Enforcement Administration issues this temporary order to schedule seven benzimidazole-opioids, as identified in this order, in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing these substances in schedule I is necessary to…

Federal Register document 2025-19542

View on Federal Register
Published October 2, 2025
DEA
Designation of P2P Methyl Glycidic Acid as a List I Chemical
Proposed rule · Comments due Nov 3, 2025
scheduling

The Drug Enforcement Administration is proposing the control of the chemical 2-methyl-3-phenyloxirane-2-carboxylic acid (also known as P2P methyl glycidic acid and BMK glycidic acid) and its esters, its optical and geometric isomers, its salts, salts of its optical and…

Federal Register document 2025-19384

View on Federal Register
DEA
Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical
Final rule · Effective Oct 2, 2025
scheduling

The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Chemical Code Number for tert-butyl 4- oxopiperidine-1-carboxylate (also known as 1-boc-4-piperidone; and CAS Number: 79099-07-3) and its salts as a list I chemical under the Controlled…

Federal Register document 2025-19349

View on Federal Register
DEA
Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
Proposed rule · Comments due Nov 3, 2025
scheduling

The Drug Enforcement Administration proposes placing methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of…

Federal Register document 2025-19348

View on Federal Register
DEA
Adjustment to the Aggregate Production Quota for d-Amphetamine (For Sale) and Methylphenidate (For Sale) for 2025 Pursuant to 21 U.S.C. 826(h)
Final order · Effective Oct 2, 2025
scheduling

The Drug Enforcement Administration (DEA) is adjusting the 2025 aggregate production quota for the schedule II-controlled substances d-amphetamine (for sale) and methylphenidate (for sale). In making this determination, DEA has considered the factors set forth in 21 CFR…

Federal Register document 2025-19335

View on Federal Register
DEA
Controlled Substances Ordering System (CSOS) Modernization
Final rule · Effective Nov 3, 2025
scheduling

This rule is amending the Drug Enforcement Administration's (DEA) regulations to conform to the Controlled Substances Ordering System (CSOS) modernization effort by requiring all CSOS enrollment applications and supporting materials to be submitted through the Diversion Control…

Federal Register document 2025-19325

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Cargill, Incorporated
Notice · Comments due Dec 1, 2025
scheduling

Cargill, Incorporated has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-19317

View on Federal Register
Published September 30, 2025
DEA
Importer of Controlled Substances Application: Groff NA Hemplex LLC
Notice · Comments due Oct 30, 2025
scheduling

Groff NA Hemplex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-18901

View on Federal Register
Published September 22, 2025
DEA
Bulk Manufacturer of Controlled Substances Application: Groff Health Inc
Notice · Comments due Nov 21, 2025
scheduling

Groff Health Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-18244

View on Federal Register
Published September 19, 2025
DEA
Adjustment to the Aggregate Production Quota for Lisdexamfetamine and d-Amphetamine (for Conversion) for 2025 Pursuant to 21 U.S.C. 826(h)
Final order · Effective Sep 19, 2025
scheduling

The Drug Enforcement Administration (DEA) is adjusting the 2025 aggregate production quota for the schedule II controlled substances lisdexamfetamine and d-amphetamine (for conversion). In making this determination, DEA has considered the factors set forth in 21 CFR 1303.13(b)…

Federal Register document 2025-18110

View on Federal Register
Published September 18, 2025
DEA
Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I
Final rule · Effective Sep 18, 2025
scheduling

The Drug Enforcement Administration places seven fentanyl- related substances, as identified in this final rule, including their isomers, esters, ethers, salts and salts of isomers, esters and ethers in schedule I of the Controlled Substances Act. The regulatory controls and…

Federal Register document 2025-18103

View on Federal Register
Published September 16, 2025
DEA
Importer of Controlled Substances Application: Catalent Greenville, Inc.
Notice · Comments due Oct 16, 2025
scheduling

Catalent Greenville, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-17819

View on Federal Register
Published September 12, 2025
FDA
Digital Health Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Generative Artificial Intelligence-Enabled Digital Mental Health Medical Devices
Notice
digital

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Digital Health Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA. The meeting will be open to the…

Federal Register document 2025-17651

View on Federal Register
DEA
Importer of Controlled Substance Application: Fisher Clinical Services, Inc.
Notice · Comments due Oct 14, 2025
scheduling

Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-17650

View on Federal Register
DEA
Routine DEA registration application notices · 4
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Fresenius Kabi USA, LLC
Notice · Comments due Oct 14, 2025
scheduling

Fresenius Kabi USA, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-17583

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.
Notice · Comments due Nov 12, 2025
scheduling

Cambridge Isotope Laboratories, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-17582

View on Federal Register
DEA
Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Notice · Comments due Oct 14, 2025
scheduling

Catalent Pharma Solutions, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-17581

View on Federal Register
DEA
Importer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.
Notice · Comments due Oct 14, 2025
scheduling

Cambridge Isotope Laboratories, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-17580

View on Federal Register
Published September 11, 2025
DEA
Importer of Controlled Substances Application: Biopharmaceutical Research Company
Notice · Comments due Oct 14, 2025
scheduling

Biopharmaceutical Research Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-17503

View on Federal Register
FDA
Development of Non-Opioid Analgesics for Chronic Pain, Draft Guidance for Industry; Availability
Notice · Comments due Nov 10, 2025

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Development of Non-Opioid Analgesics for Chronic Pain." This guidance is intended to assist sponsors in the development of non- opioid analgesics for the…

Federal Register document 2025-17442

View on Federal Register
Published September 8, 2025
DEA
Importer of Controlled Substances Application: VA Cooperative Studies Program
Notice · Comments due Oct 8, 2025
scheduling

VA Cooperative Studies Program has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-17210

View on Federal Register
Published August 21, 2025
DEA
Routine DEA registration application notices · 6
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Continuus Pharmaceuticals
Notice · Comments due Oct 20, 2025
scheduling

Continuus Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-16007

View on Federal Register
DEA
Importer of Controlled Substances Application: Vici Health Sciences, LLC
Notice · Comments due Sep 22, 2025
scheduling

Vici Health Sciences, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-16006

View on Federal Register
DEA
Importer of Controlled Substances Application: Cambrex Charles City
Notice · Comments due Sep 22, 2025
scheduling

Cambrex Charles City has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-16005

View on Federal Register
DEA
Importer of Controlled Substances Application: Catalent CTS, LLC
Notice · Comments due Sep 22, 2025
scheduling

Catalent CTS, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-16004

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.
Notice · Comments due Oct 20, 2025
scheduling

Cambrex High Point, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-16003

View on Federal Register
DEA
Importer of Controlled Substances Application: Cambrex High Point, Inc.
Notice · Comments due Sep 22, 2025
scheduling

Cambrex High Point, Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-16002

View on Federal Register
Published August 15, 2025
DEA
Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I
Temporary scheduling order · Effective Aug 15, 2025
scheduling

The Drug Enforcement Administration issues this temporary order to schedule two benzimidazole-opioids in schedule I of the Controlled Substances Act. DEA bases this action on a finding that placing these substances in schedule I is necessary to avoid imminent hazard to public…

Federal Register document 2025-15566

View on Federal Register
Published August 12, 2025
DEA
Bulk Manufacturer of Controlled Substances Application: Benuvia Operations, LLC
Notice · Comments due Oct 14, 2025
scheduling

Benuvia Operations, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-15279

View on Federal Register
Published August 11, 2025
DEA
Routine DEA registration application notices · 9
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Biopharmaceutical Research Company
Notice · Comments due Oct 10, 2025
scheduling

Biopharmaceutical Research Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-15162

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals
Notice · Comments due Oct 10, 2025
scheduling

Chattem Chemicals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-15161

View on Federal Register
DEA
Importer of Controlled Substances Application: Experic LLC
Notice · Comments due Sep 10, 2025
scheduling

Experic LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-15160

View on Federal Register
DEA
Importer of Controlled Substances Application: Chattem Chemicals
Notice · Comments due Sep 10, 2025
scheduling

Chattem Chemicals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-15159

View on Federal Register
DEA
Importer of Controlled Substances Application: Benuvia Operations, LLC
Notice · Comments due Sep 10, 2025
scheduling

Benuvia Operations, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-15158

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City
Notice · Comments due Oct 10, 2025
scheduling

Cambrex Charles City has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-15157

View on Federal Register
DEA
Importer of Controlled Substances Application: Curia New York Inc
Notice · Comments due Sep 10, 2025
scheduling

Curia New York Inc has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-15156

View on Federal Register
DEA
Importer of Controlled Substances Application: Galephar Pharmaceutical Research Inc
Notice · Comments due Sep 10, 2025
scheduling

Galephar Pharmaceutical Research Inc has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-15155

View on Federal Register
DEA
Importer of Controlled Substances Application: Veterans Pharmaceuticals, Inc.
Notice · Comments due Sep 10, 2025
scheduling

Veterans Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-15153

View on Federal Register
Published August 8, 2025
DEA
Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance
Final rule · Effective Aug 8, 2025
scheduling

The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Controlled Substances Code Number (drug code) for 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (dipentylone; N,N-dimethylpentylone) in schedule I of the Controlled Substances Act (CSA).

Federal Register document 2025-15177

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
Notice · Comments due Oct 7, 2025
scheduling

Chemtos, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-15115

View on Federal Register
Published July 25, 2025
DEA
Schedules of Controlled Substances: Extension of Temporary Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
Temporary scheduling order · Effective Jul 26, 2025
scheduling

The Acting Administrator of the Drug Enforcement Administration (DEA) is issuing this temporary scheduling order to extend the temporary schedule I status of five designer benzodiazepines--clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam. In an order dated…

Federal Register document 2025-14037

View on Federal Register
DEA
Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
Proposed rule · Comments due Aug 25, 2025
scheduling

The Drug Enforcement Administration proposes placing clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam and their salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical…

Federal Register document 2025-14022

View on Federal Register
Published July 17, 2025
DEA
Routine DEA registration application notices · 4
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Cerilliant Corporation
Notice · Comments due Aug 18, 2025
scheduling

Cerilliant Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-13458

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: AMPAC Fine Chemicals LLC
Notice · Comments due Sep 15, 2025
scheduling

AMPAC Fine Chemicals LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-13454

View on Federal Register
DEA
Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
Notice · Comments due Aug 18, 2025
scheduling

AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-13451

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation
Notice · Comments due Sep 15, 2025
scheduling

Cerilliant Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-13446

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Curia New York, Inc.
Notice · Comments due Sep 15, 2025
scheduling

Curia New York, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-13452

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Curia Missouri Inc.
Notice · Comments due Sep 15, 2025
scheduling

Curia Missouri Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-13449

View on Federal Register
Published July 1, 2025
DEA
Exempt Chemical Preparations Under the Controlled Substances Act
Notice · Comments due Sep 2, 2025
scheduling

The applications for exempt chemical preparations received by the Drug Enforcement Administration between March 1, 2023, and March 31, 2025, as listed below, were accepted for filing and have been approved or denied as indicated.

Federal Register document 2025-12198

View on Federal Register
Published June 26, 2025
DEA
Schedules of Controlled Substances: Temporary Placement of Seven Benzimidazole-Opioids in Schedule I
Notice of intent
scheduling

The Acting Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule seven benzimidazole-opioid substances in schedule I of the Controlled Substances Act. When it is finalized, the temporary scheduling order…

Federal Register document 2025-11462

View on Federal Register
Published June 24, 2025
DEA
Importer of Controlled Substances Application: Arizona Department of Corrections
Notice · Comments due Jul 24, 2025
scheduling

Arizona Department of Corrections has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-11553

View on Federal Register
Published June 18, 2025
DEA
Routine DEA registration application notices · 4
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Jul 18, 2025
scheduling

Veranova, L.P. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-11249

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem
Notice · Comments due Aug 18, 2025
scheduling

American Radiolabeled Chem has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-11247

View on Federal Register
DEA
Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
Notice · Comments due Jul 18, 2025
scheduling

AndersonBrecon, Inc. DBA PCI Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-11245

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Aug 18, 2025
scheduling

Veranova, L.P., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-11243

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances AJNA Biosciences
Notice · Comments due Aug 18, 2025
scheduling

AJNA Biosciences has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-11246

View on Federal Register
Published June 10, 2025
DEA
Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl]piperidine) in Schedule I
Proposed rule · Comments due Jul 10, 2025
scheduling

The Drug Enforcement Administration proposes placing 3- methoxyphencyclidine, including its salts, isomers, and salts of isomers, an arylcyclohexylamine hallucinogen, in schedule I of the Controlled Substances Act. This action is proposed to enable the United States to meet its…

Federal Register document 2025-10503

View on Federal Register
DEA
Schedules of Controlled Substances: Placement of Three Specific Fentanyl-Related Substances in Schedule I
Proposed rule · Comments due Jul 10, 2025
scheduling

The Drug Enforcement Administration proposes placing three fentanyl-related substances, as identified in this proposed rule, in schedule I of the Controlled Substances Act. These three substances fall within the definition of fentanyl-related substances set forth in the…

Federal Register document 2025-10372

View on Federal Register
Published June 5, 2025
DEA
Routine DEA registration application notices · 2
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Usona Institute, Inc
Notice · Comments due Aug 4, 2025
scheduling

Usona Institute, Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-10234

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: ANI Pharmaceuticals Inc.
Notice · Comments due Aug 4, 2025
scheduling

ANI Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-10230

View on Federal Register
Published June 4, 2025
DEA
Special Surveillance List of Chemicals, Products, Materials and Equipment Used in the Manufacture of Controlled Substances and Listed Chemicals
Notice
scheduling

The Controlled Substances Act provides for civil penalties for the distribution of a laboratory supply to a person who uses, or attempts to use, that laboratory supply to manufacture a controlled substance or a listed chemical, if that distribution was made with reckless…

Federal Register document 2025-10087

View on Federal Register
Published June 3, 2025
DEA
Schedules of Controlled Substances: Placement of 2-Methyl AP-237 in Schedule I; Correction
Correction · Correction effective Jun 3, 2025
scheduling

On March 15, 2024, the Drug Enforcement Administration published a final order placing 1-(2-methyl-4-(3-phenylprop-2-en-1- yl)piperazin-1-yl)butan-1-one (commonly known as 2-methyl AP-237), including its optical and geometric isomers, esters, ethers, salts, and salts of…

Federal Register document 2025-09989

View on Federal Register
DEA
Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I
Proposed rule · Comments due Jul 3, 2025
scheduling

The Drug Enforcement Administration proposes placing the substance 4-fluoroamphetamine (4-FA; 1-(4-fluorophenyl)propan-2-amine), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable…

Federal Register document 2025-09988

View on Federal Register
DEA
Designation of Propionyl Chloride as a List I Chemical
Proposed rule · Comments due Jul 3, 2025
scheduling

The Drug Enforcement Administration is proposing the control of propionyl chloride as a list I chemical under the Controlled Substances Act (CSA). The Drug Enforcement Administration finds that propionyl chloride is used in the illicit manufacture of the controlled substances…

Federal Register document 2025-09983

View on Federal Register
Published June 2, 2025
DEA
Routine DEA registration application notices · 2
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Aug 1, 2025
scheduling

Veranova, L.P. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-09929

View on Federal Register
DEA
Importer of Controlled Substances Application: ANI Pharmaceuticals Inc.
Notice · Comments due Jul 2, 2025
scheduling

ANI Pharmaceuticals Inc has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-09927

View on Federal Register
Published May 20, 2025
DEA
Routine DEA registration application notices · 3
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Quagen Pharmaceuticals LLC
Notice · Comments due Jun 20, 2025
scheduling

Quagen Pharmaceuticals LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-08998

View on Federal Register
DEA
Importer of Controlled Substances Application: Usona Institute
Notice · Comments due Jun 20, 2025
scheduling

Usona Institute. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-08997

View on Federal Register
DEA
Importer of Controlled Substances Application: Patheon API Inc.
Notice · Comments due Jun 20, 2025
scheduling

Patheon API Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-08989

View on Federal Register
Published May 14, 2025
DEA
Routine DEA registration application notices · 3
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Research Triangle Institute
Notice · Comments due Jun 13, 2025
scheduling

Research Triangle Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-08414

View on Federal Register
DEA
Importer of Controlled Substances Application: Pall Life Sciences PR, LLC
Notice · Comments due Jun 13, 2025
scheduling

Pall Life Sciences PR, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-08413

View on Federal Register
DEA
Importer of Controlled Substances Application: Wedgewood Pharmacy LLC
Notice · Comments due Jun 13, 2025
scheduling

Wedgewood Pharmacy LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-08412

View on Federal Register
Published May 1, 2025
DEA
Routine DEA registration application notices · 2
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: United States Pharmacopeial Convention
Notice · Comments due Jun 2, 2025
scheduling

United States Pharmacopeial Convention has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-07576

View on Federal Register
DEA
Importer of Controlled Substances Application: Unither Manufacturing LLC
Notice · Comments due Jun 2, 2025
scheduling

Unither Manufacturing LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-07571

View on Federal Register
Published April 28, 2025
DEA
Routine DEA registration application notices · 7
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Almac Clinical Services Inc (ASCI)
Notice · Comments due May 28, 2025
scheduling

Almac Clinical Services, Inc., (ACSI) has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-07284

View on Federal Register
DEA
Importer of Controlled Substances Application: Lipomed
Notice · Comments due May 28, 2025
scheduling

Lipomed has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-07283

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics Inc.
Notice · Comments due Jun 27, 2025
scheduling

Siemens Healthcare Diagnostics, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-07282

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US), LLC; Correction
Correction
scheduling

The Drug Enforcement Administration (DEA) published a document in the Federal Register on March 26, 2025, concerning a notice of application for bulk manufacturer of Controlled Substances. As that document indicated the registrant's incorrect plans for the listed controlled…

Federal Register document 2025-07281

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Pisgah Laboratories Inc
Notice · Comments due Jun 27, 2025
scheduling

Pisgah Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-07280

View on Federal Register
DEA
Importer of Controlled Substances Application: VHG Labs DBA LGC Standards
Notice · Comments due May 28, 2025
scheduling

VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-07279

View on Federal Register
DEA
Importer of Controlled Substances Application: Skalar Pharma LLC
Notice · Comments due May 28, 2025
scheduling

Skalar Pharma LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-07278

View on Federal Register
Published April 25, 2025
DEA
Routine DEA registration application notices · 2
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Royal Emerald Pharmaceuticals
Notice · Comments due May 27, 2025
scheduling

Royal Emerald Pharmaceuticals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-07155

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
Notice · Comments due Jun 24, 2025
scheduling

SpecGx LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-07154

View on Federal Register
Published April 21, 2025
FDA
Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee; Amendment of Notice-Extended-Release/Long-Acting Opioid Analgesic Postmarketing Requirement
Notice

The Food and Drug Administration (FDA) is announcing an amendment to the notice of joint meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee. This meeting was announced in the Federal Register of…

Federal Register document 2025-06787

View on Federal Register
Published April 18, 2025
DEA
Routine DEA registration application notices · 5
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Myonex LLC
Notice · Comments due May 19, 2025
scheduling

Myonex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-06712

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Restek Corporation
Notice · Comments due Jun 17, 2025
scheduling

Restek Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-06709

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Patheon API Services Inc.
Notice · Comments due Jun 17, 2025
scheduling

Patheon API Services Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-06707

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Stepan Company
Notice · Comments due Jun 17, 2025
scheduling

Stepan Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-06706

View on Federal Register
DEA
Importer of Controlled Substances Application: Scottsdale Research Institute
Notice · Comments due May 19, 2025
scheduling

Scottsdale Research Institute has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-06705

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Research Triangle Institute
Notice · Comments due Jun 17, 2025
scheduling

Research Triangle Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-06710

View on Federal Register
Published March 27, 2025
DEA
Bulk Manufacturer of Controlled Substances Application; Promega Corporation
Notice · Comments due May 27, 2025
scheduling

Promega Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-05283

View on Federal Register
DEA
Routine DEA registration application notices · 7
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Restek Corporation
Notice · Comments due Apr 28, 2025
scheduling

Restek Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-05282

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Royal Beverages, LLC
Notice · Comments due May 27, 2025
scheduling

The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending…

Federal Register document 2025-05281

View on Federal Register
DEA
Importer of Controlled Substances Application: Patheon API Services, Inc.
Notice · Comments due Apr 28, 2025
scheduling

Patheon API Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-05280

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Royal Emerald Pharmaceuticals
Notice · Comments due May 27, 2025
scheduling

Royal Emerald Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-05279

View on Federal Register
DEA
Importer of Controlled Substances Application: SpecGx LLC
Notice · Comments due Apr 28, 2025
scheduling

SpecGx LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-05278

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Ohana Bio Pharma, LLC
Notice · Comments due May 27, 2025
scheduling

The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending…

Federal Register document 2025-05277

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Baxter Research Lab
Notice · Comments due May 27, 2025
scheduling

The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending…

Federal Register document 2025-05276

View on Federal Register
Published March 26, 2025
DEA
Routine DEA registration application notices · 5
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Maridose LLC (I)
Notice · Comments due Apr 25, 2025
scheduling

Maridose, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-05065

View on Federal Register
DEA
Importer of Controlled Substances Application: SpecGx LLC
Notice · Comments due Apr 25, 2025
scheduling

SpecGx LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-05060

View on Federal Register
DEA
Importer of Controlled Substances Application: Pharmaron Manufacturing Services (US) LLC
Notice · Comments due Apr 25, 2025
scheduling

Pharmaron Manufacturing Services (US) LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-05056

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Pharmaron Manufacturing Services (US), LLC
Notice · Comments due May 27, 2025
scheduling

Pharmaron Manufacturing Services (US), LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-05055

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Sterling Wisconsin, LLC
Notice · Comments due May 27, 2025
scheduling

Sterling Wisconsin, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-05054

View on Federal Register
Published March 17, 2025
DEA
Importer of Controlled Substance Application: Fisher Clinical Services, Inc.
Notice · Comments due Apr 16, 2025
scheduling

Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-04285

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Sterling Pharma USA LLC
Notice · Comments due May 16, 2025
scheduling

Sterling Pharma USA LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-04284

View on Federal Register
Published March 13, 2025
DEA
Routine DEA registration application notices · 4
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Notice · Comments due Apr 14, 2025
scheduling

Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-04046

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Patheon Pharmaceuticals Inc.
Notice · Comments due May 12, 2025
scheduling

Patheon Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-04045

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals Inc.
Notice · Comments due May 12, 2025
scheduling

Sigma Aldrich Research Biochemicals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-04044

View on Federal Register
DEA
Importer of Controlled Substances Application: Meridian Medical Technologies, LLC
Notice · Comments due Apr 14, 2025
scheduling

Meridian Medical Technologies, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-04043

View on Federal Register
Published March 10, 2025
DEA
Importer of Controlled Substances Application: Stepan Company
Notice · Comments due Apr 9, 2025
scheduling

Stepan Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-03766

View on Federal Register
Published March 7, 2025
DEA
Importer of Controlled Substances Application: LTS Therapy Systems, LLC
Notice · Comments due Apr 7, 2025
scheduling

LTS Therapy Systems, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-03648

View on Federal Register
Published March 6, 2025
DEA
Routine DEA registration application notices · 2
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Aphena Pharma Solutions MD, LLC
Notice · Comments due Apr 7, 2025
scheduling

Aphena Pharma Solutions MD, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-03636

View on Federal Register
DEA
Importer of Controlled Substances Application: Indivior Inc.
Notice · Comments due Apr 7, 2025
scheduling

Indivior Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-03635

View on Federal Register
Published February 27, 2025
DEA
Bulk Manufacturer of Controlled Substances Application: Groff NA Hemplex LLC
Notice · Comments due Apr 28, 2025
scheduling

Groff Hemplex LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-03170

View on Federal Register
Published February 26, 2025
DEA
Routine DEA registration application notices · 3
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: S&B Pharma LLC DBA Norac Pharma
Notice · Comments due Mar 28, 2025
scheduling

S&B Pharma LLC DBA Norac Pharma has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-03062

View on Federal Register
DEA
Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Notice · Comments due Mar 28, 2025
scheduling

Catalent Pharma Solutions, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-03061

View on Federal Register
DEA
Importer of Controlled Substances Application: Sharp Clinical Services, LLC
Notice · Comments due Mar 28, 2025
scheduling

Sharp Clinical Services, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-03060

View on Federal Register
Published February 18, 2025
DEA
Routine DEA registration application notices · 7
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Janssen Pharmaceuticals, Inc.
Notice · Comments due Apr 21, 2025
scheduling

Janssen Pharmaceuticals, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-02740

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
Notice · Comments due Apr 21, 2025
scheduling

Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-02739

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Patheon API Inc.
Notice · Comments due Apr 21, 2025
scheduling

Patheon API Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-02738

View on Federal Register
DEA
Importer of Controlled Substances Application: Lonza Tampa, LLC
Notice · Comments due Mar 20, 2025
scheduling

Lonza Tampa, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-02737

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute
Notice · Comments due Apr 21, 2025
scheduling

Scottsdale Research Institute, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-02733

View on Federal Register
DEA
Importer of Controlled Substances Application: Mylan Pharmaceuticals, Inc.
Notice · Comments due Mar 20, 2025
scheduling

Mylan Pharmaceuticals, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-02732

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Purisys, LLC
Notice · Comments due Apr 21, 2025
scheduling

Purisys, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-02731

View on Federal Register
Published February 13, 2025
DEA
Routine DEA registration application notices · 7
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Purisys, LLC
Notice · Comments due Mar 17, 2025
scheduling

Purisys, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-02600

View on Federal Register
DEA
Importer of Controlled Substances Application: Janssen Pharmaceuticals Inc.
Notice · Comments due Mar 17, 2025
scheduling

Janssen Pharmaceuticals Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-02599

View on Federal Register
DEA
Importer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Mar 17, 2025
scheduling

Veranova, L.P. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-02597

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Maridose LLC
Notice · Comments due Apr 14, 2025
scheduling

Maridose LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-02596

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: University of Kentucky Cannabis Center
Notice · Comments due Apr 14, 2025
cannabis · scheduling

The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending…

Federal Register document 2025-02595

View on Federal Register
DEA
Importer of Controlled Substances Application: Mylan Inc.
Notice · Comments due Mar 17, 2025
scheduling

Mylan Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-02594

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Benuvia Operations, LLC
Notice · Comments due Apr 14, 2025
scheduling

Benuvia Operations, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-02593

View on Federal Register
Published January 31, 2025
DEA
Routine DEA registration application notices · 3
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Medi-Physics Inc. DBA GE Healthcare
Notice · Comments due Mar 3, 2025
scheduling

Medi-Physics Inc. DBA GE Healthcare has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-02014

View on Federal Register
DEA
Importer of Controlled Substances Application: Catalent Greenville, Inc.
Notice · Comments due Mar 3, 2025
scheduling

Catalent Greenville, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-02013

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Organic Consultants LLC DBA Cascade Chemistry
Notice · Comments due Apr 1, 2025
scheduling

Organic Consultants LLC DBA Cascade Chemistry has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-02008

View on Federal Register
Published January 28, 2025
DEA
Routine DEA registration application notices · 2
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Vici Health Sciences, LLC
Notice · Comments due Feb 27, 2025
scheduling

Vici Health Sciences, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-01767

View on Federal Register
DEA
Importer of Controlled Substances Application: Aveva Drug Delivery Systems, Inc.
Notice · Comments due Feb 27, 2025
scheduling

Aveva Drug Delivery Systems, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-01766

View on Federal Register
Published January 24, 2025
DEA
Routine DEA registration application notices · 3
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.
Notice · Comments due Mar 25, 2025
scheduling

Veranova, L.P., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-01711

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Noramco
Notice · Comments due Mar 25, 2025
scheduling

Noramco has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2025-01710

View on Federal Register
DEA
Importer of Controlled Substances Application: VHG Labs DBA LGC Standards
Notice · Comments due Feb 24, 2025
scheduling

VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-01707

View on Federal Register
Published January 21, 2025
DEA
Routine DEA registration application notices · 3
Applications to manufacture or import controlled substances
DEA
Bulk Manufacturer of Controlled Substances Application: Siegfried USA, LLC
Notice · Comments due Mar 24, 2025
scheduling

Siegfried USA, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-01350

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Groff Health, Inc.
Notice · Comments due Mar 24, 2025
scheduling

Groff Health, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-01349

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Invizyne Technologies, Inc.
Notice · Comments due Mar 24, 2025
scheduling

Invizyne Technologies, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2025-01347

View on Federal Register
Published January 17, 2025
DEA
Special Registrations for Telemedicine and Limited State Telemedicine Registrations
Proposed rule
digital · scheduling

The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (the "Ryan Haight Act") generally requires an in-person medical evaluation prior to the issuance of a prescription of controlled substances but provides an exception to this in-person medical evaluation requirement…

Federal Register document 2025-01099

View on Federal Register
DEA
Expansion of Buprenorphine Treatment via Telemedicine Encounter
Final rule · Effective Feb 18, 2025
digital · scheduling

The Drug Enforcement Administration and the Department of Health and Human Services are amending their regulations to expand the circumstances under which practitioners registered by the Drug Enforcement Administration are authorized to prescribe schedule III-V controlled…

Federal Register document 2025-01049

View on Federal Register
DEA
Continuity of Care via Telemedicine for Veterans Affairs Patients
Final rule · Effective Feb 18, 2025
digital · scheduling

This final rule authorizes Department of Veterans Affairs (VA) practitioners acting within the scope of their VA employment to prescribe controlled substances via telemedicine to a VA patient with whom they have not conducted an in-person medical evaluation. VA practitioners…

Federal Register document 2025-01044

View on Federal Register
Published January 16, 2025
FDA
Use of Cannabis-Derived Products, Including Cannabidiol, in Veterinary Practice; Request for Information
Notice · Comments due Apr 16, 2025
cannabis

The Food and Drug Administration (FDA, the Agency, or we) is soliciting comments from the public, particularly veterinarians, related to the use of cannabis-derived products (CDPs) in animals, with an emphasis on cannabidiol (CBD) products and general trends associated with…

Federal Register document 2025-00945

View on Federal Register
Published December 30, 2024
DEA
Routine DEA registration application notices · 3
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Siegfried USA, LLC
Notice · Comments due Jan 29, 2025
scheduling

Siegfried USA, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2024-31301

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Irvine Labs Inc.
Notice · Comments due Feb 28, 2025
scheduling

Irvine Labs Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2024-31293

View on Federal Register
DEA
Importer of Controlled Substances Application: Curia New York, Inc.
Notice · Comments due Jan 29, 2025
scheduling

Curia New York, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2024-31292

View on Federal Register
DEA
Schedules of Controlled Substances: Extension of Temporary Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act
Temporary scheduling order · Effective Dec 31, 2024
scheduling

The Administrator of the Drug Enforcement Administration is issuing this temporary scheduling order to extend the temporary schedule I status of seven specific fentanyl-related substances, as identified in this order, including their isomers, esters, ethers, salts, and salts of…

Federal Register document 2024-31130

View on Federal Register
DEA
Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I
Proposed rule · Comments due Jan 29, 2025
scheduling

The Drug Enforcement Administration proposes placing seven fentanyl-related substances, as identified in this proposed rule, in schedule I of the Controlled Substances Act. These seven substances fall within the definition of fentanyl-related substances set forth in the…

Federal Register document 2024-30798

View on Federal Register
DEA
Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I
Proposed rule · Comments due Jan 29, 2025
scheduling

The Drug Enforcement Administration proposes placing the substance 4-chloromethcathinone (4-CMC, 1-(4-chlorophenyl)-2- (methylamino)propan-1-one), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is being taken, in…

Federal Register document 2024-30359

View on Federal Register
Published December 27, 2024
FDA
Modifications to Labeling of Buprenorphine-Containing Transmucosal Products for the Treatment of Opioid Dependence
Notice

The Food and Drug Administration (FDA, Agency, or we) is announcing that we have concluded that certain statements set forth in the FDA-approved labeling for buprenorphine-containing transmucosal products for the treatment of opioid dependence (BTODs) related to the recommended…

Federal Register document 2024-30776

View on Federal Register
Published December 18, 2024
DEA
Importer of Controlled Substances Application: Leading Pharma LLC
Notice · Comments due Jan 17, 2025
scheduling

Leading Pharma LLC to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2024-29997

View on Federal Register
Published December 17, 2024
DEA
Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2025
Final order · Effective Dec 17, 2024
scheduling

This final order establishes the initial 2025 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.

Federal Register document 2024-30023

View on Federal Register
DEA
Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2024
Final order · Effective Dec 17, 2024
scheduling

This final order establishes the final adjusted 2024 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.

Federal Register document 2024-30019

View on Federal Register
Published December 13, 2024
DEA
Routine DEA registration application notices · 2
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Groff NA Hemplex LLC
Notice · Comments due Jan 13, 2025
scheduling

Groff NA Hemplex LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2024-29343

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: National Center for Natural Products Research
Notice · Comments due Feb 11, 2025
scheduling

National Center for Natural Products Research has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2024-29341

View on Federal Register
Published December 9, 2024
FDA
Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Extended-Release/Long-Acting Opioid Analgesic Postmarketing Requirement
Notice

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee (the Committees). The general function of the Committees…

Federal Register document 2024-28811

View on Federal Register
Published December 6, 2024
DEA
Routine DEA registration application notices · 4
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Noramco
Notice · Comments due Jan 6, 2025
scheduling

Noramco has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2024-28728

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Navinta LLC
Notice · Comments due Feb 4, 2025
scheduling

Navinta LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2024-28719

View on Federal Register
DEA
Importer of Controlled Substances Application: Organic Standards Solutions International, LLC
Notice · Comments due Jan 6, 2025
scheduling

Organic Standards Solutions International, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2024-28717

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC
Notice · Comments due Feb 4, 2025
scheduling

Kinetochem LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2024-28715

View on Federal Register
Published November 29, 2024
DEA
Routine DEA registration application notices · 2
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: Cambrex Charles City
Notice · Comments due Dec 30, 2024
scheduling

Cambrex Charles City has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2024-28064

View on Federal Register
DEA
Importer of Controlled Substances Application: Curia Wisconsin, Inc.
Notice · Comments due Dec 30, 2024
scheduling

Curia Wisconsin, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2024-28063

View on Federal Register
Published November 26, 2024
DEA
Routine DEA registration application notices · 5
Applications to manufacture or import controlled substances
DEA
Importer of Controlled Substances Application: National Center for Natural Products Research
Notice · Comments due Dec 26, 2024
scheduling

National Center for Natural Products Research has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2024-27694

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Isosciences, LLC
Notice · Comments due Jan 27, 2025
scheduling

Isosciences, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2024-27693

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Organix Chemistry Solutions, LLC
Notice · Comments due Jan 27, 2025
scheduling

Organix Chemistry Solutions, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2024-27674

View on Federal Register
DEA
Importer of Controlled Substances Application: Experic LLC
Notice · Comments due Dec 26, 2024
scheduling

Experic LLC to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Federal Register document 2024-27673

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company
Notice · Comments due Jan 27, 2025
scheduling

Cayman Chemical Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Federal Register document 2024-27670

View on Federal Register

Clinical-trial registrations

553

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works. The date shown is the day ClinicalTrials.gov first posted it.

First posted November 17, 2026
Registration
Anxiety Reduction, Learning Support, Mood, and Self-efficacy Adaptation in Families With Healthy Newborns
Status at last check: Not yet recruiting · NCT07943936

Anxiety, Parenting Stress, Depressive Symptoms — ALMA-RN Instagram-Based Parental Education Programme

ClinicalTrials.gov registration NCT07943936 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Can Spending Time in Nature Help Mothers With Depression After Childbirth? A 6-Week Forest Therapy Study
Status at last check: Enrolling by invitation · NCT07943858

Postpartum Depression, Postpartum Depression (PPD), Postnatal Depression — Forest Therapy Group, Standard Care (in control arm)

ClinicalTrials.gov registration NCT07943858 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Ketamine for Treatment of Alzheimers Disease Related Depression
Status at last check: Not yet recruiting · NCT07943741

Late Life Depression (LLD), MCI, MCI-AD, Early Stage Alzheimer's Disease — Ketamine and saline, Active Placebo (Midazolam) Infusion

ClinicalTrials.gov registration NCT07943741 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Is Restrictive Eating Behavior in Anorexia Nervosa Short-sighted? An Experimental Investigation
Status at last check: Not yet recruiting · NCT07943624

Anorexia Nervosa — Episodic Future Thinking, Standardized Episodic Thinking

ClinicalTrials.gov registration NCT07943624 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Mechanisms and Interventions of Treatment-Resistant Schizophrenia Based on Brain Organoids
Status at last check: Not yet recruiting · NCT07943559

Treatment-resistant Schizophrenia

ClinicalTrials.gov registration NCT07943559 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Addressing Violence in the Context of Opioid Use Disorder Care
Status at last check: Not yet recruiting · NCT07943455

Sexual Violence, Opioid Use Disorder, Posttraumatic Stress Disorder — SHE-OUD

ClinicalTrials.gov registration NCT07943455 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Exploring the Interplay Between Maternal Stress, Human Milk, and Epigenetic Changes in Preterm Infant's Neurodevelopment
Status at last check: Recruiting · NCT07943130

Maternal Depression, Maternal Anxiety, Preterm Birth Infants

ClinicalTrials.gov registration NCT07943130 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Axe Intestin-cerveau & TDAH
Status at last check: Completed · NCT07942467

ADHD - Attention Deficit Disorder With Hyperactivity

ClinicalTrials.gov registration NCT07942467 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The Effects of Prayer on Psychological, Physical, and Spiritual Well-being in Adults With Cancer: A Pilot Study
Status at last check: Completed · NCT07942454

Depressive Symptoms, Anxiety Symptoms, Pain, Quality of Life — Prayer

ClinicalTrials.gov registration NCT07942454 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The Effect of Mindfulness-Based Psychoeducation on Psychological Resilience and Insight in Individuals Diagnosed With Schizophrenia
Status at last check: Completed · NCT07942441

SCHIZOPHRENIA 1 (Disorder), Mindfulness, Insight, Resilience, Mental Health — Mindfulness-Based Psychoeducation

ClinicalTrials.gov registration NCT07942441 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Healing and Improving Postnatal Nights Through Sleep (HIPNoS)
Status at last check: Not yet recruiting · NCT07942246

Insomnia, Depression — Perinatal Understanding of Mindful Awareness for Sleep (PUMAS), Sleep Hygiene Education (SHE)

ClinicalTrials.gov registration NCT07942246 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Remote Exercise iNtErvention for Wellbeing (RENEW) Trial
Status at last check: Not yet recruiting · NCT07942064

Exercise Adherence (Primary), Depressive Symptoms (Secondary), Anxiety (Secondary), Presenteeism Secondary), Wellbeing (Secondary), Psychological Stress (Secondary), Burnout (Secondary), Absenteeism (Secondary), Health Status Measures (Secondary), Flourishing (Secondary)…

ClinicalTrials.gov registration NCT07942064 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Association Between Maternal Intrapartum Pethidine Exposure and Respiratory Depression in Late-Preterm Newborns
Status at last check: Not yet recruiting · NCT07941986

Neonatal Respiratory Depression, Late Preterm Infant, Meperidine, Cervical Ripening, Cervical Dilatation, Pregnant Women, Premature Birth — pethidine hydrochloride

ClinicalTrials.gov registration NCT07941986 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Biphasic Effect of Alcohol on Pain
Status at last check: Not yet recruiting · NCT07941895

Alcohol Use, Chronic Low-back Pain (cLBP), Alcohol Use Disorder (AUD), Quantitative Sensory Testing, Pain Alleviation — Alcohol (IV), Saline (0.9%, sterile, for infusion)

ClinicalTrials.gov registration NCT07941895 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Analysis of Music in Ketamine Infusion Therapy
Status at last check: Completed · NCT07941882

Treatment Resistant Depression (TRD)

ClinicalTrials.gov registration NCT07941882 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Using Narrative Exposure Therapy to Treat Violent Offenders With Post Traumatic Stress and Emotion Dysregulation.
Status at last check: Recruiting · NCT07941817

PTSD - Post Traumatic Stress Disorder, CPTSD, Compelx Post-traumatic Stress Disorder, Emotion Dysregulation, Post Traumatic Stress Symptoms — Narrative Exposure Therapy

ClinicalTrials.gov registration NCT07941817 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Telehealth Stepped Care for Child and Adolescent Mental Health
Status at last check: Not yet recruiting · NCT07941804

Anxiety, Depression Symptom, Disruptive Behaviors, Child and Adolescent Mental Health — 12-Session Telehealth Cognitive Behavioral Therapy, 4-Session Telehealth Cognitive Behavioral Therapy, Enhanced Psychoeducational Materials

ClinicalTrials.gov registration NCT07941804 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Efficacy and Mechanisms of Time-Domain Interferential Transcranial Electrical Stimulation in Treating Depression Associated With Childhood Trauma
Status at last check: Not yet recruiting · NCT07941687

Major Depressive Disorder (MDD, Temporal Interference (TI) Electrical Stimulation — Active Transcranial Temporal Interference (TI) Stimulation, Sham Transcranial Temporal Interference (TI) Stimulation, Escitalopram Oxalate Medication

ClinicalTrials.gov registration NCT07941687 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Exploring the Efficacy and Mechanism of Accelerated High-Definition Transcranial Direct Current Stimulation (HD-tDCS) in the Treatment of Obsessive-compulsive Disorder
Status at last check: Not yet recruiting · NCT07940816

Obsessive Compulsive Disorder (OCD) — high-definition transcranial direct current stimulation (HD-tDCS), sham HD-tDCS

ClinicalTrials.gov registration NCT07940816 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Cognitive Augmentation, Remediation, and TDCS for Schizophrenia
Status at last check: Not yet recruiting · NCT07940712

Schizophrenia / Schizoaffective Disorder — High-definition transcranial direct current stimulation, Cognitive remediation therapy, Sham cognitive remediation therapy

ClinicalTrials.gov registration NCT07940712 · first posted Nov 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted November 16, 2026
Registration
Effect of a Video-based Information Intervention on Family Outcomes in Neurocritical Care
Status at last check: Not yet recruiting · NCT07940218

Post-traumatic Stress Symptoms, Depression Anxiety Disorder — Educational videos, Usual family support

ClinicalTrials.gov registration NCT07940218 · first posted Nov 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Individualized Brain Stimulation for Irritable Bowel Syndrome With Depressive Symptoms
Status at last check: Recruiting · NCT07939698

Irritable Bowel Syndrome (IBS), Depressive Symptoms — Individualized Intermittent Theta-Burst Stimulation, Sham Intermittent Theta-Burst Stimulation

ClinicalTrials.gov registration NCT07939698 · first posted Nov 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Study of Neurorehabilitation for Substance Use Disorder
Status at last check: Completed · NCT07939542

Cannabis Use Disorder — Transcranial Direct Current Stimulation (Active), Sham Transcranial Direct Current Stimulation

ClinicalTrials.gov registration NCT07939542 · first posted Nov 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Multitarget HD-tDCS and Spatial Navigation Memory in Schizophrenia
Status at last check: Completed · NCT07939477

Schizophrenia — Active Multitarget HD-tDCS, Sham HD-tDCS

ClinicalTrials.gov registration NCT07939477 · first posted Nov 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
AVATAR Therapy for Distressing Voices in India and Ethiopia
Status at last check: Not yet recruiting · NCT07939347

Psychosis, Hallucinations — AVATAR Therapy

ClinicalTrials.gov registration NCT07939347 · first posted Nov 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Deep Brain Reorienting (DBR) in Post-traumatic Stress Disorder (PTSD)
Status at last check: Not yet recruiting · NCT07939178

PTSD, Post-traumatic Stress Disorder (PTSD) — Deep Brain Reorienting (DBR), Treatment-as-usual (TAU)

ClinicalTrials.gov registration NCT07939178 · first posted Nov 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Preventing Mood Disorders in High-risk Offspring: Protocol for the Randomized Controlled Trial of the MARIO Online Preventive Intervention Platform
Status at last check: Recruiting · NCT07938593

Mood Disorders, Mood Disorders in Children and Adolescents, Depressive Symptoms, Mania, Resilience, Psychological, Bipolar Disorder (BD) — KOPPsupport, Moodpep, Grow It!

ClinicalTrials.gov registration NCT07938593 · first posted Nov 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effect of Guided Imagery on Anxiety, Depression, and Fatigue in Patients Receiving Hemodialysis
Status at last check: Not yet recruiting · NCT07938372

Hemodialysis, Anxiety, Depression, Fatigue, Guided Imagery Exercise, Randomized Controlled Trial — Guided imagery

ClinicalTrials.gov registration NCT07938372 · first posted Nov 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Sotatercept in the Treatment of Methamphetamine-Associated Pulmonary Arterial Hypertension
Status at last check: Not yet recruiting · NCT07938294

Pulmonary Arterial Hypertension (PAH), Methamphetamine Use Disorder — Sotatercept

ClinicalTrials.gov registration NCT07938294 · first posted Nov 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Clinical High Risk for Psychosis (CHR) Cohort
Status at last check: Recruiting · NCT07938177

Clinical High Risk for Psychosis

ClinicalTrials.gov registration NCT07938177 · first posted Nov 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The Effect of Social Cognition and Interaction Training on Patients With Schizophrenia
Status at last check: Completed · NCT07938047

SCHIZOPHRENIA — the social cognition and interaction training

ClinicalTrials.gov registration NCT07938047 · first posted Nov 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Early Intervention for Postpartum PTSD: Comparing Written Exposure and Capnometry-Guided Breathing Therapy - Phase 2
Status at last check: Not yet recruiting · NCT07937865

Written Exposure Therapy, Breathing Techniques, PTSD (Childbirth-Related), Postpartum Care — Written Exposure Therapy (WET), Capnometry-Guided Breathing Intervention (CGRI)

ClinicalTrials.gov registration NCT07937865 · first posted Nov 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Traditional Chinese Medicine Augmentation Therapy for Obsessive-Compulsive Disorder
Status at last check: Not yet recruiting · NCT07937774

Obsessive-Compulsive Disorder, OCD, Traditional Chinese Medicine (TCM), Therapy, Non, Nonrespond — Chaixia Dingzhi Powder, Placebo Group

ClinicalTrials.gov registration NCT07937774 · first posted Nov 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effects of Painting-Based Art Interventions in Individuals With Schizophrenia
Status at last check: Completed · NCT07937761

Schizophrenia — Painting-Based Art Intervention

ClinicalTrials.gov registration NCT07937761 · first posted Nov 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effect of Clinical Pharmacist-Led Pharmaceutical Care in Major Depressive Disorder
Status at last check: Completed · NCT07937644

Major Depressive Disorder (MDD), Medication Adherence — Clinical Pharmacist-Led Pharmaceutical Care

ClinicalTrials.gov registration NCT07937644 · first posted Nov 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted November 13, 2026
Registration
CYOA App Intervention for Social Media Use in Adolescents With Depression
Status at last check: Not yet recruiting · NCT07936890

Major Depressive Disorder, Depression, Adolescent Depression, Problematic Social Media Use — Choose Your Own Adventure App

ClinicalTrials.gov registration NCT07936890 · first posted Nov 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Mindfulness Program for Blood Sugar Control, Heart Rate Variability, Anxiety, and Depression in Type 2 Diabetes
Status at last check: Completed · NCT07936357

Type 2 Diabetes Mellitus, Diabetic Autonomic Neuropathy, Anxiety, Depression — Six-week audio-guided mindfulness program

ClinicalTrials.gov registration NCT07936357 · first posted Nov 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Nurse-Led Simulation-Based Prosocial Skills Training in Individuals With Schizophrenia
Status at last check: Completed · NCT07936149

SCHIZOPHRENIA 1 (Disorder) — Nurse-Led Simulation-Based Prosocial Skills Training

ClinicalTrials.gov registration NCT07936149 · first posted Nov 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Melodies for Mums to Be: Community Group Singing Intervention for Pregnant Women With Antenatal Depressive Symptoms
Status at last check: Not yet recruiting · NCT07935824

Antenatal Depression — Melodies for Mums to Be, Usual Care

ClinicalTrials.gov registration NCT07935824 · first posted Nov 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
θTACS for Schizophrenia (SCZ)
Status at last check: Not yet recruiting · NCT07935746

Schizophrenia Disorder — Active 4.5Hz θ tACS Stimulation, Active 6Hz θ tACS Stimulation, sham tACS Stimulation

ClinicalTrials.gov registration NCT07935746 · first posted Nov 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effect of Nature-based Interventions on Mental Health and Markers of Inflammation in Women Victims of Violence Residing in the City of Bogotá
Status at last check: Completed · NCT07935096

Gender-Based Violence, Post-Traumatic Stress Disorder, PTSD, Anxiety, Depression Disorder, Chronic Inflammation, Immune System Dysregulation, Cortisol, Nature-based Interventions — Nature-based interventions

ClinicalTrials.gov registration NCT07935096 · first posted Nov 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Written Exposure Therapy for Childbirth-related Post-Traumatic Stress
Status at last check: Recruiting · NCT07935070

PTSD (Childbirth-Related), PTSD - Post Traumatic Stress Disorder, PTSD — Written Exposure Therapy

ClinicalTrials.gov registration NCT07935070 · first posted Nov 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Efficacy and Neural Mechanisms of Individualized Neuromodulation Combined With Think/No-Think Training in Individuals With Internalizing Disorders
Status at last check: Not yet recruiting · NCT07935005

Anxiety, Depression Disorder, OCD, PTSD, CPTSD, Compelx Post-traumatic Stress Disorder — Individualized Transcranial Alternating Current Stimulation (tACS), Individualized Temporal Interference Stimulation (TIS), Autobiographical Think/No-Think Thought Suppression Training

ClinicalTrials.gov registration NCT07935005 · first posted Nov 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The Mother-infant Touch Study
Status at last check: Not yet recruiting · NCT07934784

Depression — Physical touch

ClinicalTrials.gov registration NCT07934784 · first posted Nov 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
VA Secure Homes Lethal Means Intervention
Status at last check: Not yet recruiting · NCT07934706

Suicide, Firearm Injury — SecureHomes, Health and Stress Counseling

ClinicalTrials.gov registration NCT07934706 · first posted Nov 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Mental Health Link for Veterans Referred to Mental Health Services
Status at last check: Not yet recruiting · NCT07934680

Depression — Mental Health Link

ClinicalTrials.gov registration NCT07934680 · first posted Nov 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted November 12, 2026
Registration
Exploring Ketamine's Effects on Depression and Anxiety in Adults With Low Vision
Status at last check: Not yet recruiting · NCT07934043

Depression, Anxiety, Low Vision — Ketamine

ClinicalTrials.gov registration NCT07934043 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Implementing an Evidence-based Alcohol Use and Sexual Risk Intervention in Young Adult Homeless Service Settings
Status at last check: Not yet recruiting · NCT07933406

Alcohol Consumption, Alcohol Use Disorder (AUD), Substance Use (Drugs, Alcohol), Substance Use Disorder (SUD), Condomless Sex, Unprotected Sex, High-risk Sex — AWARE

ClinicalTrials.gov registration NCT07933406 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Predicting Transitions From Depression to Wellbeing Through a Network-based Operationalization of Plasticity
Status at last check: Not yet recruiting · NCT07933276

Major Depressive Disorder (MDD) — Clinical and cognitive assessments, Multimodal MRI, Blood sampling for multi-omic analyses

ClinicalTrials.gov registration NCT07933276 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Efficacy of Vaped Cannabidiol in Cannabis Use Disorder
Status at last check: Not yet recruiting · NCT07933081

Cannabis Use Disorder — CBD vape liquid, Placebo Liquid

ClinicalTrials.gov registration NCT07933081 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Evaluating EWPPT and NECT for People With Schizophrenia
Status at last check: Enrolling by invitation · NCT07932236

Schizophrenia Patients — Enhanced WELLFOCUS PPT, Culturally adapted NECT

ClinicalTrials.gov registration NCT07932236 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Unveiling Maternal-fetal BRAin-body Interactions in Pregnant WOmen Affected by Depression
Status at last check: Recruiting · NCT07932093

Depression in Pregnancy, Major Depressive Disorder, Pregnancy — Multimodal MRI and EEG-ECG/PPG recordings, Biological sampling, Clinical and neurodevelopmental assessments

ClinicalTrials.gov registration NCT07932093 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Electrical Brain Stimulation for College Students With Short-Form Video Addiction: Effects and Mechanisms
Status at last check: Not yet recruiting · NCT07931729

Short-form Video Addiction — Active High-Definition Transcranial Direct Current Stimulation (Active HD-tDCS), Sham High-Definition Transcranial Direct Current Stimulation (Sham HD-tDCS)

ClinicalTrials.gov registration NCT07931729 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Safety, Tolerability and Efficacy of RGH-202 in Social Anxiety Disorder (STAGE)
Status at last check: Not yet recruiting · NCT07931703

Social Anxiety Disorder — RGH-202, Placebo

ClinicalTrials.gov registration NCT07931703 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
STRIVES: Status-Neutral TeleHealth Concierge Intervention for Unhoused People Who Use Drugs Via Engagement Through Street Medicine
Status at last check: Not yet recruiting · NCT07931612

HIV, Substance Use Disorder (SUD), HEPATITIS C (HCV), Homelessness — Standard of Care (Patient Navigation to Off-Site Clinic), Status-Neutral Telehealth Concierge (SN-THR)

ClinicalTrials.gov registration NCT07931612 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Mild Cognitive Impairment in Older Adults With and Without Depressive Symptom
Status at last check: Not yet recruiting · NCT07931586

Mild Cognitive Impairment (MCI), Depression and Anxiety Symptoms

ClinicalTrials.gov registration NCT07931586 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Health Assessment in People With Severe Mental Illness
Status at last check: Recruiting · NCT07931456

Severe Mental Illness, Schizophrenia, Bipolar Disorder, Depression / Major Depressive Disorder

ClinicalTrials.gov registration NCT07931456 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Nature-Based Exercise for Major Depressive Disorder
Status at last check: Not yet recruiting · NCT07931443

Major Depressive Disorder (MDD) — Nature-Based Combined Exercise Program, Indoor Combined Exercise Program, Usual Mental Healthcare and Occupational Activities

ClinicalTrials.gov registration NCT07931443 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Peer Recovery Support in the Homeless Health Care Setting
Status at last check: Not yet recruiting · NCT07931430

Opioid Use Disorder — Peer support

ClinicalTrials.gov registration NCT07931430 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Study of Anxiety Free Experiences at the Dentist
Status at last check: Recruiting · NCT07931131

Dental Phobia, Dental Anxiety in Children, Dental Fear, Dental Fear and Anxiety — One-Session Treatment for Dental Phobia (OSTD), Psychoeducation and Relaxation Training (RELAX)

ClinicalTrials.gov registration NCT07931131 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Aggression in Military Personnel
Status at last check: Not yet recruiting · NCT07931079

Aggression, Anger, Posttraumatic Stress Disorder (PTSD) — Manage Emotions to Reduce Aggression (MERA), Self-Monitoring

ClinicalTrials.gov registration NCT07931079 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Longitudinal Assessment of Biomarkers Among Patients With MDD
Status at last check: Recruiting · NCT07931001

Major Depressive Disorder (MDD) — No Intervention: Observational Cohort

ClinicalTrials.gov registration NCT07931001 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Auricular Vagus Nerve Stimulation for Anxiety and Sleep Quality in Patients With Generalized Anxiety Disorder
Status at last check: Not yet recruiting · NCT07930871

Generalized Anxiety Disorder (GAD) — Transcutaneous Auricular Vagus Nerve Stimulation (taVNS), Sham Transcutaneous Auricular Vagus Nerve Stimulation (sham-taVNS)

ClinicalTrials.gov registration NCT07930871 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Nurse-Led Self-Management Support After Coronary Artery Bypass Surgery
Status at last check: Not yet recruiting · NCT07930819

Coronary Artery Disease, Coronary Artery Bypass Grafting (CABG), Depression, Anxiety, Psychological Stress, Readmission, Emergency Visit — BRIDGE-SM model

ClinicalTrials.gov registration NCT07930819 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Peer-Support Cognitive Behavioral Intervention for Military Life Transitions (Mil-iTransition)
Status at last check: Completed · NCT07930234

Peer-Support Intervention, Military-to-Civilian Transition, Medical Disability, Suicide Prevention, Pilot Randomized Controlled Trial — Telephone- Based Peer Support + TAU

ClinicalTrials.gov registration NCT07930234 · first posted Nov 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted November 10, 2026
Registration
Phase-Locked Accelerated Intermittent Theta Burst Stimulation for Treatment-Resistant Depression
Status at last check: Completed · NCT07930000

Treatment Resistant Depression (TRD) — Phase-Locked Accelerated Intermittent Theta Burst Stimulation, Random-Phase Accelerated Intermittent Theta Burst Stimulation

ClinicalTrials.gov registration NCT07930000 · first posted Nov 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Evaluation of the EPDS and PC-PTSD-5 Scales for Screening Postpartum Mental Health Disorders Among Migrant Women.
Status at last check: Not yet recruiting · NCT07929272

Post Partum Depression — psychiatric interview

ClinicalTrials.gov registration NCT07929272 · first posted Nov 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Project Raising Exposure Awareness for Caregiver Help-Seeking
Status at last check: Not yet recruiting · NCT07929077

Anxiety, Obsessive Compulsive Disorder (OCD), Trauma and Stress Related Disorders — Tailored Dissemination Campaign, Dissemination-as-usual

ClinicalTrials.gov registration NCT07929077 · first posted Nov 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Virtual Reality vs. Gym-Based Martial Arts Training for Aggression in Children With Conduct Disorder
Status at last check: Completed · NCT07929025

Conduct Disorder, Externalizing Behavior, Child Mental Health — Immersive VR-Based Martial Arts Training, Club-Based Martial Arts Training

ClinicalTrials.gov registration NCT07929025 · first posted Nov 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Transcranial Magnetic Therapy (TMS) for Treatment of Perinatal Depression
Status at last check: Active, not recruiting · NCT07928908

Perinatal Depression — Transcranial Magnetic Stimulation (TMS)

ClinicalTrials.gov registration NCT07928908 · first posted Nov 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Low Intensity Focused Ultrasound in Cocaine Use Disorder
Status at last check: Not yet recruiting · NCT07928648

Cocaine Use Disorder (CUD) — Low Intensity Focused Ultrasound

ClinicalTrials.gov registration NCT07928648 · first posted Nov 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Mentalization Orientated Psychoeducation Group for Adult ADHD (MOPAD)
Status at last check: Not yet recruiting · NCT07928440

ADHD - Attention Deficit Disorder With Hyperactivity — The MOPAD study tests whether an introductory Mentalization-Based Treatment (iMBT)

ClinicalTrials.gov registration NCT07928440 · first posted Nov 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Neurocomputational Training to Improve Reward Responsiveness in Veterans With Anhedonia
Status at last check: Not yet recruiting · NCT07928310

Anhedonia, Depression — ReLIT (Reward Learning Intensive Training), ST (Sham Training)

ClinicalTrials.gov registration NCT07928310 · first posted Nov 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Study of Brenipatide in Participants With Major Depressive Disorder
Status at last check: Not yet recruiting · NCT07928245

Major Depressive Disorder — Brenipatide, Placebo

ClinicalTrials.gov registration NCT07928245 · first posted Nov 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Higher-Dose Maintenance With ERZOFRI 351 mg in Adults With Schizophrenia
Status at last check: Not yet recruiting · NCT07927946

SCHIZOPHRENIA 1 (Disorder) — Paliperidone Palmitate

ClinicalTrials.gov registration NCT07927946 · first posted Nov 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Temporal Interference Stimulation Targeting Thalamus for Schizophrenia-Related Cognitive Dysfunction
Status at last check: Not yet recruiting · NCT07927790

Schizophrenia Disorder, Cognitive Impairments — temporal interference stimulation, Sham TIS

ClinicalTrials.gov registration NCT07927790 · first posted Nov 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Decentralized, Status Neutral, Stakeholder-engaged, Post-incarceration Intervention for People Living With and at Risk for HIV
Status at last check: Not yet recruiting · NCT07927673

Substance Use Disorder (SUD), HIV (Human Immunodeficiency Virus), Viral Suppression of HIV Infection — DEST2nation model, Standard of care referral

ClinicalTrials.gov registration NCT07927673 · first posted Nov 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Relapse Prevention and Changing Habits in Anorexia Nervosa 2.0
Status at last check: Not yet recruiting · NCT07927504

Anorexia Nervosa, Atypical Anorexia Nervosa — Relapse Prevention and Changing Habits (REACH+ 2.0)

ClinicalTrials.gov registration NCT07927504 · first posted Nov 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Medical Nitrous Oxide Combined With Personalized Traumatic Script Exposure for the Treatment of Post-Traumatic Stress Disorder
Status at last check: Not yet recruiting · NCT07927192

PTSD - Post Traumatic Stress Disorder — MEOPA (Nitrous Oxide/Oxygen Premix), Medical Air in Oxygen, Personalized Traumatic Script Exposure

ClinicalTrials.gov registration NCT07927192 · first posted Nov 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted November 9, 2026
Registration
Enhancing the Effect of Stellate Ganglion Block in the Treatment of PTSD: Bupivacaine vs Bupivacaine + Ketamine
Status at last check: Not yet recruiting · NCT07927036

Posttraumatic Stress Disorder (PTSD) — SGB - Combined Solution of Bupivacaine + Saline, SGB - Combined Solution of Bupivacaine + Ketamine Adjuvant

ClinicalTrials.gov registration NCT07927036 · first posted Nov 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Supporting Families of School-Aged Children With ADHD: A Dual-Generation Therapy Approach Through the BRIDGE Program
Status at last check: Not yet recruiting · NCT07926776

ADHD, Maternal Mental Health, Dialectical Behavior Therapy, Parenting Intervention, Children — BRIDGE-ADHD

ClinicalTrials.gov registration NCT07926776 · first posted Nov 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Community Context and Psychological Flexibility in Residential Substance Use Treatment: A Longitudinal Sequential Mediation Study
Status at last check: Active, not recruiting · NCT07926750

Substance-Related Disorders, Substance Use Disorders — Routine residential therapeutic community treatment (not assigned by the study)

ClinicalTrials.gov registration NCT07926750 · first posted Nov 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Healing Trauma Plus
Status at last check: Completed · NCT07926568

Trauma-related PTSD, Anxiety and Distress, Depression — Healing Trauma Plus (HT+): A Brief Intervention for Women and Gender-Diverse People

ClinicalTrials.gov registration NCT07926568 · first posted Nov 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression
Status at last check: Recruiting · NCT07925762

Postpartum Depression, Depression, Postpartum — Smartphone-Assisted Single-Session Psychotherapy Intervention

ClinicalTrials.gov registration NCT07925762 · first posted Nov 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The Mediating Role of Social Support and Self-Esteem in the Effect of Physical Activity on the Mental Health of University Students
Status at last check: Completed · NCT07925346

Depression, Life Satisfaction

ClinicalTrials.gov registration NCT07925346 · first posted Nov 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Emotional Reactivity in Severe Alcohol Use Disorder and Major Depressive Disorder Using Eye-tracking, Physiological, and Interoceptive Measures (ERAD)
Status at last check: Recruiting · NCT07925281

Alcohol Use Disorder, Major Depressive Disorder (MDD) — Emotional Reactivity Experimental Protocol

ClinicalTrials.gov registration NCT07925281 · first posted Nov 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Prevalence and Factors Associated With Depression Among Children and Adolescents With Type 1 Diabetes Mellituss
Status at last check: Not yet recruiting · NCT07925164

Depression in Type 1 Diabetes Mellituss — Observation follow-up

ClinicalTrials.gov registration NCT07925164 · first posted Nov 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Individualized Temporal Interference Stimulation for Reward Processing in Late-Life Depression
Status at last check: Not yet recruiting · NCT07925047

Major Depressive Disorder (MDD — Active Temporal Interference Stimulation, Sham Temporal Interference Stimulation

ClinicalTrials.gov registration NCT07925047 · first posted Nov 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Individualized Temporally Interfering Electrical Stimulation in Major Depressive Disorder
Status at last check: Recruiting · NCT07924917

Major Depressive Disorder (MDD) — Single-target active temporally interfering electrical stimulation, Dual-target active temporally interfering electrical stimulation, Sham temporally interfering electrical stimulation

ClinicalTrials.gov registration NCT07924917 · first posted Nov 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Neuromodulation of Motivation and Reward Oscillations
Status at last check: Recruiting · NCT07924852

Cannabis Use Disorder, Major Depression, Anhedonia, Transcranial Alternating Current Stimulation — Transcranial Alternating Current Stimulation Sham, Transcranial Alternating Current Delta Stimulation., Transcranial Alternating Current Theta Stimulation

ClinicalTrials.gov registration NCT07924852 · first posted Nov 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Study of Remission Criteria in Anorexia Nervosa: A Multidimensional Exploratory Observational Study of Recovery Among Patients in Remission According to the Bardone-Cone Criteria
Status at last check: Not yet recruiting · NCT07924358

Anorexia Nervosa — Scales and questionnaires

ClinicalTrials.gov registration NCT07924358 · first posted Nov 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted November 6, 2026
Registration
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Status at last check: Not yet recruiting · NCT07923617

Conduct Disorder — Lidexamfetamine

ClinicalTrials.gov registration NCT07923617 · first posted Nov 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
SERENE Low-Intensity Focused Ultrasound for Cognitive Control
Status at last check: Not yet recruiting · NCT07923461

Suicidal Ideation, Cognitive Control, Neurocognitive Function — DIADEM Low-Intensity Focused Ultrasound Neuromodulation

ClinicalTrials.gov registration NCT07923461 · first posted Nov 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Low-Intensity Focused Ultrasound for Gambling Disorder
Status at last check: Not yet recruiting · NCT07923032

Gambling Disorder, Gambling Addiction, Gambling Problem, Gambling — Active Low-Intensity Focused Ultrasound (LIFU), Sham Low-Intensity Focused Ultrasound (LIFU)

ClinicalTrials.gov registration NCT07923032 · first posted Nov 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A MRT to Optimize a JITAI for Alcohol Craving and Suicide Ideation
Status at last check: Not yet recruiting · NCT07922590

Alcohol Use Disorder (AUD), Suicide Ideation — Text Message (to remind of Integrated Plan content)

ClinicalTrials.gov registration NCT07922590 · first posted Nov 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Micronutrient Supplementation and Chronotherapy in Children With ADHD
Status at last check: Recruiting · NCT07922252

Attention Deficit Hyperactivity Disorder (ADHD) — Broad-spectrum multivitamin and mineral supplementation, Chronotherapy-Based Lifestyle Guidance

ClinicalTrials.gov registration NCT07922252 · first posted Nov 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Substance Use and Media Preferences
Status at last check: Not yet recruiting · NCT07922239

Substance Use Behavior, Cannabis Intoxication, Alcohol Intoxication — Alcohol beverage, Cannabis (smoked flower), Simultaneous Alcohol and Cannabis

ClinicalTrials.gov registration NCT07922239 · first posted Nov 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Bioequivalence Study of Olanzapine Samidofen Tablets in Healthy Subjects Under Fasting Conditions.
Status at last check: Completed · NCT07922070

Bipolar I Disorder — Test Olanzapine Samidofen Tablets, reference (LYBALVI®) Olanzapine Samidofen Tablets

ClinicalTrials.gov registration NCT07922070 · first posted Nov 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
AI-assisted Home-based Intervention for ADHD Children
Status at last check: Recruiting · NCT07922018

ADHD - Attention Deficit Disorder With Hyperactivity, ADHD - Combined Type, ADHD - Inattentive Type — Generative artificial intelligence assisted diary platform home-based intervention, Consultations and psychoeducation on child emotional management

ClinicalTrials.gov registration NCT07922018 · first posted Nov 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Pharmacokinetics and Relative Bioavailability of Intranasal vs Intramuscular Olanzapine in Healthy Adult Participants
Status at last check: Not yet recruiting · NCT07921966

Healthy Adult Participants — NRL-1004 2.5 mg, ZYPREXA IM 10mg, NRL-1004 5.0 mg

ClinicalTrials.gov registration NCT07921966 · first posted Nov 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Sleep Monitoring for Early Detection of Relapse in People With Schizophrenia or Bipolar Disorder Receiving Usual Treatment
Status at last check: Not yet recruiting · NCT07921667

Bipolar Disorder (BD), SCHIZOPHRENIA 1 (Disorder)

ClinicalTrials.gov registration NCT07921667 · first posted Nov 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Acute Intermittent Hypoxia Therapy for Depression
Status at last check: Withdrawn · NCT07921654

Major Depressive Disorder (MDD) — Acute Intermittent Hypoxia (AIH), Normoxic Sham Intervention, Acute Intermittent Hypoxia Delivery Device

ClinicalTrials.gov registration NCT07921654 · first posted Nov 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Status at last check: Not yet recruiting · NCT07921446

Adverse Childhood Experience, Depression / Major Depressive Disorder, Anxiety Depression, Anxiety — Lifestyle psychoeducation intervention, Personalized digital psychoeducation intervention on emotion regulation

ClinicalTrials.gov registration NCT07921446 · first posted Nov 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Concomitant Fibromyalgia and Psychiatric Disorders
Status at last check: Completed · NCT07920913

Fibromyalgia (FM), Depression

ClinicalTrials.gov registration NCT07920913 · first posted Nov 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted November 5, 2026
Registration
Effects of C-Tactile-optimal Touch on Alcohol Craving and Relapse-Related Biomarkers in Alcohol Use Disorder
Status at last check: Completed · NCT07920601

Alcohol Use Disorder — CT- optimal Robotic skin stimulation, Non-CT-optimal Robotic skin stimulation

ClinicalTrials.gov registration NCT07920601 · first posted Nov 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Affective Cognitive Training in Mood Disorders and High-risk Relatives
Status at last check: Recruiting · NCT07920302

Major Depressive Disorder (MDD), Bipolar Disorder (BD) — Targeted affective cognitive training

ClinicalTrials.gov registration NCT07920302 · first posted Nov 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Feasibility of a Web-based Single-session Intervention Combined With Ecological Momentary Assessment and Intervention for Patients With Complex Posttraumatic Stress Disorder Awaiting Inpatient Treatment
Status at last check: Not yet recruiting · NCT07920107

PTSD - Post Traumatic Stress Disorder, Depression, Anxiety, Complex Post-Traumatic Stress Disorder (CPTSD), Dissociation — Digital self-administered web-based single-session intervention, While Waiting application: Ecological momentary assessments and interventions

ClinicalTrials.gov registration NCT07920107 · first posted Nov 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Psilocybin for Amblyopia - Targeting Critical Periods in Humans
Status at last check: Recruiting · NCT07920081

Amblyopia — Amblyopia Therapy, 1 mg Psilocybin, 5 mg Psilocybin

ClinicalTrials.gov registration NCT07920081 · first posted Nov 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Evaluation of Purple Town
Status at last check: Completed · NCT07919639

Alcohol Use, Cannabis Use, Health Literacy — Purple Town prevention program, Purple town mobile game

ClinicalTrials.gov registration NCT07919639 · first posted Nov 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Repetitive Transcranial Magnetic Stimulation Versus Theta Burst Stimulation on Impulsivity, Emotional Dysregulation, and Non-Suicidal Self-Injury in Borderline Personality Disorder Patients
Status at last check: Recruiting · NCT07919587

Borderline Personality Disorder (BPD) — Repetitive Transcranial Magnetic Stimulation, Intermittent Theta-Burst Stimulation, Sham Stimulation

ClinicalTrials.gov registration NCT07919587 · first posted Nov 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Restoring Emotional Needs With Exogenous Ketones for Women With Postpartum Depression
Status at last check: Recruiting · NCT07919392

Postpartum Depression (PPD) — Exogenous ketone supplementation, Matched placebo beverage, Group-Mediated Cognitive Behavioral Counseling

ClinicalTrials.gov registration NCT07919392 · first posted Nov 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Expressive Arts Therapy in Major Depression: An RCT
Status at last check: Not yet recruiting · NCT07919288

Depression - Major Depressive Disorder — Expressive Art Therapy, Usual Care

ClinicalTrials.gov registration NCT07919288 · first posted Nov 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Sequential Treatment Approaches for Treatment-Resistant Schizophrenia
Status at last check: Recruiting · NCT07918222

Treatment-resistant Schizophrenia — [Phase 1] Clozapine, [Phase 1] Aripiprazole, [Phase 1] Amisulpride

ClinicalTrials.gov registration NCT07918222 · first posted Nov 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted November 4, 2026
Registration
Ashwagandha Added to Risperidone for Quality of Life and Inflammation in Schizophrenia
Status at last check: Completed · NCT07917637

Schizophrenia — Withania somnifera (Ashwagandha) Extract, Risperidone 4mg/day, Placebo capsules

ClinicalTrials.gov registration NCT07917637 · first posted Nov 4, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Parent-Based Intervention for Childhood Avoidant/Restrictive Food Intake Disorder (ARFID)
Status at last check: Not yet recruiting · NCT07916974

Anxiety Disorder of Adolescence, Avoidant / Restrictive Food Intake Disorder — Supportive Parenting for Anxious Childhood Emotions (SPACE), Nutritional Support (NS)

ClinicalTrials.gov registration NCT07916974 · first posted Nov 4, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Pre-post Study of a Lethal Means Safety Planning Intervention for Youth at Elevated Suicide Risk in the Emergency Department
Status at last check: Not yet recruiting · NCT07916792

Suicidal Ideas, Suicidal Ideation, Suicidal Thoughts, Firearm Safety — TEEN LENS, Usual Care

ClinicalTrials.gov registration NCT07916792 · first posted Nov 4, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Adapting the "Do More, Feel Better" Intervention for Older People Living With HIV
Status at last check: Not yet recruiting · NCT07915934

Depression, HIV — "Do More, Feel Better" for Older People with HIV

ClinicalTrials.gov registration NCT07915934 · first posted Nov 4, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
HERDA: Pharmacist-Led Culturally Adapted Intervention for Depression Medication Adherence
Status at last check: Active, not recruiting · NCT07915427

Depression — HERDA Pharmacist-Led Culturally Adapted Intervention

ClinicalTrials.gov registration NCT07915427 · first posted Nov 4, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Be Body Brave: Digital Written Exposure Therapy for Eating Disorders
Status at last check: Not yet recruiting · NCT07914712

Eating Disorders — Imaginal exposure, Eating disorder journaling

ClinicalTrials.gov registration NCT07914712 · first posted Nov 4, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted November 3, 2026
Registration
Virtual Reality Assisted Trauma Focused CBT
Status at last check: Recruiting · NCT07914634

PTSD - Post Traumatic Stress Disorder — VR Photoscan, Trauma-Focused Cognitive Behavioural Therapy (TF-CBT)

ClinicalTrials.gov registration NCT07914634 · first posted Nov 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Cognitive-Motor Training With the DextEgg in Children With ADHD
Status at last check: Not yet recruiting · NCT07913997

Attention Deficit Hyperactivity Disorder (ADHD) — Cognitive-motor DextEgg training, Motor-only DextEgg training

ClinicalTrials.gov registration NCT07913997 · first posted Nov 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Exploring The Effect of TikTok Trigger Warnings in a Clinical Sample of Youth at Risk of Suicide
Status at last check: Enrolling by invitation · NCT07913854

Suicide Prevention, Social Media Users — Trigger Warning

ClinicalTrials.gov registration NCT07913854 · first posted Nov 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
N-Acetylcysteine for Bipolar and Alcohol Use Disorders
Status at last check: Not yet recruiting · NCT07913542

Bipolar Disorder, Alcohol Use Disorder — N-acetyl cysteine, Placebo

ClinicalTrials.gov registration NCT07913542 · first posted Nov 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Time Course of Clozapine-associated Agranulocytosis Over 19 Years
Status at last check: Completed · NCT07913529

Agranulocytosis, Neutropenia, SCHIZOPHRENIA 1 (Disorder), Treatment-resistant Schizophrenia

ClinicalTrials.gov registration NCT07913529 · first posted Nov 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Inspiratory Muscle Training and Diaphragmatic Breathing in GAD
Status at last check: Recruiting · NCT07913503

Generalized Anxiety Disorder (GAD) — Inspiratory Muscle Training, Diaphragmatic Breathing Exercises, Progressive Muscle Relaxation

ClinicalTrials.gov registration NCT07913503 · first posted Nov 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Examining the Effectiveness of a Brief Therapeutic Intervention for Reducing Self-Harm Among Adolescents
Status at last check: Not yet recruiting · NCT07913425

Self Injurious Behavior, Self Injurious Behavior Without Suicidal Intent — Cutting Down Program - a three-month cognitive-behavioral psychotherapy focused on reducing self-injury urges and behaviors in adolescents

ClinicalTrials.gov registration NCT07913425 · first posted Nov 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Real-World Impact of TV-44749 in Adults With Schizophrenia
Status at last check: Not yet recruiting · NCT07913100

Schizophrenia — TV-44749

ClinicalTrials.gov registration NCT07913100 · first posted Nov 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Family Accommodation Reduction in Adult Obsessive Compulsive Disorder
Status at last check: Enrolling by invitation · NCT07912177

Obsessive - Compulsive Disorder, Family Accommodation, OCD, CBT, Psychoeducation — Family Accommodation Reduction, Family Psychoeducation

ClinicalTrials.gov registration NCT07912177 · first posted Nov 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Phase 3 Study of HS-10380 for Acute Schizophrenia in Chinese Adults
Status at last check: Not yet recruiting · NCT07911787

SCHIZOPHRENIA 1 (Disorder) — HS-10380, Aripiprazole, Placebo

ClinicalTrials.gov registration NCT07911787 · first posted Nov 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted November 2, 2026
Registration
Connecting Online Military Personnel to Alcohol Harm-reducing Smartphone Support Study
Status at last check: Not yet recruiting · NCT07911345

Alcohol Use Disorder (AUD) — VetChange (Explorer/Research version) Mobile App, Sober Time

ClinicalTrials.gov registration NCT07911345 · first posted Nov 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Justice Core Trial
Status at last check: Not yet recruiting · NCT07911332

Pregnancy, Substance Use Disorder (SUD), Prisoners — Jail Diversion into Treatment, Referral at Release

ClinicalTrials.gov registration NCT07911332 · first posted Nov 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Single-dose Effects of Ayahuasca Compared to Esketamine on Experimentally Induced Pain
Status at last check: Completed · NCT07910838

Healthy Adult Participants — Ayahuasca, Esketamine 0.2 mg/kg

ClinicalTrials.gov registration NCT07910838 · first posted Nov 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
FLOW: Influence of the Menstrual Cycle on Alcohol Use in Women
Status at last check: Not yet recruiting · NCT07910643

Alcohol Use, Alcohol Consumption, Menstrual Cycle, Women's Health

ClinicalTrials.gov registration NCT07910643 · first posted Nov 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The Immunobiological Mechanisms of Depression in Perimenopause
Status at last check: Recruiting · NCT07910552

Perimenopause, Major Depressive Episode (MDE)

ClinicalTrials.gov registration NCT07910552 · first posted Nov 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Neurostructural and Biochemical Signatures of Tobacco Smoking in Mood Disorders
Status at last check: Not yet recruiting · NCT07910318

Major Depressive Disorder, Bipolar Disorder, Tobacco Use Disorder, Mood Disorders

ClinicalTrials.gov registration NCT07910318 · first posted Nov 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Neurobiological Markers of Non-suicidal Self-injury and Treatment Mechanisms of Adolescent Self-injury Intervention Skills Training
Status at last check: Recruiting · NCT07910110

Non-suicidal Self-injury (NSSI), Adolescent — Adolescent Self-Injury Intervention Skills Training (ASIST), Treatment as Usual (TAU)

ClinicalTrials.gov registration NCT07910110 · first posted Nov 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effects of Qigong Exercise on Anxiety and Depression in Patients Receiving Inpatient Treatment for Substance Use Disorder
Status at last check: Completed · NCT07909447

Substance Use Disorder (SUD), Anxiety, Depression — Qigong Exercises

ClinicalTrials.gov registration NCT07909447 · first posted Nov 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Psilocybin FCR Early-Stage Breast Cancer
Status at last check: Not yet recruiting · NCT07909408

Early-stage Breast Cancer, Fear of Cancer Recurrence, Anxiety, Depression — Psilocybin 25 mg, Psilocybin 5 mg

ClinicalTrials.gov registration NCT07909408 · first posted Nov 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Temporal Interference Transcranial Alternating Current Stimulation Targeting the BNST or Amygdala for Generalized Anxiety Disorder
Status at last check: Recruiting · NCT07909200

Generalized Anxiety Disorder (GAD) — Temporal Interference transcranial Alternating Current Stimulation (TI-tACS), Temporal Interference transcranial Alternating Current Stimulation (TI-tACS), Sham Temporal Interference transcranial Alternating Current Stimulation (TI-tACS)

ClinicalTrials.gov registration NCT07909200 · first posted Nov 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Study to Assess the Safety, Tolerability and Pharmacokinetics of XEP527 in Patients With Stable Schizophrenia
Status at last check: Recruiting · NCT07908680

Schizophrenia — XEP527, Placebo

ClinicalTrials.gov registration NCT07908680 · first posted Nov 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effectiveness of Internet-based Unified Protocol (iUP) for Emotional Problems: A Randomized Controlled Trial
Status at last check: Not yet recruiting · NCT07908628

Depression - Major Depressive Disorder, Generalised Anxiety Disorder, Anxiety Disorder (Panic Disorder or GAD), Depressive and Anxiety Disorders — Internet-based Unified Protocol (iUP), Waitlist Control Group

ClinicalTrials.gov registration NCT07908628 · first posted Nov 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Dupilumab in Major Depressive Disorder
Status at last check: Recruiting · NCT07908563

Major Depressive Disorder — Dupilumab Injection

ClinicalTrials.gov registration NCT07908563 · first posted Nov 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 30, 2026
Registration
Trauma-Related Attributions in Trauma Treatment: An Observational Study
Status at last check: Completed · NCT07908186

PTSD

ClinicalTrials.gov registration NCT07908186 · first posted Oct 30, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
FUS Neuromodulation for Binge Eating Disorder
Status at last check: Not yet recruiting · NCT07907328

Binge-Eating Disorder — LIFU Neuromodulation

ClinicalTrials.gov registration NCT07907328 · first posted Oct 30, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Acceptance and Committment Therapy Combined With Ketamine in Difficult-to-Treat Depression.
Status at last check: Not yet recruiting · NCT07906496

Major Depressive Disorder (MDD) — K-ACT Intervention

ClinicalTrials.gov registration NCT07906496 · first posted Oct 30, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Hybrid Type 1 Randomized Controlled Trial of an Online and Text-Messaging Intervention to Prevent Alcohol and Cannabis Initiation, Escalation, and Consequences Among First-Year College Students
Status at last check: Not yet recruiting · NCT07905846

Alcohol, Cannabis — Online and Text Message Intervention

ClinicalTrials.gov registration NCT07905846 · first posted Oct 30, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 29, 2026
Registration
Validation of Wearable Core Body Temperature-Based Circadian Rhythm Digital Biomarkers
Status at last check: Not yet recruiting · NCT07905378

Mood Disorders, Major Depressive Diorder, Bipolar Disorders, Mental Disorder

ClinicalTrials.gov registration NCT07905378 · first posted Oct 29, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Written Exposure Therapy Plus Adjunctive Methylphenidate Treatment for Veterans With PTSD
Status at last check: Not yet recruiting · NCT07904000

PTSD - Post Traumatic Stress Disorder — Written Exposure Therapy (WET), methylphenidate (MPH), placebo (PBO)

ClinicalTrials.gov registration NCT07904000 · first posted Oct 29, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Multimodal Intervention for Individuals With Posttraumatic Stress Disorder (PTSD) and Hazardous Alcohol Use
Status at last check: Not yet recruiting · NCT07903974

Post Traumatic Stress Disorder PTSD, Hazardous Alcohol Use — Written Exposure Therapy (WET), Clinician Supported PTSD Coach App (CS-PTSD), Phone follow up

ClinicalTrials.gov registration NCT07903974 · first posted Oct 29, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
RISE for PTSD and Substance Use Disorder in Veterans
Status at last check: Not yet recruiting · NCT07903753

Stress Disorders, Post-Traumatic, Substance-Related Disorders — Written Exposure Therapy, Cognitive Behavioral Therapy for Substance Use Disorders (skill components), Cognitive Behavioral Therapy for Substance Use Disorders

ClinicalTrials.gov registration NCT07903753 · first posted Oct 29, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Prospective Study of Anxiety, Depression, and Bipolar Disorder in People
Status at last check: Recruiting · NCT07903246

Anxiety Disorders, Depressive Disorder, Bipolar Disorder (BD)

ClinicalTrials.gov registration NCT07903246 · first posted Oct 29, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Investigation of the Gut-Brain Axis in Alcohol Use Disorder
Status at last check: Not yet recruiting · NCT07902635

Alcohol Use Disorder (AUD), Alcohol Abstinence — Fecal Microbiota Transplantation (FMT) Procedure and Cognitive Behavioral Therapy (CBT) Procedure

ClinicalTrials.gov registration NCT07902635 · first posted Oct 29, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations
Status at last check: Recruiting · NCT07902518

Auditory Verbal Hallucinations, Schizophrenia, Schizoaffective Disorder, Psychotic Disorders — Theta-Burst Transcranial Magnetic Stimulation (TBS)

ClinicalTrials.gov registration NCT07902518 · first posted Oct 29, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 28, 2026
Registration
A Web-based Intervention Program for Postpartum Depression
Status at last check: Recruiting · NCT07902141

Postpartum Depression (PPD), Web-based Intervention — Web-based program for postpartum depression

ClinicalTrials.gov registration NCT07902141 · first posted Oct 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Friends/Family of Individuals at Risk of Suicide Training Program
Status at last check: Recruiting · NCT07902089

Caregiver, Caregiver Mental Health, Caregiver Stress, Suicide — FIRST Program

ClinicalTrials.gov registration NCT07902089 · first posted Oct 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
BEAR for Women Who Have Experienced Sexual Assault and Have Suicidal Thoughts
Status at last check: Not yet recruiting · NCT07902050

Sexual Assault and Rape, Suicidal Thoughts — BEAR Therapeutic Group

ClinicalTrials.gov registration NCT07902050 · first posted Oct 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder
Status at last check: Recruiting · NCT07901179

Major Depressive Disorder (MDD) — ALKS 7290 Dose, Placebo

ClinicalTrials.gov registration NCT07901179 · first posted Oct 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 3
Status at last check: Recruiting · NCT07900893

Schizophrenia / Schizoaffective Disorder, SCHIZOPHRENIA 1 (Disorder), Healthy Adult — Motion Perception Task, Sine Wave Speech Task, Volatility Task

ClinicalTrials.gov registration NCT07900893 · first posted Oct 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
FUS Neuromodulation for PTSD
Status at last check: Not yet recruiting · NCT07900841

Post Traumatic Stress Disorder PTSD — Focused Ultrasound

ClinicalTrials.gov registration NCT07900841 · first posted Oct 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Peer-led, Mobile App Supported Linkage to Opioid Use Disorder Treatment
Status at last check: Not yet recruiting · NCT07900828

Opioid Use Disorder — Mobile phone-assisted intervention, Peer navigator, Standard of care referral for out-patient MAT

ClinicalTrials.gov registration NCT07900828 · first posted Oct 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Multimodal Biomarkers Predicting Medication-Induced Adverse Effects in Children With ADHD
Status at last check: Recruiting · NCT07900451

ADHD — methylphenidate

ClinicalTrials.gov registration NCT07900451 · first posted Oct 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Development and Evaluation of a Digital Game Intervention Targeting Children Vulnerable to ADHD
Status at last check: Not yet recruiting · NCT07900048

ADHD or ADHD Traits — Digital Game Intervention, Tetris

ClinicalTrials.gov registration NCT07900048 · first posted Oct 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 27, 2026
Registration
Microbiota Modulation for Psychiatry Patients
Status at last check: Not yet recruiting · NCT07899424

Depression - Major Depressive Disorder, Generalized Anxiety Disorder (GAD), Anxiety — Dietary Supplement: Acetate (Apple Cider Vinegar)

ClinicalTrials.gov registration NCT07899424 · first posted Oct 27, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Integrated Psychoeducation Program for Internalized Stigma in Schizophrenia
Status at last check: Not yet recruiting · NCT07898852

Schizophrenia, Schizoaffective Disorder, Internalized Stigma, Social Stigma — Integrated Psychoeducation Program

ClinicalTrials.gov registration NCT07898852 · first posted Oct 27, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Reducing Stigma - A Treatment for Early Psychosis to Prevent Suicide
Status at last check: Not yet recruiting · NCT07898631

Suicide, Mental Health Stigma — RESTEPS

ClinicalTrials.gov registration NCT07898631 · first posted Oct 27, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
e-Perinatal Butterfly: An Embedded Study for Parents Experiencing Perinatal Loss
Status at last check: Not yet recruiting · NCT07898176

Depressive Symptoms, Perinatal Loss, Perinatal Grief, Anxiety Symptoms — e-Perinatal Butterfly, Standard routine maternal care

ClinicalTrials.gov registration NCT07898176 · first posted Oct 27, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Evaluation of National Highly Specialized Care for Children and Adolescents With Severe Self-Harm or Eating Disorders
Status at last check: Recruiting · NCT07898059

Self-harm Behavior, Eating Disorders, Non-suicidal Self-injury (NSSI) — National Highly Specialized Care (NHV)

ClinicalTrials.gov registration NCT07898059 · first posted Oct 27, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Non-Invasive Vagus Nerve Stimulation as a Probe to Map Functional Connectivity in Schizophrenia Using Functional Magnetic Resonance Imaging
Status at last check: Not yet recruiting · NCT07897266

Schizophrenia Spectrum Disorders — nVNS (non-invasive vagal nerve stimulation)

ClinicalTrials.gov registration NCT07897266 · first posted Oct 27, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Continuous Theta-Burst Stimulation for Obsessive-Compulsive Disorder: An Open-Label Study
Status at last check: Completed · NCT07896837

Obsessive-Compulsive Disorder (OCD), Transcranial Magnetic Stimulation, Electroencephalography — Continuous Theta-Burst Stimulation

ClinicalTrials.gov registration NCT07896837 · first posted Oct 27, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Understanding the Neural Underpinnings of Risk-Taking Behavior in Psychiatric Disease
Status at last check: Recruiting · NCT07896343

Depression - Major Depressive Disorder — Approach-Avoidance Decision-Making Task

ClinicalTrials.gov registration NCT07896343 · first posted Oct 27, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 26, 2026
Registration
Assessment of the Seasonality of Depressive Symptoms in Adolescents
Status at last check: Not yet recruiting · NCT07895758

Depressive Symptoms — Measuring the intensity of the seasonality of depressive symptoms in adolescents

ClinicalTrials.gov registration NCT07895758 · first posted Oct 26, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Linear Accelerator Radiosurgical Anterior Capsulotomy With Task-based fMRI Identification of PERSonalized and PrEdictiVE Biomarkers of REsponse in Treatment-Refractory Obsessive-Compulsive Disorder (PERSEVERE Trial)
Status at last check: Not yet recruiting · NCT07895706

Treatment-refractory Obsessive-compulsive Disorder (trOCD) — Radiosurgical anterior capsulotomy

ClinicalTrials.gov registration NCT07895706 · first posted Oct 26, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
R34 Asthma Depression
Status at last check: Not yet recruiting · NCT07895576

Asthma, Depression — SAMBA, Cognitive Behavioral Therapy-Asthma Depression (CBT-AD), Original SAMBA

ClinicalTrials.gov registration NCT07895576 · first posted Oct 26, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Psilocybin for Depression in Veterans
Status at last check: Not yet recruiting · NCT07895134

Major Depression — Psilocybin, modafinil, zolpidem

ClinicalTrials.gov registration NCT07895134 · first posted Oct 26, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Expand Your Horizon-Spanish
Status at last check: Not yet recruiting · NCT07894978

Body Image, Body Image Dissatisfaction, Eating Disorders, University Students, Prevention — Expand Your Horizon (EYH), Creative Writing Control

ClinicalTrials.gov registration NCT07894978 · first posted Oct 26, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Pain Sensitivity, Alcohol-Induced Analgesia, and Heavy Drinking in Individuals With Opioid Use Disorder
Status at last check: Not yet recruiting · NCT07894276

Opioid Use Disorder, Alcohol Intoxication, Pain — Alcohol, Placebo

ClinicalTrials.gov registration NCT07894276 · first posted Oct 26, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Phase 1: Thrive Together
Status at last check: Not yet recruiting · NCT07894094

Attention-Deficit/Hyperactivity Disorder (ADHD)

ClinicalTrials.gov registration NCT07894094 · first posted Oct 26, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Acute Effects of a Single Dose of Ayahuasca on Cerebral Metabolism in Healthy Volunteers: a PET Study
Status at last check: Enrolling by invitation · NCT07893912

Healthy Adult Participants — Ayahuasca

ClinicalTrials.gov registration NCT07893912 · first posted Oct 26, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effects of Different Doses of Ayahuasca on Personality in Healthy Volunteers
Status at last check: Completed · NCT07893769

Healthy Adult Participants — Ayahuasca, Ayahuasca, Ayahuasca

ClinicalTrials.gov registration NCT07893769 · first posted Oct 26, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 23, 2026
Registration
Specialist Supportive Clinical Management (SSCM) for Children and Adolescents With Anorexia Nervosa and Atypical Anorexia Nervosa
Status at last check: Recruiting · NCT07893145

Anorexia Nervosa, Atypical Anorexia Nervosa — Specialist Supportive Clinical Management for Children and Adolescents (SSCM-Youth)

ClinicalTrials.gov registration NCT07893145 · first posted Oct 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Randomized, 52-Week Extension Study to Evaluate the Maintenance of Remission, Relapse Prevention, and Long-Term Safety of CreNeuroS™ in Patients With Major Depressive Disorder Who Achieved Remission Following an 8-Week Parent Study
Status at last check: Recruiting · NCT07893002

Adjunct in the Treatment of Depressive Disorder — No intervention, CreNeuroS™ CNS Fish Oil Plus Softgels, 1 capsule orally once daily, CreNeuroS™ CNS Fish Oil Plus Softgels, 2 capsule orally once daily

ClinicalTrials.gov registration NCT07893002 · first posted Oct 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Clinical Trial to Evaluate the Efficacy and Safety of Meltz, a Digital Therapeutic Device, for Improving Panic Symptoms in Patients With Panic Disorder
Status at last check: Not yet recruiting · NCT07892885

Panic Disorder, Agoraphobia — Meltz, Sham Application

ClinicalTrials.gov registration NCT07892885 · first posted Oct 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effectiveness of Single-Session Acceptance and Commitment Therapy for Generalized Anxiety Symptoms.
Status at last check: Completed · NCT07892768

Generalised Anxiety Disorder, Anxiety — Single-Session Acceptance and Commitment Therapy (SS-ACT)

ClinicalTrials.gov registration NCT07892768 · first posted Oct 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effect of Neurofeedback and TMS
Status at last check: Not yet recruiting · NCT07892287

Depression - Major Depressive Disorder — Repetitive Transcranial Magnetic Stimulation, Alpha-down EEG Neurofeedback

ClinicalTrials.gov registration NCT07892287 · first posted Oct 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
REM Sleep Disruption and Its Potential Uses in Depression Management
Status at last check: Completed · NCT07891806

Depression / Major Depressive Disorder, Depressed Mood — REM-Contingent Smartwatch Haptic Stimulation, Smartwatch Sleep Monitoring and Smart Alarm

ClinicalTrials.gov registration NCT07891806 · first posted Oct 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effects of a School-Based Trauma-Informed Psychosocial Competence Intervention on Nonsuicidal Self-Injury in Adolescents
Status at last check: Not yet recruiting · NCT07891754

Nonsuicidal Self-Injury — Trauma-Informed Psychosocial Competence (TIPC) Program

ClinicalTrials.gov registration NCT07891754 · first posted Oct 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Neural Mechanisms of Real-world Emotions and Internalizing
Status at last check: Recruiting · NCT07891624

Major Depression, Generalized Anxiety, Emotions — Academic Performance Feedback

ClinicalTrials.gov registration NCT07891624 · first posted Oct 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Trauma Suppression Training for Veterans
Status at last check: Completed · NCT07891559

Posttraumatic Stress Disorder (PTSD) — Web-based Think/No-Think retrieval-suppression training

ClinicalTrials.gov registration NCT07891559 · first posted Oct 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Pilot Study of a Behavioral Program for Depression in Skilled Nursing Facility Residents and Care Partners
Status at last check: Completed · NCT07891546

Nursing Home Resident, Skilled Nursing Facility, Depression, Feasibility Studies, Caregiver — Interventions for Stressful Transitions in Later Life (InSTILL)

ClinicalTrials.gov registration NCT07891546 · first posted Oct 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 22, 2026
Registration
Improving Women's Mental Health Through Tele-based Wellbeing Centres in Bangladesh.
Status at last check: Recruiting · NCT07890896

Depression, Anxiety — Tele-counselling, In-person counselling

ClinicalTrials.gov registration NCT07890896 · first posted Oct 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Evaluating the PolarUs App in People With Bipolar Disorder
Status at last check: Not yet recruiting · NCT07890805

Bipolar Disorder (BD), Quality of Life (QOL) — PolarUs Mobile App

ClinicalTrials.gov registration NCT07890805 · first posted Oct 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Testing a Non-Deceptive Placebo Intervention for Subclinical Depressive Symptoms
Status at last check: Not yet recruiting · NCT07889908

Depression - Major Depressive Disorder, Psychological Distress, Depression / Major Depressive Disorder — Non-deceptive placebo (NDP)

ClinicalTrials.gov registration NCT07889908 · first posted Oct 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Sensation Seeking and TMS Response in TRD
Status at last check: Recruiting · NCT07889739

MDD, Severe Depression, Major Depressive Episode — Transcranial Magnetic Stimulation (TMS)

ClinicalTrials.gov registration NCT07889739 · first posted Oct 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of Stay
Status at last check: Not yet recruiting · NCT07888933

Suicidal Ideation, Suicidal Behavior — Esketamine, Midazolam (Intravenous)

ClinicalTrials.gov registration NCT07888933 · first posted Oct 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Targeted Health Dialogues for Individuals With Psychosis Spectrum Disorders
Status at last check: Not yet recruiting · NCT07888894

Psychoses, Metabolic Syndrome — Targeted Health Dialogues

ClinicalTrials.gov registration NCT07888894 · first posted Oct 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Temporal Interference Stimulation in Major Depressive Disorder: A Pilot Feasibility Study
Status at last check: Completed · NCT07888387

Major Depressive Disorder (MDD) — Temporal Interference Stimulation, Temporal Interference Stimulation, Temporal Interference Stimulation

ClinicalTrials.gov registration NCT07888387 · first posted Oct 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Dialectical Behavior Therapy for Adolescent With Repeated Suicidal and Self-harming Behavior in Tanta University Hospitals
Status at last check: Completed · NCT07888270

Dialectical Behavior Therapy, Suicidal, Adolescent, Behavior — Dialectical Behavior Therapy, Individual and Group Supportive Therapy group

ClinicalTrials.gov registration NCT07888270 · first posted Oct 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Temporal Interference Stimulation (TI) for Schizophrenia (SCZ)
Status at last check: Not yet recruiting · NCT07887997

Schizophrenia — Active transcranial temporal interference stimulation, Sham transcranial temporal interference stimulation

ClinicalTrials.gov registration NCT07887997 · first posted Oct 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 21, 2026
Registration
SONATA Dose Duration LIFU for OCD
Status at last check: Recruiting · NCT07887633

Obsessive - Compulsive Disorder — ATTN201 - Low Intensity Focused Ultrasound

ClinicalTrials.gov registration NCT07887633 · first posted Oct 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Methyl Donor-Rich Diet in the Postpartum Period
Status at last check: Recruiting · NCT07887178

Postpartum Depression (PPD), Breastfeeding, Maternal Nutrition, Infant Development — Methyl Donor-Rich Dietary Intervention

ClinicalTrials.gov registration NCT07887178 · first posted Oct 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Salience Network Informed rTMS for PTSD
Status at last check: Not yet recruiting · NCT07886840

Stress Disorders, Post-Traumatic — Active MRI-Guided intermittent theta burst stimulation (iTBS), Sham MRI-Guided intermittent theta burst stimulation (iTBS)

ClinicalTrials.gov registration NCT07886840 · first posted Oct 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Cannabidiol in Opioid Use Disorder and Chronic Pain With Buprenorphine
Status at last check: Recruiting · NCT07886606

Chronic Pain, Opioid Use Disorder — 400 mg Cannabidiol, 800 mg Cannabidiol, 1200 mg Cannabidiol

ClinicalTrials.gov registration NCT07886606 · first posted Oct 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Evaluation of a Multi-Layered Digital Phenotyping, Digital Safety Plan, and Pharmacogenomic Intervention for Suicide Prevention in Adults With Depression
Status at last check: Recruiting · NCT07885722

Depressive Disorder, Major Depressive Disorder, Suicidal Ideation, Suicide, Attempted, Suicide Prevention — Digital Monitoring (Active/Passive EMA), Ecological Momentary Intervention (EMI) via Digital Safety Plan, Pharmacogenetic-Guided Care and Therapeutic Drug Monitoring

ClinicalTrials.gov registration NCT07885722 · first posted Oct 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A School-Based Intervention to Prevent Disordered Eating in Middle School Students
Status at last check: Completed · NCT07885631

Disordered Eating Behaviors — School-Based Disordered Eating Prevention Education Program

ClinicalTrials.gov registration NCT07885631 · first posted Oct 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 20, 2026
Registration
Cognitive Behavioral Therapy for Substance Use and Mental Health in University Students
Status at last check: Completed · NCT07884422

Substance Use Behavior — Cognitive-Behavioral Therapy (CBT)-Based Group Intervention, Group Counseling Program

ClinicalTrials.gov registration NCT07884422 · first posted Oct 20, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Developing Virtual Reality Programs to Address Social Skills Deficits in Youth With ADHD
Status at last check: Not yet recruiting · NCT07882823

Attention-Deficit/Hyperactivity Disorder (ADHD) — VIP Suite

ClinicalTrials.gov registration NCT07882823 · first posted Oct 20, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 19, 2026
Registration
French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls
Status at last check: Recruiting · NCT07881016

Schizophrenia / Schizoaffective Disorder, First Episode Psychosis (FEP), Bipolar Disorder (BD), Major Depressive Disorder (MDD, Treatment-resistant Depression (TRD), Autism Spectrum Disorder (ASD — 3T Brain MRI, Biological Sampling, Clinical, Cognitive and Digital Assessments

ClinicalTrials.gov registration NCT07881016 · first posted Oct 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Dietary Education Intervention for Subthreshold Depression (MIND-Trial)
Status at last check: Not yet recruiting · NCT07880652

Subthreshold Depression — Mediterranean-Style Dietary Education Program, Befriending

ClinicalTrials.gov registration NCT07880652 · first posted Oct 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Improving Perinatal Mental Health Through a Collaborative, Community Health Worker and Social Worker Intervention
Status at last check: Not yet recruiting · NCT07880457

Perinatal Anxiety, Perinatal Depression — Patient Navigation (PN), Problem Solving Therapy (PST)

ClinicalTrials.gov registration NCT07880457 · first posted Oct 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Deep TMS for PTSD With Suicidal Ideation
Status at last check: Not yet recruiting · NCT07880340

Post Traumatic Stress Disorder PTSD, Suicidal Ideation — Deep Transcranial Magnetic Stimulation (DTMS)

ClinicalTrials.gov registration NCT07880340 · first posted Oct 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Test of Acceptance-based Bibliotherapy for Hoarding Disorder
Status at last check: Not yet recruiting · NCT07880236

Hoarding Disorder — Acceptance and Commitment Therapy Bibliotherapy

ClinicalTrials.gov registration NCT07880236 · first posted Oct 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Adapted Group Therapy Compared With Usual Care for Anxiety and Depression in Adults With an Autism Diagnosis
Status at last check: Not yet recruiting · NCT07880028

Autism Spectrum Disorder (ASD), Anxiety, Depression — Autism-adapted group cognitive behavioral therapy

ClinicalTrials.gov registration NCT07880028 · first posted Oct 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Digital Phenotypes for Predicting Depression_Validation
Status at last check: Enrolling by invitation · NCT07880015

Major Depressive Disorder, Bipolar I Disorder, Bipolar II Disorder, Mood Disorders

ClinicalTrials.gov registration NCT07880015 · first posted Oct 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Dual Neuromodulation for Depression: Boosting TMS With tES
Status at last check: Not yet recruiting · NCT07879924

Depression - Major Depressive Disorder — Transcranial Magnetic Stimulation, Transcranial Alternating Current Stimulation

ClinicalTrials.gov registration NCT07879924 · first posted Oct 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Semaglutide for the Treatment of Cannabis Use Disorder
Status at last check: Not yet recruiting · NCT07879612

Cannabis Use Disorder, Cue-reactivity — semaglutide

ClinicalTrials.gov registration NCT07879612 · first posted Oct 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 16, 2026
Registration
A Mobile App to Support Mood, Daily Routines and Medication Adherence in Adults With Severe Mental Illness
Status at last check: Not yet recruiting · NCT07879131

Severe Mental Illness, Bipolar Disorder, Schizophrenia, Schizoaffective Disorder, Major Depressive Disorder — MoodSync, Standard care

ClinicalTrials.gov registration NCT07879131 · first posted Oct 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effect of Occupational Therapy on Psychosocial Parameters and Functioning in Individuals With Severe Mental Illness
Status at last check: Not yet recruiting · NCT07879118

Schizophenia Disorder, Severe Mental Illness, Bipolar Disorder, Nonorganic Psychosis, Schizo-affective Disorder — Occupational Therapy Group Intervention

ClinicalTrials.gov registration NCT07879118 · first posted Oct 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Evaluation of National Highly Specialized Care for Adults With Treatment-Resistant Self-Harm and Eating Disorders: Substudy 1
Status at last check: Recruiting · NCT07878897

Self-harm Behavior, Eating Disorders, Non-suicidal Self-injury (NSSI) — National Highly Specialized Care (NHV)

ClinicalTrials.gov registration NCT07878897 · first posted Oct 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Remote Medical Monitoring of Patients With Depression
Status at last check: Recruiting · NCT07878754

Depression Chronic, Depression and Quality of Life, Depression, Major Depressive Episode — Use of ThIA Medical Device

ClinicalTrials.gov registration NCT07878754 · first posted Oct 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Vocal Biomarkers of Craving
Status at last check: Recruiting · NCT07878624

Addiction — Cue reactivity paradigm, Ecological momentary assessment

ClinicalTrials.gov registration NCT07878624 · first posted Oct 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
An Investigation of Mechanisms That Underly Paranoia in Behaviour and Brain That Can Inform Clinical Diagnoses That Include Paranoid Symptoms.
Status at last check: Not yet recruiting · NCT07878130

None Volunteer — Low-dose THC administration via IV, High-Dose THC administration via IV, Saline administration via IV

ClinicalTrials.gov registration NCT07878130 · first posted Oct 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The Impact of Dose on the Impairing, Intoxicating, and Abuse-Related Effects of Psilocybin
Status at last check: Not yet recruiting · NCT07877987

Psilocybin Intoxication — 0mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink, 1mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink, 5mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink

ClinicalTrials.gov registration NCT07877987 · first posted Oct 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Fecal Microbiota Transplantation in Females With Anorexia Nervosa
Status at last check: Not yet recruiting · NCT07877675

Anorexia Nervosa — Fecal Microbiota Transplantation Capsule, Placebo Capsule(s)

ClinicalTrials.gov registration NCT07877675 · first posted Oct 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effectiveness of Health Communication on Depression Elderly in Ho Chi Minh City
Status at last check: Recruiting · NCT07877571

Depression - Major Depressive Disorder — Health Communication, Health communication

ClinicalTrials.gov registration NCT07877571 · first posted Oct 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Treating Seasonal Depression With Daylight
Status at last check: Not yet recruiting · NCT07877402

Depression — Outdoor, Indoor

ClinicalTrials.gov registration NCT07877402 · first posted Oct 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Artificial Intelligence-Powered Virtual Reality Exposure Therapy for OCD in College Students: A Proof-of-Concept Study
Status at last check: Not yet recruiting · NCT07877363

Obsessive Compulsive Disorder (OCD) — Traditional Exposure and Response Prevention (ERP), Artificial Intelligence-Powered Virtual Reality Exposure Therapy (AI-VRET)

ClinicalTrials.gov registration NCT07877363 · first posted Oct 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
AI-Supported CBT-Based Psychoeducation for Caregivers of Individuals With Schizophrenia
Status at last check: Not yet recruiting · NCT07877207

Schizophrenia Caregiver, Caregiver Burden, Emotional Expressivity — Control, Interactive AI-Supported Learning Activities, AI-Supported Cognitive Behavioral Approach-Based Psychoeducation Program

ClinicalTrials.gov registration NCT07877207 · first posted Oct 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 15, 2026
Registration
SAINT® Therapy for Memory Problems in Older Adults With Treatment-Resistant Depression
Status at last check: Recruiting · NCT07876908

Depressive Disorder, Treatment-Resistant, Memory Deficits — Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT®) with the Magnus Neuromodulation System

ClinicalTrials.gov registration NCT07876908 · first posted Oct 15, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Feasibility and Preliminary Outcomes of Compassion-Focused Group Therapy for Depression and Anxiety
Status at last check: Completed · NCT07876453

Depression / Major Depressive Disorder, Anxiety Disorder (Panic Disorder or GAD) — Compassion-Focused Group Therapy (CFT)

ClinicalTrials.gov registration NCT07876453 · first posted Oct 15, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Validation and Comparative Multi-Omics Benchmarking of Fluid-Derived Volatilomics Biomarkers for the Prevention and Early Detection of Schizophrenia
Status at last check: Active, not recruiting · NCT07876089

Schizophrenia / Schizoaffective Disorder

ClinicalTrials.gov registration NCT07876089 · first posted Oct 15, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2
Status at last check: Not yet recruiting · NCT07875790

SCHIZOPHRENIA 1 (Disorder), Schizo Affective Disorder, Healthy Adult — Motion Perception Task, Sine Wave Speech Task, Volatility Task

ClinicalTrials.gov registration NCT07875790 · first posted Oct 15, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Disease Intervention Specialist (DIS) for SUD
Status at last check: Not yet recruiting · NCT07875361

Substance Use Disorder (SUD), Opioid Use Disorder, Alcohol Use Disorder (AUD), Drug Use, Overdose

ClinicalTrials.gov registration NCT07875361 · first posted Oct 15, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
An Online Tailored Cognitive Therapy-Based Intervention for Depression in Multiple Sclerosis: ACTION-MS Online
Status at last check: Not yet recruiting · NCT07875309

Depression and Anxiety Symptoms, Multiple Sclerosis — ACTION-MS website - an 8-week cognitive behavioural therapy intervention for depression., The 'Health and Wellbeing in MS' website

ClinicalTrials.gov registration NCT07875309 · first posted Oct 15, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effectiveness of Enhanced Dialectical Behavior Therapy Skills Training Group for Borderline Personality Disorder
Status at last check: Recruiting · NCT07875166

Borderline Personality Disorder (BPD), Dialectical Behavior Therapy, Public Health, Suicide Behavior, Self Harm — Enhanced Dialectical Behavior Therapy Skills Training, Dialectical Behavior Therapy, Treatment as Usual (TAU)

ClinicalTrials.gov registration NCT07875166 · first posted Oct 15, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain
Status at last check: Recruiting · NCT07874620

Chronic Pain, Pain, Opioid Withdrawal (Disorder), Opioid Use Disorder — Cebranopadol, Cebranopadol, Placebo

ClinicalTrials.gov registration NCT07874620 · first posted Oct 15, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 14, 2026
Registration
Recovery Management Checkup Scalability and Sustainability Hybrid Experiment
Status at last check: Not yet recruiting · NCT07873944

Substance Use Disorder (SUD), Opioid Use Disorders, Stimulant Overdose, Overdose Risk, Alcohol Use Disorder — Recovery Management Checkups (RMC) delivered by community-based agencies (RMC adopters), Recovery Management Checkups (RMC) delivered by staff under the research team…

ClinicalTrials.gov registration NCT07873944 · first posted Oct 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Digital Single-Session Cognitive Behavioural Therapy in Healthy Adults
Status at last check: Completed · NCT07873905

Depression / Major Depressive Disorder, Anxiety, Anxiety Disorder Generalized — Digital single-session cognitive behavioural therapy, Digital memory task

ClinicalTrials.gov registration NCT07873905 · first posted Oct 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The PSP Alcohol Reset Course
Status at last check: Recruiting · NCT07873684

Alcohol Misuse — Self-Guided PSP Alcohol Reset Course

ClinicalTrials.gov registration NCT07873684 · first posted Oct 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Comparing 10 Hz rTMS and iTBS for Adolescent Depression
Status at last check: Recruiting · NCT07873060

Depressive Disorder, Major Depressive Disorder, Adolescence — 10 Hz Repetitive Transcranial Magnetic, Intermittent Theta Burst Stimulation

ClinicalTrials.gov registration NCT07873060 · first posted Oct 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Low-intensity Ultrasound for Individuals With Obsessive-compulsive Disorder
Status at last check: Not yet recruiting · NCT07872917

Obsessive Compulsive Disorder (OCD) — Low-intensity focused ultrasound (Active), Low-intensity focused ultrasound (Sham)

ClinicalTrials.gov registration NCT07872917 · first posted Oct 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
BAROMETRE : Study on the Prognosis and Course of Individuals With Bipolar Spectrum Disorder
Status at last check: Not yet recruiting · NCT07872878

Bipolar Disorder (BD) — Structured clinical follow-up and psychometric assessment, Structured clinical follow-up and psychometric assessment

ClinicalTrials.gov registration NCT07872878 · first posted Oct 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Mindful RAVANS Study
Status at last check: Not yet recruiting · NCT07872761

mTBI - Mild Traumatic Brain Injury, Posttraumatic Stress Disorder, Posttraumatic Headache — Cala-RAVANS (Model CR-2), Sham

ClinicalTrials.gov registration NCT07872761 · first posted Oct 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 13, 2026
Registration
The Study is Investigating the Effectiveness of the Traditional Islamically Integrated Psychotherapy Using the Islamic Workbook for Religious Obsessive-Compulsive Disorder in Turkish Adults Who Suffer From Scrupulosity
Status at last check: Completed · NCT07872462

Obsessive - Compulsive Disorder — Islamically integrated cognitive behavioral intervention

ClinicalTrials.gov registration NCT07872462 · first posted Oct 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use Disorder
Status at last check: Not yet recruiting · NCT07871877

Opioid Use Disorder, Opioid Withdrawal, Substance Use Disorders — Ibogaine Hydrochloride, Extended-release naltrexone injection, 380 mg, Matching Oral Placebo

ClinicalTrials.gov registration NCT07871877 · first posted Oct 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Digital Mindfulness-Based Program for OCD
Status at last check: Not yet recruiting · NCT07871344

Obsessive-Compulsive Disorder (OCD) — Mindfulness-based cognitive-behavioral therapy digital program

ClinicalTrials.gov registration NCT07871344 · first posted Oct 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effects of Cannabidiol (CBD) on a Fixed Dose of Delta-9-tetrahydrocannabinol (THC)
Status at last check: Not yet recruiting · NCT07870187

Cannabis Intoxication — 0mg THC + 0mg CBD Brownie, 10mg THC + 0mg CBD Brownie, 10mg THC + 10mg CBD Brownie

ClinicalTrials.gov registration NCT07870187 · first posted Oct 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Emotion-Belief Intervention for Subthreshold Depression in College Students
Status at last check: Completed · NCT07869810

Subthreshold Depression — Single-session emotion-belief intervention, Continuous emotion-belief intervention, Sport-belief control

ClinicalTrials.gov registration NCT07869810 · first posted Oct 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 9, 2026
Registration
Alleviating Suicidality by Combining Psychotherapy and IM Ketamine for Rapid Treatment in the Emergency Department
Status at last check: Recruiting · NCT07868913

Suicidal Ideation — Ketamine Injectable Solution, Placebo Injection, Crisis Response Plan

ClinicalTrials.gov registration NCT07868913 · first posted Oct 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Novel and Conventional Interventions for Cognitive and Emotional Flexibility in Patient Trauma
Status at last check: Active, not recruiting · NCT07868627

Depression, Anxiety, Trauma Patients — D-Cycloserine (DCS), Transcranial Magnetic Stimulation, Unified Protocol

ClinicalTrials.gov registration NCT07868627 · first posted Oct 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Post-traumatic Estradiol Administration and Care Evaluation (PEACE)
Status at last check: Not yet recruiting · NCT07868536

Chronic Musculoskeletal Pain, Sexual Assault, Posttraumatic Stress Disorder (PTSD) — 17β-estradiol, Placebo

ClinicalTrials.gov registration NCT07868536 · first posted Oct 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
PREWELL Digital Well-being Promotion Intervention With the BitHabit App
Status at last check: Active, not recruiting · NCT07868146

General Mental Health and Well-Being, Mental Disorders, Common Mental Disorders (CMD) — Digital wellbeing promoting intervention with the BitHabit app

ClinicalTrials.gov registration NCT07868146 · first posted Oct 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Self-administered Neurostimulation Intervention for Firefighter Traumatic Stress to Reduce Alcohol Use: Pilot Study
Status at last check: Not yet recruiting · NCT07868055

Posttraumatic Stress Symptoms, Heavy Alcoholic Consumption, Alcohol Use Disorder (AUD) — Transcutaneous auricular neurostimulation (tAN), Active Sham

ClinicalTrials.gov registration NCT07868055 · first posted Oct 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Feasibility Trial of a Parent Peer-Co-Led Caregiver Group for Pediatric Early Onset Schizophrenia Spectrum Disorders
Status at last check: Not yet recruiting · NCT07867964

Schizophrenia; Psychosis — Group Therapy, Treatment as Usual (TAU)

ClinicalTrials.gov registration NCT07867964 · first posted Oct 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 8, 2026
Registration
Dysfunction of Respiratory Enzymes in Adults With Mental Illness (DREAM)
Status at last check: Completed · NCT07866833

Schizophrenia and Other Psychotic Disorders, Healthy Adult — Methylene Blue

ClinicalTrials.gov registration NCT07866833 · first posted Oct 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Group Transdiagnostic Cognitive Behavioural Therapy for Intolerance of Uncertainty Versus Applied Relaxation
Status at last check: Not yet recruiting · NCT07866794

Mental Disorders, Mood Disorders, Anxiety Disorders, Generalized Anxiety Disorder — Group Transdiagnostic Cognitive Behavioural Therapy for Intolerance of Uncertainty (CBT-IU), Group Transdiagnostic Applied Relaxation (AR)

ClinicalTrials.gov registration NCT07866794 · first posted Oct 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Cognitive Reappraisal Intervention for Suicide Prevention (CRISP 70+) for Suicidal Older Adults in a Swedish Geropsychiatric Setting
Status at last check: Active, not recruiting · NCT07866079

Suicidal Ideation, Suicide, Suicide Attempt — CRISP 70+

ClinicalTrials.gov registration NCT07866079 · first posted Oct 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
AI-Enabled Wearable Monitoring for Detection of Postpartum Depression and Anxiety
Status at last check: Not yet recruiting · NCT07866053

Postpartum Depression (PPD), Postpartum Anxiety

ClinicalTrials.gov registration NCT07866053 · first posted Oct 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Transdiagnostic Sleep Intervention to Improve Mental Health in Adolescents
Status at last check: Not yet recruiting · NCT07865728

Sleep Disturbance, Sleep Problems, Substance Use (Drugs, Alcohol), Anxiety, Depression — Transdiagnostic Intervention for Sleep and Circadian Dysfunction, Healthy habits psychoeducation

ClinicalTrials.gov registration NCT07865728 · first posted Oct 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Expanding Access to Evidence-Based Suicide Risk Assessment and Intervention in a Crisis Stabilization Setting
Status at last check: Not yet recruiting · NCT07864961

Suicide, Suicide Attempt, Randomized Controlled Trial (RCT) — Jaspr

ClinicalTrials.gov registration NCT07864961 · first posted Oct 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Digital OC Training in Children and Adolescents
Status at last check: Not yet recruiting · NCT07864675

Obsessive Compulsive Behavior — Digital behavioral training

ClinicalTrials.gov registration NCT07864675 · first posted Oct 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 7, 2026
Registration
High-Intensity Interval Training and Mental Health in Psychiatric Inpatients
Status at last check: Active, not recruiting · NCT07864324

Anxiety, Depression, Mental Health, Psychiatric Inpatients — High-Intensity Interval Training (1 × 4)

ClinicalTrials.gov registration NCT07864324 · first posted Oct 7, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
An Interrupted Time-Series Pilot Trial of LGBTQ-Affirming Cognitive Processing Therapy for Interpersonal and Developmental Trauma
Status at last check: Not yet recruiting · NCT07863817

Post-Traumatic Stress Disorder, Chronic, Depressed Mood, Depressive and Anxiety Disorders, Anxiety, Depression - Major Depressive Disorder — Cognitive Processing Therapy

ClinicalTrials.gov registration NCT07863817 · first posted Oct 7, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Digital Cognitive Behavioral Therapy for Gambling Disorder
Status at last check: Recruiting · NCT07863440

Gambling Disorder, Gambling — Digital Cognitive Behavioral Therapy for Gambling Disorder, Digital Family Intervention for Gambling-Related Harms, Face-to-Face Cognitive Behavioral Therapy for Gambling Disorder

ClinicalTrials.gov registration NCT07863440 · first posted Oct 7, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effects of HIIT and Dual-Task Training in Children With ADHD
Status at last check: Completed · NCT07863362

Attention-Deficit/Hyperactivity Disorder (ADHD), Physiotherapy — High-Intensity Interval Training With Dual-Task Training

ClinicalTrials.gov registration NCT07863362 · first posted Oct 7, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
RECONNECT - Treatments for Complex PTSD
Status at last check: Not yet recruiting · NCT07863089

Complex Post-Traumatic Stress Disorder (CPTSD) — Prolonged Exposure, EMDR, ESTAIR

ClinicalTrials.gov registration NCT07863089 · first posted Oct 7, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Gamified Virtual Reality Exercise for Suicidal Ideation in Older Adults
Status at last check: Completed · NCT07862803

Suicidal Ideation, Mental Health, Depression, Geriatric Psychiatry, Aging — Gamified VR-Based Exercise Program, Conventional Exercise Program

ClinicalTrials.gov registration NCT07862803 · first posted Oct 7, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Assessing Trauma-related Links Between Affective and Metabolic Systems
Status at last check: Not yet recruiting · NCT07862712

Posttraumatic Stress Disorder, Metabolic Syndrome, Insulin Resistance — prazosin

ClinicalTrials.gov registration NCT07862712 · first posted Oct 7, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
EEG-Guided Transcranial Magnetic Stimulation for Adults With Depression
Status at last check: Recruiting · NCT07862205

Major Depressive Disorder (MDD), Treatment Resistant Depression, Major Depression — MagVenture TMS Therapy System with Localite Navigation System and actiCHamp EEG

ClinicalTrials.gov registration NCT07862205 · first posted Oct 7, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 6, 2026
Registration
Anorexia Nervosa, Evaluation and MOdification of Attention
Status at last check: Not yet recruiting · NCT07861919

Anorexia Nervosa, Attentional Bias, Psychophysiology, Food, Interoception, Anxiety — Attentional Bias Modification Training

ClinicalTrials.gov registration NCT07861919 · first posted Oct 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Midday Bright Light Therapy for Bipolar Depression
Status at last check: Completed · NCT07860957

Bipolar Disorder (BPD) — Bright Light Therapy, Placebo Light Therapy

ClinicalTrials.gov registration NCT07860957 · first posted Oct 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Circuit-Guided Neuromodulation for Anorexia Nervosa
Status at last check: Not yet recruiting · NCT07860320

Anorexia Nervosa — Intermittent theta-burst stimulation (iTBS), Continuous theta-burst stimulation (cTBS), Sham theta-burst stimulation

ClinicalTrials.gov registration NCT07860320 · first posted Oct 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
TMS + Exposure Therapy for Pediatric OCD: Second Phase
Status at last check: Recruiting · NCT07859683

Obsessive Compulsive Behavior — Transcranial Magnetic Stimulation: continuous theta burst to pre supplementary motor area, Transcranial Magnetic Stimulation: Sham, Exposure with Response Prevention

ClinicalTrials.gov registration NCT07859683 · first posted Oct 6, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 5, 2026
Registration
Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective Disorder
Status at last check: Recruiting · NCT07858565

Schizophrenia, Bipolar Affective Disorder — Quetiapine (drug), quetiapine + aripiprazole, quetiapine + haloperidol

ClinicalTrials.gov registration NCT07858565 · first posted Oct 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Evaluation of Effectiveness of the LifeSkills Training - Lombardia - Primary Shool Program ( Val3P-LST )
Status at last check: Active, not recruiting · NCT07858513

Well Being, Drug Addiction, Tobacco Use, Alcohol Abuse, Life Skills, Violence, Bullying, Health Literacy — life skills primary prevention

ClinicalTrials.gov registration NCT07858513 · first posted Oct 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Cardiovascular Safety of Atomoxetine in Children With ADHD
Status at last check: Not yet recruiting · NCT07858448

Attention Deficit Hyperactivity Disorder

ClinicalTrials.gov registration NCT07858448 · first posted Oct 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Brief Psychoanalytic Therapy Versus Cognitive Behavioral Therapy for Major Depressive Disorder
Status at last check: Not yet recruiting · NCT07857629

Major Depressive Disorder (MDD — Brief Psychoanalytic Therapy, Cognitive Behavioral Therapy

ClinicalTrials.gov registration NCT07857629 · first posted Oct 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Clinical Protocol for VR-Assisted CBT Targeting Quality of Life Outcomes for OCD
Status at last check: Active, not recruiting · NCT07857577

OCD — VR-CBT, G-VRET

ClinicalTrials.gov registration NCT07857577 · first posted Oct 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Videoconference-Based Brief Cognitive Behavioral Therapy for Patients With Mood Disorders at High Risk for Suicide
Status at last check: Recruiting · NCT07857291

Suicidal Ideation and Behavior, Mood Disorders, Suicide Attempt, Cognitive Behavior Therapy — Videoconference-Based Brief Cognitive Behavioral Therapy, Treatment as Usual (TAU)

ClinicalTrials.gov registration NCT07857291 · first posted Oct 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Seasonality, Chronotype, Impulsivity, and Suicidality in Mood Disorder Patients
Status at last check: Completed · NCT07857213

Bipolar Disorder in Remission, Major Depression in Remission

ClinicalTrials.gov registration NCT07857213 · first posted Oct 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Evaluating the Therapeutic Potential of Focal Electrically Administered Seizure Therapy (FEAST) in the Treatment of Depression: A Multicenter Randomized Clinical Trial
Status at last check: Not yet recruiting · NCT07857122

Major Depressive Episode (MDE), Unipolar Disorder, Bipolar 1 Disorder — Stimulation by the Sigma ECT/FEAST device, Stimulation by Sigmastim ECT 200J device administered in right unilateral (RUL), Stimulation by Sigmastim ECT 200J device administered in bilateral (BT)

ClinicalTrials.gov registration NCT07857122 · first posted Oct 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Cognitive and Behavioral Approaches to Reduce Binge Eating and Excess Weight in Adolescents (Online)
Status at last check: Not yet recruiting · NCT07856784

Binge Eating, Overweight and Obesity, Eating Disorders in Adolescence — Cognitive-Behavioral Therapy for Adolescent Binge Eating, Lifestyle Behavioral Obesity Intervention, Active Control

ClinicalTrials.gov registration NCT07856784 · first posted Oct 5, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 2, 2026
Registration
A Study of JNJ-99245354 (ITI-1284) as an Adjunctive Treatment in Participants With Generalized Anxiety Disorder (GAD) Who Have an Inadequate Response to GAD Treatment
Status at last check: Recruiting · NCT07856420

Generalized Anxiety Disorder — JNJ-99245354, Placebo

ClinicalTrials.gov registration NCT07856420 · first posted Oct 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Understanding Lifespan Trajectories of Social Cognition, Brain Microstructure and Iron Dysregulation in Schizophrenia
Status at last check: Recruiting · NCT07856381

Healthy Control Subjects, Schizophrenia Diagnosis

ClinicalTrials.gov registration NCT07856381 · first posted Oct 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Neuronavigated rTMS for Treatment-Resistant Auditory Hallucinations
Status at last check: Recruiting · NCT07856368

Schizophrenia, Auditory Verbal Hallucinations — Neuronavigated repetitive transcranial magnetic stimulation (rTMS), Sham repetitive transcranial magnetic stimulation (rTMS)

ClinicalTrials.gov registration NCT07856368 · first posted Oct 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Is Craving a Central Criterion for Diagnosing a Behavioral Addiction?
Status at last check: Recruiting · NCT07854912

Addictive Behaviors, Internet Addiction Disorder, Gambling, Technology Addiction, Food Addiction, Compulsive Sexual Behavior, Screen Use — Questionnaires, Telephone interview

ClinicalTrials.gov registration NCT07854912 · first posted Oct 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effect of TMS Treatment on Defense Mechanisms and Functionality in Patients With Depression
Status at last check: Not yet recruiting · NCT07853989

Major Depressive Disorder (MDD)

ClinicalTrials.gov registration NCT07853989 · first posted Oct 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
Status at last check: Recruiting · NCT07853807

SCHIZOPHRENIA 1 (Disorder), Schizoaffective Disorder, Healthy Adult Participants — Motion Perception Task, Sine Wave Speech Task, Volatility Task

ClinicalTrials.gov registration NCT07853807 · first posted Oct 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted October 1, 2026
Registration
Predictors of Treatment Outcome in Major Depressive Disorder
Status at last check: Not yet recruiting · NCT07853365

Major Depressive Disorder

ClinicalTrials.gov registration NCT07853365 · first posted Oct 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Brave Heart Intervention and Mental Health Outcomes Among Young People in Sierra Leone
Status at last check: Completed · NCT07853092

Substance-related Disorders, Mental Health Literacy, Adolescent Health, Substance Use Disorder (SUD) — Brave Heart Intervention

ClinicalTrials.gov registration NCT07853092 · first posted Oct 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Motivational Intervention for Patients With Schizophrenia
Status at last check: Not yet recruiting · NCT07853079

Schizo-affective Disorder, Non Organic Psychosis, Schizophenia Disorder — Positive Emotion Program for Schizophrenia (PEPS), a psychotherapeutic intervention,

ClinicalTrials.gov registration NCT07853079 · first posted Oct 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Examination of Transcranial Focused Ultrasound on Brain Activity in Adults With Cocaine Use Disorder
Status at last check: Not yet recruiting · NCT07852923

Cocaine Use Disorder (CUD) — tFUS, Sham tFUS

ClinicalTrials.gov registration NCT07852923 · first posted Oct 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effects of Psilocybin on Craving in Nicotine Dependence
Status at last check: Not yet recruiting · NCT07852832

Nicotine Dependence — Psilocybin (drug)

ClinicalTrials.gov registration NCT07852832 · first posted Oct 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
HBOT Effects on First Responders' Cognition and Well-Being
Status at last check: Recruiting · NCT07852728

Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder, Anxiety, Depression, Post Concussion Symptoms — Hyperbaric Oxygen Therapy (HBOT)

ClinicalTrials.gov registration NCT07852728 · first posted Oct 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Pilot Study of a DBT-Informed Caregiver Risk Management Workshop
Status at last check: Not yet recruiting · NCT07852429

Caregivers, Suicide, Nonsuicidal Self Injury, Adolescent, Young Adult — Workshop and consultation for caregivers of at risk youth

ClinicalTrials.gov registration NCT07852429 · first posted Oct 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
iTBS Versus Standard 10 Hz rTMS for Treatment-Resistant Depression (TRD)
Status at last check: Active, not recruiting · NCT07852065

Major Depression — iTBS, rTMS

ClinicalTrials.gov registration NCT07852065 · first posted Oct 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Sleep Architecture, Cognitive Function, and Quality of Life During Early Recovery From Substance Use Disorder
Status at last check: Not yet recruiting · NCT07852052

Substance-Related Disorders, Substance Use Disorder, Sleep Wake Disorders, Cognitive Dysfunction

ClinicalTrials.gov registration NCT07852052 · first posted Oct 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Validation of an Algorithm for Predicting Awakenings Associated With Trauma-related Nightmares, Based on the Analysis of Physiological Patterns in Military and Former Military Patients Suffering From Post-traumatic Stress Disorder
Status at last check: Recruiting · NCT07851480

PTSD - Post Traumatic Stress Disorder, Trauma-related Nightmares — CAUD-PIN (CAUchemar Detection on INdividualized Parameters) - AI-based predictive algorithm forTrauma-related nightmare awakenings

ClinicalTrials.gov registration NCT07851480 · first posted Oct 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Anger, Social Cognition and Post-traumatic Stress Disorder in Former French Military Personnel
Status at last check: Recruiting · NCT07851090

Post Traumatic Stress Disorder

ClinicalTrials.gov registration NCT07851090 · first posted Oct 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Focused Ultrasound for Behavioral Health
Status at last check: Recruiting · NCT07851038

Depression, Anxiety, Obsessive Compulsive Disorder (OCD) — ATTN201 head-worn focused ultrasound

ClinicalTrials.gov registration NCT07851038 · first posted Oct 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 30, 2026
Registration
Assessment of the Preventive Effect of Defusing on Traumatic Kindling
Status at last check: Not yet recruiting · NCT07850193

Acute Stress Disorder, Post Traumatic Stress Disorder PTSD — Defusing, Psychological First Aid (PFA)

ClinicalTrials.gov registration NCT07850193 · first posted Sep 30, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Brain Imaging of DSP-2342
Status at last check: Not yet recruiting · NCT07850102

SCHIZOPHRENIA 1 (Disorder) — DSP-2342

ClinicalTrials.gov registration NCT07850102 · first posted Sep 30, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Anhedonia Beyond Depressive Symptoms in Children and Adolescents With Conduct Disorder
Status at last check: Not yet recruiting · NCT07849985

Conduct Disorder, Depression

ClinicalTrials.gov registration NCT07849985 · first posted Sep 30, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Transcranial Magnetic Stimulation for Methamphetamine Use Disorder During Pregnancy
Status at last check: Not yet recruiting · NCT07849530

Methamphetamine Use Disorder, Pregnancy — 4- Week Dual-Target Transcranial Magnetic Stimulation (TMS), Accelerated Dual-Target Transcranial Magnetic Stimulation (aTMS), Treatment as Usual (TAU)

ClinicalTrials.gov registration NCT07849530 · first posted Sep 30, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Hyperbaric Oxygen Therapy for Veterans With TBI and PCS: A Biomarker Study
Status at last check: Recruiting · NCT07849465

Traumatic Brain Injury (TBI) Patients, Post Concussive Symptoms, PTSD — Hyperbaric Oxygen Therapy (HBOT)

ClinicalTrials.gov registration NCT07849465 · first posted Sep 30, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Acceptance and Commitment Therapy-Based Chatbot for Non-suicidal Self-Injury in Adolescents
Status at last check: Not yet recruiting · NCT07848620

Non-suicidal Self-injury (NSSI) — ACT-Based Chatbot

ClinicalTrials.gov registration NCT07848620 · first posted Sep 30, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
PROMOTE: Effects of 5-HT4 Agonism on Cognition and Sleep in Peopl With Low Mood
Status at last check: Recruiting · NCT07848477

Low Mood, Depression - Major Depressive Disorder — Prucalopride, Placebo Comparator

ClinicalTrials.gov registration NCT07848477 · first posted Sep 30, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 29, 2026
Registration
Brain Connectivity and Inflammatory Markers During Short-Term Psychotherapy for Treatment-Resistant Depression
Status at last check: Completed · NCT07847242

Depressive Disorder, Treatment-Resistant — Short-Term Dynamic Psychotherapy, Mindfulness-Based Cognitive Therapy

ClinicalTrials.gov registration NCT07847242 · first posted Sep 29, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Evaluation of a Brief, Scalable Module to Mitigate Suicidal Ideation Among Youth (Phase 2)
Status at last check: Not yet recruiting · NCT07847008

Perceived Burdensomeness, Suicidal Ideation — Safety Planning, Give to Others (GO) Module, MATCH (Modular Approach to Therapy for Children) - Anxiety and Depression Modules

ClinicalTrials.gov registration NCT07847008 · first posted Sep 29, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Youth Overdose & Use Reduction in Rural Systems
Status at last check: Not yet recruiting · NCT07846735

Substance Abuse, Opioid Abuse (Disorder), Overdose Prevention, Substance Use Disorder (SUD), Adolescent Substance Use, Rural Health — Navigator - Flexible Care Management

ClinicalTrials.gov registration NCT07846735 · first posted Sep 29, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The Effect of Probiotic Foods on Depression
Status at last check: Completed · NCT07846072

Fermented Food, Depression — Individualized diet excluding fermented foods, Lower-frequency fermented-food dietary intervention, Higher-frequency fermented-food dietary intervention

ClinicalTrials.gov registration NCT07846072 · first posted Sep 29, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Multi-Component Training Versus Motor Learning Techniques in Adults With ADHD
Status at last check: Not yet recruiting · NCT07845981

Attention Deficit Hyperactivity Disorder — Multi-Component Training, Motor Learning Techniques

ClinicalTrials.gov registration NCT07845981 · first posted Sep 29, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Precision Depression Adalimumab Trial
Status at last check: Recruiting · NCT07845604

Major Depressive Disorder (MDD) — Adalimumab Biosimilars Injection, Placebo

ClinicalTrials.gov registration NCT07845604 · first posted Sep 29, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Testing Intervention Strategies for Addressing Binge Eating and Food Insecurity
Status at last check: Recruiting · NCT07845461

Binge Eating, Food Insecurity — FoodSteps, Weekly Stipend, Monthly Stipend

ClinicalTrials.gov registration NCT07845461 · first posted Sep 29, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 28, 2026
Registration
Targeted Alternating Current and Cognitive Training Intervention for Cognitive Control in Bipolar Disorders
Status at last check: Not yet recruiting · NCT07845409

Bipolar Disorder, Bipolar and Related Disorders, Veterans, Suicide, Suicidal Ideation, Mental Disorders — Soterix 1x1 tES mini-CT

ClinicalTrials.gov registration NCT07845409 · first posted Sep 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Methodology of Super-Early Training of Developer Engineers and Leading Analysts With a Diagnosis of ADHD/ASD for Ensuring the Engineering Sovereignty of the State: Time Horizon: 2026-2038-2050
Status at last check: Active, not recruiting · NCT07845292

Attention Deficit Hyperactivity Disorder (ADHD) — Voice of Sleep "MamaBee" training modules (Fairy Tales)

ClinicalTrials.gov registration NCT07845292 · first posted Sep 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Slow-Paced Breathing and Electrical Vagus Nerve Stimulation as Add-on Treatments for Depression
Status at last check: Not yet recruiting · NCT07844733

Depression - Major Depressive Disorder — Slow-Paced Breathing, Transcutaneous Auricular Vagus Nerve Stimulation (tVNS), Sham Auricular Electrical Stimulation

ClinicalTrials.gov registration NCT07844733 · first posted Sep 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Study on Thiamine Supplementation to REduce braiN Injury Associated With Chronic Alcohol Use in Outpatients With Alcohol Use Disorder
Status at last check: Recruiting · NCT07844720

Alcohol Use Disorder — Thiamine

ClinicalTrials.gov registration NCT07844720 · first posted Sep 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Dehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-resistant Depression.
Status at last check: Recruiting · NCT07843927

Treatment Resistant Depression (TRD) — Dehydroepiandrosterone (DHEA), Placebo

ClinicalTrials.gov registration NCT07843927 · first posted Sep 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Personalized Accelerated iTBS Versus Sham for Major Depressive Disorder
Status at last check: Not yet recruiting · NCT07843875

Major Depressive Disorder (MDD) — Personalized Functional-Connectivity-Targeted Accelerated iTBS, Sham Accelerated iTBS

ClinicalTrials.gov registration NCT07843875 · first posted Sep 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Parenting-STAIR Modular for Military Fathers and OCONUS Families
Status at last check: Not yet recruiting · NCT07843654

Depressive Symptoms, Emotional Depression, Depression, Parent Child Relationship, Parent-Child Relationship, Parent-Child Relations, Stress Disorder, Post Traumatic, PTSD, Parenting, Child Behavior, Emotional Regulation, Emotion Regulation — Parenting-STAIR Modular (PSTAIR-M)…

ClinicalTrials.gov registration NCT07843654 · first posted Sep 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 25, 2026
Registration
A Clinical Trial to Compare the Efficacy and Safety of WAS123 Versus Daily Aripiprazole in the Maintenance Treatment of Patients With Schizophrenia.
Status at last check: Completed · NCT07843056

Schizophenia Disorder — WAS123, Aripiprazole (Fixed dose)

ClinicalTrials.gov registration NCT07843056 · first posted Sep 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Helping Kentuckians Overcome Depression and Opioid Addiction With Brain Stimulation
Status at last check: Recruiting · NCT07842601

Opioid Use Disorder, Major Depressive Disorder (MDD) — Transcranial Magnetic Stimulation (TMS), Sham Transcranial Magnetic Stimulation (TMS)

ClinicalTrials.gov registration NCT07842601 · first posted Sep 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Examining the Relationship Between Ongoing Alcohol Use, Suicidal Thoughts and Behaviors and Related Constructs, and Behavioral Economic Decision-Making.
Status at last check: Not yet recruiting · NCT07842588

Alcohol Use Disorder (AUD), Suicidal Ideation — CBT4CBT

ClinicalTrials.gov registration NCT07842588 · first posted Sep 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
AI Mental Health Tool vs. Psychoeducation Control
Status at last check: Active, not recruiting · NCT07841483

Depressive Disorder, Depressive Symptoms — Ash, Psychoeducation

ClinicalTrials.gov registration NCT07841483 · first posted Sep 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Psychotherapy for Self-Disorders in Schizophrenia Spectrum Disorder
Status at last check: Not yet recruiting · NCT07841418

Schizophrenia Spectrum Disorders (SSD) — SELF-7, F-ACT

ClinicalTrials.gov registration NCT07841418 · first posted Sep 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Deep Brain Reorienting for Posttraumatic Stress Disorder
Status at last check: Recruiting · NCT07840417

Posttraumatic Stress Disorder (PTSD), Posttraumatic Stress Symptom — Deep Brain Reorienting, Treatment as Usual (TAU)

ClinicalTrials.gov registration NCT07840417 · first posted Sep 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 24, 2026
Registration
Creative Art Teletherapy for Veterans With PTSD
Status at last check: Not yet recruiting · NCT07840079

Post-Traumatic Stress Disorder F03.950.750.500 D013313 — Art-therapy Remote Treatment for Veterans Experiencing Trauma

ClinicalTrials.gov registration NCT07840079 · first posted Sep 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Study Comparing Oral Ketamine With Oral Midazolam for the Treatment of Major Depressive Episodes
Status at last check: Not yet recruiting · NCT07839338

Major Depressive Episode — Oral ketamine, Oral midazolam

ClinicalTrials.gov registration NCT07839338 · first posted Sep 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Measurement-Based Care to Support Buprenorphine-Naloxone Treatment in Outpatient Addiction Clinics
Status at last check: Not yet recruiting · NCT07839182

Opioid Use Disorder — Bup-MBC

ClinicalTrials.gov registration NCT07839182 · first posted Sep 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Psychological Capital and Suicide Ideation
Status at last check: Completed · NCT07839117

Suicide Ideation — Psychological Capital (PsyCap) Development Intervention

ClinicalTrials.gov registration NCT07839117 · first posted Sep 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Brain Function and Cognitive Control Training in Children With Obsessive-Compulsive Symptoms
Status at last check: Not yet recruiting · NCT07839013

Obsessive-Compulsive Symptoms, Cognitive Control — Cognitive Control Training

ClinicalTrials.gov registration NCT07839013 · first posted Sep 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Delayed-Release, Extended-Release Methylphenidate (Jornay PM) for Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder
Status at last check: Not yet recruiting · NCT07838311

ADHD, Cannabis Use Disorder — Delayed-release, extended-release methylphenidate, Placebo

ClinicalTrials.gov registration NCT07838311 · first posted Sep 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Implementing BEAM: A Scalable Digital Mental Health Program, for Families of Children Referred to Neurodevelopmental Services
Status at last check: Not yet recruiting · NCT07837791

Depression and Anxiety Symptom, Anger, Parenting, Stress (Psychology), Parent Child Relationship, Child Development, Neurodevelopmental Conditions — The Building Emotional Awareness and Mental Health (BEAM) Program

ClinicalTrials.gov registration NCT07837791 · first posted Sep 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 23, 2026
Registration
Psychological Resilience and Quality of Life Among Caregivers of Patients With Schizophrenia
Status at last check: Not yet recruiting · NCT07837479

Schizophrenia, Caregiver Burden, Quality of Life

ClinicalTrials.gov registration NCT07837479 · first posted Sep 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Novel Approaches to Supporting Students With ADHD in Multi-Tiered Systems of Support
Status at last check: Not yet recruiting · NCT07836972

Attention Deficit Hyerpactivity Disorder — Academic Competency Enhancement (ACE) classroom, School as Usual Classroom Supports

ClinicalTrials.gov registration NCT07836972 · first posted Sep 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD
Status at last check: Recruiting · NCT07836647

Post Traumatic Stress Disorder — TSND-201, Placebo

ClinicalTrials.gov registration NCT07836647 · first posted Sep 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Physical Activity for Depressive Symptoms in Adults With Obesity: A Randomized Controlled Feasibility Trial
Status at last check: Not yet recruiting · NCT07836582

Obesity & Overweight, Depression Disorders — Supervised Physical Activity Program

ClinicalTrials.gov registration NCT07836582 · first posted Sep 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Closed Unit Incorporating Soteria Elements Versus a Conventional Closed Psychiatric Ward
Status at last check: Recruiting · NCT07836348

Psychotic Disorders — Inpatient Care in a Closed Unit Incorporating Soteria Elements, Conventional Closed Psychiatric Inpatient Care

ClinicalTrials.gov registration NCT07836348 · first posted Sep 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Predicting the Outcome of ADHD in White Matter Injure Neonates With Multi-modality MRI
Status at last check: Completed · NCT07836244

White Matter Abnormalities, Nonspecific, ADHD, Neurodevelopment Outcome

ClinicalTrials.gov registration NCT07836244 · first posted Sep 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Thrive at Home: A Virtual Reality Social Intervention for Older Adults
Status at last check: Not yet recruiting · NCT07835568

Mental Health (Depression), Mental Health and General Well-being, Loneliness, Well Being, Caregiver Burden, Caregiver Wellbeing, Mild Cognitive Impairment(MCI), Alzheimer Dementia (AD), Dementia — Full Virtual Reality Social Intervention, Abbreviated Virtual Reality Social…

ClinicalTrials.gov registration NCT07835568 · first posted Sep 23, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 22, 2026
Registration
Home-Based Randomized Trial of Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression
Status at last check: Not yet recruiting · NCT07834762

Treatment Resistant Depression (TRD), Major Depressive Disorder (MDD) — Spaced Transcranial Direct Current Stimulation (tDCS), Sham Spaced tDCS

ClinicalTrials.gov registration NCT07834762 · first posted Sep 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Singula Phase 0.1 Primary Care Pilot
Status at last check: Recruiting · NCT07834684

Depression - Major Depressive Disorder, Anxiety

ClinicalTrials.gov registration NCT07834684 · first posted Sep 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Virtual Reality (VR-GINSO) as an Complement to Intervention for Alcohol and Cannabis Use in Youth in Residential Care
Status at last check: Recruiting · NCT07834606

Dual Diagnosis, Risk Youth, Antisocial Behavior — Virtual Reality, Treatment as Usual (TAU)

ClinicalTrials.gov registration NCT07834606 · first posted Sep 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Clinical and Biological Correlates of Obsessive-Compulsive Disorder and Online Mindfulness-Based Cognitive Therapy
Status at last check: Recruiting · NCT07834567

Obsessive - Compulsive Disorder — Mindfulness-based Cognitive Therapy for OCD

ClinicalTrials.gov registration NCT07834567 · first posted Sep 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Comparison of Group Cognitive Behavioural Therapy (CBT) and Structured Activity Group for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status at last check: Recruiting · NCT07834437

ADHD — Group CBT based on DBT-skills training, Activity group

ClinicalTrials.gov registration NCT07834437 · first posted Sep 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
State Representation in Early Psychosis 2
Status at last check: Recruiting · NCT07834203

Early Psychosis, Psychosis, Schizophrenia, Bipolar Disorder With Psychosis, Schizoaffective Disorder

ClinicalTrials.gov registration NCT07834203 · first posted Sep 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Body Weight Changes After Switching to Lurasidone for Antipsychotic-induced Weight Gain in Bipolar Disorder
Status at last check: Completed · NCT07834112

Bipolar Disorder (BD) — Lurasidone

ClinicalTrials.gov registration NCT07834112 · first posted Sep 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
ADEPT Psilocybin-Assisted Therapy With DBT for Borderline Personality Disorder
Status at last check: Not yet recruiting · NCT07833761

Borderline Personality Disorder, Borderline Personality Pathology, Depressive Symptoms, Emotion Dysregulation, Suicidal Ideation — Psilocybin, Psilocybin-Assisted Therapy With Dialectical Behavior Therapy

ClinicalTrials.gov registration NCT07833761 · first posted Sep 22, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 21, 2026
Registration
Attachment and Substance Use Disorder: An Interventional Study in an Addictology Day Hospital
Status at last check: Completed · NCT07831135

Addiction Disorders — attachment-focused therapeutic program, psychoeducation-based intervention (standard care)

ClinicalTrials.gov registration NCT07831135 · first posted Sep 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Physiopathology of Behavioral Addictions and Biomarkers
Status at last check: Not yet recruiting · NCT07830680

Food Addiction, Sexual Addiction — blood sampling

ClinicalTrials.gov registration NCT07830680 · first posted Sep 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Amygdala-Targeted Transcranial Temporal Interference Stimulation for Major Depressive Disorder: A Randomized Sham-Controlled Trial of Clinical Efficacy and Neurobiological Mechanisms
Status at last check: Not yet recruiting · NCT07829575

Major Depressive Disorder (MDD — Transcranial Temporal Interference Stimulation, Sham Transcranial Temporal Interference Stimulation

ClinicalTrials.gov registration NCT07829575 · first posted Sep 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Transforming Trauma Care
Status at last check: Not yet recruiting · NCT07829510

Post-Traumatic Stress Disorder (PTSD), Depression, Substance Use Disorder, Traumatic Injury — Trauma Resilience and Recovery Program Portal 2.0 (TRRP 2.0)

ClinicalTrials.gov registration NCT07829510 · first posted Sep 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 18, 2026
Registration
Open-label Feasibility Trial of HD-tDCS During Cognitive Behavioral Therapy for Cocaine Use Disorder
Status at last check: Recruiting · NCT07829263

Cocaine Use Disorder — High Definition Transcranial Direct Current Stimulation

ClinicalTrials.gov registration NCT07829263 · first posted Sep 18, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Development of Low-Intensity Focused Ultrasound for Post Traumatic Brain Injury Depression
Status at last check: Not yet recruiting · NCT07828483

Post-traumatic Brain Injury Depression, Veteran Health — Active Low-Intensity Focused Ultrasound (LIFU), Sham Low-Intensity Focused Ultrasound (LIFU)

ClinicalTrials.gov registration NCT07828483 · first posted Sep 18, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Assessment of Childbirth-Related Post-Traumatic Stress Disorder
Status at last check: Not yet recruiting · NCT07827508

Childbirth-related Post-traumatic Stress Disorder — City Birth Trauma Scale and Questionnaire on the assessment of healthcare utilization

ClinicalTrials.gov registration NCT07827508 · first posted Sep 18, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 17, 2026
Registration
Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder
Status at last check: Recruiting · NCT07825857

Methamphetamine Use Disorder — Tirzepatide, Placebo (saline)

ClinicalTrials.gov registration NCT07825857 · first posted Sep 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Imaging Mitochondrial Complex-I in Alcohol Use Disorder
Status at last check: Recruiting · NCT07825818

Alcohol Use Disorder (AUD), Healthy Controls Group - Age and Sex-matched — [F-18]BCPP-EF, [F-18]FDG

ClinicalTrials.gov registration NCT07825818 · first posted Sep 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Ketamine Treatment for Treatment-Resistant Depression - the Role of Framing
Status at last check: Not yet recruiting · NCT07824973

Treatment Resistant Depression (TRD) — Psychedelic framing, Biomedical framing

ClinicalTrials.gov registration NCT07824973 · first posted Sep 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Lumateperone Added to Antidepressant Therapy in Adults With Major Depressive Disorder Experiencing Emotional Blunting
Status at last check: Not yet recruiting · NCT07824206

Blunted Emotion in Major Depressive Disorder — lumateparone 42 mg once daily, lumateparone

ClinicalTrials.gov registration NCT07824206 · first posted Sep 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Exercise Training Decreases Alcohol Consumption and Tissue Injury by an FGF21-dependent Mechanism
Status at last check: Recruiting · NCT07824089

Alcohol Use Disorder (AUD), Alcohol Related Liver Disease — Endurance Exercise

ClinicalTrials.gov registration NCT07824089 · first posted Sep 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 16, 2026
Registration
Longitudinal Effects of Brain Stimulation on Decision-Making and Reward Learning
Status at last check: Not yet recruiting · NCT07823218

Depression / Major Depressive Disorder

ClinicalTrials.gov registration NCT07823218 · first posted Sep 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Biobehavioral Mechanisms of Activity and Loss of Control Eating in Children
Status at last check: Not yet recruiting · NCT07823153

Binge Eating Behaviour, Eating Disorders, Physical Activity, Functional Magnetic Resonance Imaging (fMRI), Ecological Momentary Assessment, Loss of Control Eating — Go/No-go task, Visual food task, Emotion regulation task

ClinicalTrials.gov registration NCT07823153 · first posted Sep 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Cohort Study of Obsessive-Compulsive Disorder
Status at last check: Not yet recruiting · NCT07822516

Obsessive - Compulsive Disorder

ClinicalTrials.gov registration NCT07822516 · first posted Sep 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Brexanolone Lifting Outcomes Of Moms
Status at last check: Recruiting · NCT07822321

Depression, Postpartum, Postpartum Depression (PPD), Post-partum Depression, Postnatal Depression, Post-Natal Depression, Peripartum Depression — LPCN 1154A, Placebo

ClinicalTrials.gov registration NCT07822321 · first posted Sep 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Migration-Focused Adaptation of EMDR for Psychological Distress Among Turkish Migrants
Status at last check: Completed · NCT07822165

Depression, Anxiety, Stress, Social Adaptation — EMDR

ClinicalTrials.gov registration NCT07822165 · first posted Sep 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
CannaRiver CBD Calm for Anxiety, Sleep, and Well-Being in Adults With Generalized Anxiety Disorder
Status at last check: Not yet recruiting · NCT07821840

Generalized Anxiety Disorder — Cannabidiol (CBD) With Cannabinol (CBN) and Cannabigerol (CBG) Oral Tincture (CannaRiver CBD Calm)

ClinicalTrials.gov registration NCT07821840 · first posted Sep 16, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 15, 2026
Registration
Developing Microbiome and Dietary Strategies Based on Chrono-nutrition for Targeting ADHD
Status at last check: Enrolling by invitation · NCT07821060

ADHD, ADHD - Attention Deficit Disorder With Hyperactivity — Circadian fasting

ClinicalTrials.gov registration NCT07821060 · first posted Sep 15, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Building a Computational Model of Auditory Hallucinations
Status at last check: Not yet recruiting · NCT07820553

Schizophrenia / Schizoaffective Disorder, Schizophrenia and Disorders With Psychotic Feature, Psychosis, SCHIZOPHRENIA 1 (Disorder), Schizophreni-form Disorder

ClinicalTrials.gov registration NCT07820553 · first posted Sep 15, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial
Status at last check: Not yet recruiting · NCT07820033

Advanced Cancer, Stage IV Solid Tumor Cancer, Stage IV Sarcoma of Bone, Stage IV Lymphoma, Stage IV Melanoma, Endocrine Cancer — Psilocybin (high dose), Psilocybin (low dose), PEARL Therapy

ClinicalTrials.gov registration NCT07820033 · first posted Sep 15, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Study of the Correlation Between the Severity of Substance Use Disorder and the Intensity of Dependence on Generative Artificial Intelligence
Status at last check: Not yet recruiting · NCT07819851

Substance-related Disorders, Behavior, Addictive, Artificial Intelligence (AI) — Questionnaire assessment

ClinicalTrials.gov registration NCT07819851 · first posted Sep 15, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Device for Treating Generalized Anxiety
Status at last check: Recruiting · NCT07819773

Generalized Anxiety Disorder (GAD) — EXOMIND (BTL-699-2) Active treatment, EXOMIND (BTL-699-2) Sham treatment

ClinicalTrials.gov registration NCT07819773 · first posted Sep 15, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Preventox - a Digital Intervention for Patients With Intoxications in Intensive Care
Status at last check: Not yet recruiting · NCT07819500

Intoxication, Delirium Tremens (DTs), Poisoning by Psychoactive Substances, Suicidal Attempt — Preventox, a digital self-help tool for patients with intoxications in intensive care., Preventox control group

ClinicalTrials.gov registration NCT07819500 · first posted Sep 15, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Aerobic Exercise as an Adjunct Therapy for Depression
Status at last check: Recruiting · NCT07819448

Depressive Disorder — Structured Aerobic exercise

ClinicalTrials.gov registration NCT07819448 · first posted Sep 15, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 14, 2026
Registration
Study to Refine the Effectiveness of New Generation Therapies for Suicide
Status at last check: Recruiting · NCT07818889

Suicide Risk, Suicide Attempt, Treatment Response — Brief Cognitive Behavioral Therapy

ClinicalTrials.gov registration NCT07818889 · first posted Sep 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety: R33 Phase
Status at last check: Recruiting · NCT07818876

Anxiety Disorders — Cognitive Bias Modification for Interpretations (CBM-I), Cognitive Restructuring (CR)

ClinicalTrials.gov registration NCT07818876 · first posted Sep 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Circles of Hope: Group Intervention for Adolescents With Suicidal Symptoms
Status at last check: Not yet recruiting · NCT07818863

Suicidal Ideation — Circles of Hope Group Psychotherapy

ClinicalTrials.gov registration NCT07818863 · first posted Sep 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
MLS101 Study in PMDD
Status at last check: Not yet recruiting · NCT07818720

Premenstrual Dysphoric Disorder ( PMDD), PMDD — MLS101 psilocybin, Placebo capsules

ClinicalTrials.gov registration NCT07818720 · first posted Sep 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
tACS for Self-Other Boundary in Schizophrenia
Status at last check: Recruiting · NCT07818668

Schizophrenia / Schizoaffective Disorder — Transcranial Alternating Current Stimulation (tACS), Sham Transcranial Alternating Current Stimulation (tACS)

ClinicalTrials.gov registration NCT07818668 · first posted Sep 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation
Status at last check: Recruiting · NCT07818564

Phase I — Psilocybin (Usona Institute), Inactive Placebo (Usona Institute)

ClinicalTrials.gov registration NCT07818564 · first posted Sep 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
CHW-Enhanced Trauma Recovery
Status at last check: Not yet recruiting · NCT07818161

Traumatic Injury, Posttraumatic Stress Disorder, Depression, Social Determinants of Health — CHW support

ClinicalTrials.gov registration NCT07818161 · first posted Sep 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Validity of the 3-item Patient Health Questionnaire (PHQ-3) for Identifying Moderate-to-Severe Depressive Symptoms Among Elderly Perioperative Patients: A Secondary Analysis of a National Prospective Cohort
Status at last check: Completed · NCT07818057

Depressive Disorder — Retrospective data analysis

ClinicalTrials.gov registration NCT07818057 · first posted Sep 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effects of Nitraria Retusa Infusion on Clozapine-induced Metabolic Side Effects
Status at last check: Recruiting · NCT07817069

Treatment Resistant Schizophrenia, Obesity & Overweight, Abdominal Obesity — The Nitraria retusa arm

ClinicalTrials.gov registration NCT07817069 · first posted Sep 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 11, 2026
Registration
Endocannabinoids in Reward
Status at last check: Recruiting · NCT07815691

Cannabis Use Disorder — Dronabinol, Placebo

ClinicalTrials.gov registration NCT07815691 · first posted Sep 11, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Phase I Trial of HHK101 in Patients With Schizophrenia
Status at last check: Not yet recruiting · NCT07815210

Schizophrenia — HHK101-Single Dose 1, HHK101-Single Dose 2, HHK101-Single Dose 3

ClinicalTrials.gov registration NCT07815210 · first posted Sep 11, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Auricular Vagal Neuromodulation for Depression and Anxiety in Substance Use Disorder
Status at last check: Not yet recruiting · NCT07814755

Substance Use Disorder (SUD) — Transcutaneous Auricular Vagus Nerve Stimulation

ClinicalTrials.gov registration NCT07814755 · first posted Sep 11, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 10, 2026
Registration
Dexmedetomidine Combined With Transcutaneous Vagus Nerve Stimulation (taVNS) Can Reduce the Incidence of PTSD in Trauma Patients After Surgery
Status at last check: Recruiting · NCT07813962

PTSD - Post Traumatic Stress Disorder, taVNS, Dexmedetomidine — Dexmedetomidine 0.1μg/kg/h, tavns

ClinicalTrials.gov registration NCT07813962 · first posted Sep 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Internet-Delivered Acceptance and Commitment Therapy (iACT) for Youth With PTSD and Chronic Pain
Status at last check: Recruiting · NCT07813728

Chronic Pain, PTSD — iACT

ClinicalTrials.gov registration NCT07813728 · first posted Sep 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effect of an ACT-based Intervention to Reduce Anxiety in Medical Students
Status at last check: Completed · NCT07813520

Anxiety, Somatization, Depressive Symptom, Stress (Psychology) — ACT_based intervention, Active Control group

ClinicalTrials.gov registration NCT07813520 · first posted Sep 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Activity-Based Intervention to Address Cannabis Use
Status at last check: Not yet recruiting · NCT07813442

Cannabis Use — Motivational and Behavioral Economics Informed Intervention, Enhanced Usual Care

ClinicalTrials.gov registration NCT07813442 · first posted Sep 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Study on iTBS Regulating the Reward Circuit Function to Improve Anhedonia in Depression
Status at last check: Recruiting · NCT07813169

Major Depression, Anhedonia, Melancholic Depression, Theta Burst Stimulation — Left DLPFC + OFC iTBS, Left DLPFC iTBS

ClinicalTrials.gov registration NCT07813169 · first posted Sep 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Rapid Entrainment and Signal-guided Neuromodulation for Behavioral Health
Status at last check: Active, not recruiting · NCT07812987

Anxiety, PTSD, ADHD, Depression Disorders, Post-traumatic Stress, Substance Use, Executive Function, Sleep Disturbance — AIP-Informed Integrative Psychotherapy, Transcutaneous Auricular Vagus Nerve Stimulation, Regulated Breathing and Autonomic Regulation

ClinicalTrials.gov registration NCT07812987 · first posted Sep 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Personalising ADHD Medication Treatment for Children and Young People
Status at last check: Not yet recruiting · NCT07812948

ADHD — PETRA decision-aid tool, Best-evidence decision-support tool

ClinicalTrials.gov registration NCT07812948 · first posted Sep 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Behavioral Activation for Treatment of Depression in Autistic Adolescents With Below Average Intelligence
Status at last check: Recruiting · NCT07812870

Autism, Depressed, Depressed Mood — BA-A

ClinicalTrials.gov registration NCT07812870 · first posted Sep 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
ADHD and Mental Effort
Status at last check: Not yet recruiting · NCT07812714

ADHD

ClinicalTrials.gov registration NCT07812714 · first posted Sep 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Evaluating the Effects of StrongMinds Community-Based Group Interpersonal Therapy on Depression and Secondary Outcomes in Uganda
Status at last check: Active, not recruiting · NCT07812311

Depression - Major Depressive Disorder — Group Interpersonal Therapy (IPT-G), Enhanced treatment as usual

ClinicalTrials.gov registration NCT07812311 · first posted Sep 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Expanded-Coming-Out-Proud Group on Reducing Self-stigma for People With a Severe Mental Illness- A Randomized Control Trial With Six-month Follow-up
Status at last check: Completed · NCT07812298

Expanded Coming Out Proud Group, Control Group — Expanded Coming Out Proud group, control group

ClinicalTrials.gov registration NCT07812298 · first posted Sep 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Transcutaneous Electrical Acupoint Stimulation Combined With Exposure and Response Prevention in the Treatment of Patients With Obsessive-Compulsive Disorder: A Randomized Controlled Trial
Status at last check: Not yet recruiting · NCT07811778

Obsessive Compulsive Disorder (OCD) — Exposure and Response Prevention, Active Transcutaneous Acupoint Electrical Stimulation, Sham Transcutaneous Acupoint Electrical Stimulation

ClinicalTrials.gov registration NCT07811778 · first posted Sep 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Mobile Application-Based Interventions for Cannabis Use in Young Adults With First Episode Psychosis
Status at last check: Not yet recruiting · NCT07811466

First Episode Psychosis (FEP), Psychosis, Schizophreni-form Disorder, Dependence Addictive — CHAMPS, I Can Change

ClinicalTrials.gov registration NCT07811466 · first posted Sep 10, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 9, 2026
Registration
Intravenous Acetate as an Adjunctive Treatment for Alcohol Withdrawal in Hospitalized Patients
Status at last check: Not yet recruiting · NCT07810946

Alcohol Withdrawal, Alcohol Abstinence, Alcohol Use Disorder — Sodium Acetate, Placebo

ClinicalTrials.gov registration NCT07810946 · first posted Sep 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The BAARD Study : Evaluating a Computerized Approach to Treatment Selection in Older Adults With Treatment Resistant Depression.
Status at last check: Not yet recruiting · NCT07810738

Late Life Treatment Resistant Depression, Depression - Major Depressive Disorder, Treatment Resistant Depression — Aripiprazole Augmentation, Bupropion Augmentation

ClinicalTrials.gov registration NCT07810738 · first posted Sep 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effectiveness of an AI-Integrated Proactive Thought Control Intervention for Young Adults With Social Anxiety Disorder
Status at last check: Completed · NCT07810348

Social Anxiety Disorder (SAD) — AI-Proactive thought control, Cognitive Behavior Therapy, Active Control

ClinicalTrials.gov registration NCT07810348 · first posted Sep 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Pilot Testing of the emPath Platform to Improve Medication for Opioid Use Disorder (MOUD) Linkage and Retention Among Adults With Opioid Use Disorder in Durham, North Carolina
Status at last check: Recruiting · NCT07810322

Opioid Use Disorder, Digital Health Intervention, Telemedicine, Outreach Intervention — emPath Intervention

ClinicalTrials.gov registration NCT07810322 · first posted Sep 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Intramuscular Ketamine for Suicidal Patients in the Evanston Hospital Emergency Department for Suicidal Distress
Status at last check: Enrolling by invitation · NCT07810023

Suicidal, Suicidal Ideation, Suicidal Ideation and Behavior, Depression / Major Depressive Disorder — Ketamine (0.5 mg/kg)

ClinicalTrials.gov registration NCT07810023 · first posted Sep 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Food Menu Labelling Effects on Individuals With Eating Disorders and Other Mental Health Conditions.
Status at last check: Not yet recruiting · NCT07809295

Food Labelling, Eating Behaviour, Mental Health, Eating Disorder — Control condition, Calorie labelling, Nutri-Score labelling

ClinicalTrials.gov registration NCT07809295 · first posted Sep 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Mental Health Reinforcement in Wayapi and Teko Communities in French Guiana : Evaluation of the Impact of a Mediation Based Activity in Municipalities of Camopi and Trois Saut in French Guiana
Status at last check: Not yet recruiting · NCT07808801

Mental Disease

ClinicalTrials.gov registration NCT07808801 · first posted Sep 9, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 8, 2026
Registration
HD-tACS for Alcohol Use Disorder
Status at last check: Recruiting · NCT07808190

Alcohol Use Disorder — HD-tACS, Sham HD-tACS

ClinicalTrials.gov registration NCT07808190 · first posted Sep 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Comparative Effects of Acceptance and Commitment Therapy, Cognitive Behavioral Therapy, and Treatment-as-Usual on Depression Among People With Marital Crisis
Status at last check: Not yet recruiting · NCT07808021

Depression - Major Depressive Disorder, Anxiety, Marital Conflict — Acceptance and Commitment Therapy, Cognitive Behavioral Therapy

ClinicalTrials.gov registration NCT07808021 · first posted Sep 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Individual Narratives of Stimulation (ECT and TMS)
Status at last check: Not yet recruiting · NCT07807930

Major Depression — There is no intervention in this observation study (qualitative interviews about past treatment experiences)

ClinicalTrials.gov registration NCT07807930 · first posted Sep 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)
Status at last check: Recruiting · NCT07807865

Generalized Anxiety Disorder — ITI-1284

ClinicalTrials.gov registration NCT07807865 · first posted Sep 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
FlexED: National Substudy
Status at last check: Recruiting · NCT07807774

Eating Disorders, Body Image — FlexED

ClinicalTrials.gov registration NCT07807774 · first posted Sep 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Evaluation of an 8-week Behavior Skills-based Virtual Reality Program for Adolescents With Depression. (MDD)
Status at last check: Not yet recruiting · NCT07807735

Major Depression — Virtual reality

ClinicalTrials.gov registration NCT07807735 · first posted Sep 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effect of Peripartum 40 Hz Audiovisual Stimulation on Postpartum Depression in Women Undergoing Elective Cesarean Section: A Randomized Clinical Trial
Status at last check: Not yet recruiting · NCT07807462

Depression, Postpartum — 40 Hz Audiovisual Stimulation, Placebo Audiovisual Stimulation

ClinicalTrials.gov registration NCT07807462 · first posted Sep 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
iACT & iTBS for Sleep Quality in Depressed Adolescents
Status at last check: Completed · NCT07807072

Depressive Disorder, Sleep Disturbance — Internet-Delivered Acceptance and Commitment Therapy, Intermittent Theta Burst Stimulation

ClinicalTrials.gov registration NCT07807072 · first posted Sep 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Efficacy and Safety of Individualized Sequential Accelerated Theta Burst Stimulation in Improving Cognitive Function in Schizophrenia
Status at last check: Recruiting · NCT07806877

Schizophrenia / Schizoaffective Disorder, TMS, Cognitive, PET / MR — Sequential Dual-Site Accelerated Theta Burst Stimulation (SD-aTBS), Sham Sequential Dual-Site Accelerated Theta Burst Stimulation

ClinicalTrials.gov registration NCT07806877 · first posted Sep 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
An Ultra-Brief ICBT Intervention: The 'Things You Do' Program
Status at last check: Recruiting · NCT07806864

Depression, Anxiety — Things You Do Program (Ultra-Brief ICBT), Things You Do Program Plus Personalized Feedback

ClinicalTrials.gov registration NCT07806864 · first posted Sep 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Evaluation of the Acceptability, Feasibility and Exploration of the Efficacy of an Integrated Care Pathway CARIBOU
Status at last check: Not yet recruiting · NCT07806825

Major Depressive Disorder (MDD) — CARIBOU Integrated Care Pathway, Treatment as Usual (TAU)

ClinicalTrials.gov registration NCT07806825 · first posted Sep 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar Disorder
Status at last check: Not yet recruiting · NCT07806227

Bipolar Disorder Depression — Lurasidone (Latuda)

ClinicalTrials.gov registration NCT07806227 · first posted Sep 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Relation Between Craving Induction and Treatment Response in Deep Transcranial Magnetic Stimulation (dTMS) for Reducing Antipsychotic-induced Weight Gain in Schizophrenia
Status at last check: Recruiting · NCT07805980

Schizophrenia, Antipsychotic Induced Weight Gain — Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Active, Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Sham

ClinicalTrials.gov registration NCT07805980 · first posted Sep 8, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 4, 2026
Registration
Dynamic Relationships Between Estrogen Fluctuations, Sleep, and Psychiatric Complexity Among Adolescent Females With ADHD
Status at last check: Not yet recruiting · NCT07805382

ADHD

ClinicalTrials.gov registration NCT07805382 · first posted Sep 4, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Efficacy and Mechanism of Transcranial Temporal Interference Stimulation (tTIS) for Patients With Obsessive-Compulsive Disorders
Status at last check: Recruiting · NCT07805200

Obsessive - Compulsive Disorder — Transcranial Temporal Interference Stimulation

ClinicalTrials.gov registration NCT07805200 · first posted Sep 4, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Uncovering Neurocognitive Mechanisms and Enhancement of Exposure-based Fear Learning With Cognitive Training
Status at last check: Not yet recruiting · NCT07805070

Anxiety, Fear Extinction — Cognitive training, Cognitive training

ClinicalTrials.gov registration NCT07805070 · first posted Sep 4, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Comparison of Efficacy of Minocyclin and Celecoxib as Adjunctive Treatment in Treatment Resistant Cases of Major Depressive Disorder
Status at last check: Completed · NCT07804979

Major Depressive Disorder (MDD), Treatment-resistant Depression (TRD) — Minocycline, Celecoxib

ClinicalTrials.gov registration NCT07804979 · first posted Sep 4, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Individualized fMRI-guided TMS for Depression
Status at last check: Not yet recruiting · NCT07804459

Depression, Major Depressive Disorder (MDD), Depression - Major Depressive Disorder, Persistent Depressive Disorder, PDD, MDD — Active Repetitive Transcranial Magnetic Stimulation (rTMS), Sham Transcranial Magnetic Stimulation (TMS)

ClinicalTrials.gov registration NCT07804459 · first posted Sep 4, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 3, 2026
Registration
Adult ADHD Symptoms, Depression, Anxiety, and Academic Performance in Medical Students
Status at last check: Not yet recruiting · NCT07803224

Attention Deficit Hyperactivity Disorder, Depression, Anxiety, Academic Performance

ClinicalTrials.gov registration NCT07803224 · first posted Sep 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Lemborexant for Cannabis Use Disorder
Status at last check: Not yet recruiting · NCT07802990

Cannabis Use Disorder — Lemborexant 10mg, Placebo, Brief Behavioural Intervention

ClinicalTrials.gov registration NCT07802990 · first posted Sep 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Discontinuing Psychotropic Medication Before Psychotherapy for PTSD
Status at last check: Not yet recruiting · NCT07802158

Post-traumatic Stress Disorder (PTSD)

ClinicalTrials.gov registration NCT07802158 · first posted Sep 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Prospective, Observational, Single-Arm, Multicenter Real-World Study Evaluating the Treatment Pattern, Safety and Effectiveness of Xanomeline and Trospium Chloride Capsules (KarXT) in the Treatment of Chinese Adult Participants With Schizophrenia
Status at last check: Not yet recruiting · NCT07802132

Schizophrenia Disorder — Xanomeline and trospium chloride (KarXT)

ClinicalTrials.gov registration NCT07802132 · first posted Sep 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Behavioural Activation Therapy and Ketamine for Treatment-Resistant Depression
Status at last check: Recruiting · NCT07801703

Treatment Resistant Depression, Major Depressive Disorder (MDD) — Ketamine (0.5 mg/kg), Behavioural Activation Therapy

ClinicalTrials.gov registration NCT07801703 · first posted Sep 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Comparative Efficacy of Cognitive Behavioral and Mindfulness Therapies in Reducing Post-Traumatic Stress Disorder Among Interpersonal Violence Survivors
Status at last check: Active, not recruiting · NCT07801534

Post-traumatic Stress Disorder (PTSD), Post-Traumatic Stress Disorder — Cognitive Behavioral Therapy (CBT), Mindfulness-Based Therapy (MBT), Psychoeducation

ClinicalTrials.gov registration NCT07801534 · first posted Sep 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Ecological Momentary Assessment of State-Dependent Decision-Making and Metacognition Across a Psychopathology Continuum
Status at last check: Not yet recruiting · NCT07801079

Depression, Anxiety, Addiction, Emotion, Craving, Stress

ClinicalTrials.gov registration NCT07801079 · first posted Sep 3, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 2, 2026
Registration
Sensory Hyperstimulation for Treating Depression
Status at last check: Completed · NCT07800663

Depressive Disorder — sensory hyperstimulation

ClinicalTrials.gov registration NCT07800663 · first posted Sep 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder
Status at last check: Recruiting · NCT07800520

Opioid Use Disorder, OAT — [11C]OMAR

ClinicalTrials.gov registration NCT07800520 · first posted Sep 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Midwife-led Cognitive Behavioral Intervention for Perinatal Depression. Multisite RCT
Status at last check: Not yet recruiting · NCT07800299

Perinatal Depression, Social Support, Perceived Stress — Midwife-led Cognitive Behaviroal Intervention

ClinicalTrials.gov registration NCT07800299 · first posted Sep 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Investigation of the Association of Multimodal Neuroimaging and Peripheral Biomarkers With Executive Functions and Emotional Regulation in Adolescents With Attention-Deficit/Hyperactivity Disorder
Status at last check: Active, not recruiting · NCT07800117

Attention-Deficit/Hyperactivity Disorder (ADHD) — No Intervention

ClinicalTrials.gov registration NCT07800117 · first posted Sep 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Caplyta Versus Placebo for Adults With Social Anxiety Disorder
Status at last check: Recruiting · NCT07799493

Social Anxiety Disorder (SAD) — Lumateperone 42 mg, Placebo

ClinicalTrials.gov registration NCT07799493 · first posted Sep 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Single Session Personalized Aperiodic Transcranial Alternating Current Stimulation (PandA-tACS) for Antenatal Depression
Status at last check: Recruiting · NCT07799480

Antenatal Depression — Sham (placebo) tACS, IAF-tACS, PandA-tACS

ClinicalTrials.gov registration NCT07799480 · first posted Sep 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Acupuncture for Generalized Anxiety Disorder
Status at last check: Not yet recruiting · NCT07798986

Generalized Anxiety Disorder (GAD) — sham electro-acupuncture, 2Hz electro-acupuncture, 100Hz electro-acupuncture

ClinicalTrials.gov registration NCT07798986 · first posted Sep 2, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted September 1, 2026
Registration
Frequency- and Intensity-Dependent After-Effects of High-Definition Transcranial Alternating Current Stimulation on Resting-State Electroencephalography
Status at last check: Completed · NCT07798804

Schizophrenia With Auditory Hallucinations — high-definition transcranial alternating current stimulation(HD-tACS), sham high-definition transcranial alternating current stimulation(HD-tACS)

ClinicalTrials.gov registration NCT07798804 · first posted Sep 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effectiveness of Solution-Focused Therapy for Generalized Anxiety Disorder in Emerging Adults
Status at last check: Recruiting · NCT07798063

Generalized Anxiety Disorder (GAD) — Solution-Focused Therapy

ClinicalTrials.gov registration NCT07798063 · first posted Sep 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Trauma Informed Goal Management Training With a "Support Person" Module for Individuals Impacted by Post-Traumatic Stress
Status at last check: Not yet recruiting · NCT07797543

Post Traumatic Stress — Trauma-Informed Goal Management Training (TIGMT), Trauma Informed Goal Management Training - Assist (TIGMT-Assist)

ClinicalTrials.gov registration NCT07797543 · first posted Sep 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Virtual Group Therapy for IBD Patients With Anxiety and Depression
Status at last check: Not yet recruiting · NCT07796568

Crohn's Disease (CD), Ulcerative Colitis (UC), Inflammatory Bowel Diseases (IBD), Anxiety, Depression — Group Psychotherapy Intervention

ClinicalTrials.gov registration NCT07796568 · first posted Sep 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Prescribing the Right Agent for Depression in Adults
Status at last check: Not yet recruiting · NCT07796295

Major Depressive Disorder (MDD) — PRADA Tool, PETRUSHKA Tool

ClinicalTrials.gov registration NCT07796295 · first posted Sep 1, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted August 31, 2026
Registration
The ConCERN Intervention for Loved Ones of Those With Opioid Use Disorder
Status at last check: Not yet recruiting · NCT07795840

Opioid Use Disorder — ConCERN intervention, Treatment as Usual

ClinicalTrials.gov registration NCT07795840 · first posted Aug 31, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain
Status at last check: Recruiting · NCT07795554

Schizophrenia Spectrum, Schizophrenia, Antipsychotic Induced Weight Gain — dTMS of accelerated intermittent theta burst stimulation, ACC-iTBS, Sham stimulation

ClinicalTrials.gov registration NCT07795554 · first posted Aug 31, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Young Athlete Body Project (YABP) - Prevention of Body Dissatisfaction and Eating Disorders Among Adolescent Athletes
Status at last check: Enrolling by invitation · NCT07795333

Eating Disorders in Adolescence, Body Dissatisfaction, Mental Health — Young Athlete Body Project

ClinicalTrials.gov registration NCT07795333 · first posted Aug 31, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Symptom Assessment in Adolescents Placed on Child Welfare
Status at last check: Recruiting · NCT07794332

Complex Post-Traumatic Stress Disorder (CPTSD), Borderline Personality Disorder (BPD), Post-Traumatic Stress Disorder, PTSD

ClinicalTrials.gov registration NCT07794332 · first posted Aug 31, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Mediterranean Diet on Postpartum Depression
Status at last check: Completed · NCT07793864

Postpartum Depressive Symptoms, Breastfeeding — Mediterranean diet, Standard nutrition information

ClinicalTrials.gov registration NCT07793864 · first posted Aug 31, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted August 28, 2026
Registration
Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 3
Status at last check: Recruiting · NCT07793383

Opioid Abuse (Disorder), Clinical Decision Support — Refined EMBED CDS, Provider alert that nurse completed COWS

ClinicalTrials.gov registration NCT07793383 · first posted Aug 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Oral Thiamine (Vitamin B1) for Depression in Children and Adolescents
Status at last check: Not yet recruiting · NCT07793071

Major Depressive Disorder (MDD), Thiamine, Vitamin B1, Thiamine Diphosphate (TDP), Pediatrics — thiamine hydrochloride 100 mg

ClinicalTrials.gov registration NCT07793071 · first posted Aug 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Binaural Beats Stimulation for Adults With Attention-Deficit/Hyperactivity Disorder
Status at last check: Recruiting · NCT07793045

Attention-Deficit/Hyperactivity Disorder (ADHD) — Music-Based Binaural Beats Stimulation, Music Listening Without Binaural Beats

ClinicalTrials.gov registration NCT07793045 · first posted Aug 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Psilocybin-Assisted Psychotherapy for Veterans With PTSD
Status at last check: Not yet recruiting · NCT07792538

Posttraumatic Stress Disorder (PTSD) — Psilocybin-assisted Psychotherapy

ClinicalTrials.gov registration NCT07792538 · first posted Aug 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
REWIRE: Real-world Engagement With Interventional and Rejoyn Effectiveness
Status at last check: Not yet recruiting · NCT07792252

Major Depressive Disorder (MDD) — Rejoyn, Cognitive Behavioral Therapy (CBT) exercises

ClinicalTrials.gov registration NCT07792252 · first posted Aug 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Women Who Are Victims of Violence: Treatment of PTSD Through Reactivation of Traumatic Memories Using Propranolol
Status at last check: Not yet recruiting · NCT07792122

Post-Traumatic Stress Disorder, PTSD — Propranolol, Psychotherapy

ClinicalTrials.gov registration NCT07792122 · first posted Aug 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
MB-PAT for Demoralization in Advanced Cancer ('PAT-MIND') Trial
Status at last check: Not yet recruiting · NCT07791901

Advanced Cancer, Demoralization, Existential Distress, Psychological Distress — PEX010 25 mg psilocybin, PEX010 5 mg psilocybin, Standard Psilocybin-Assisted Therapy

ClinicalTrials.gov registration NCT07791901 · first posted Aug 28, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted August 27, 2026
Registration
Dissecting Immunological and Autoimmune Mechanisms of Neuropsychiatric Diseases
Status at last check: Not yet recruiting · NCT07791212

Neuropsychiatric Symptom

ClinicalTrials.gov registration NCT07791212 · first posted Aug 27, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Parental Stress and Its Relationship With Perceived Social Support and Screen Time Among Caregivers of Children With Attention-Deficit/Hyperactivity Disorder
Status at last check: Not yet recruiting · NCT07790432

ADHD - Attention Deficit Disorder With Hyperactivity

ClinicalTrials.gov registration NCT07790432 · first posted Aug 27, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Activating Voice Journaling for Mental Health With Voice Biomarkers
Status at last check: Completed · NCT07789808

Depression / Major Depressive Disorder, Anxiety

ClinicalTrials.gov registration NCT07789808 · first posted Aug 27, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted August 26, 2026
Registration
NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia
Status at last check: Not yet recruiting · NCT07788755

Schizophrenia, Schizoaffective Disorder, Cognitive Impairment, Visual Impairment — Perceptual Discrimination Training, Cognitive Control Training

ClinicalTrials.gov registration NCT07788755 · first posted Aug 26, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Sensory and Physical Reactions to Beverage Cues
Status at last check: Recruiting · NCT07788716

Alcohol Use Disorder (AUD) — Alcohol Cue Reactivity Paradigm

ClinicalTrials.gov registration NCT07788716 · first posted Aug 26, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Applying Neuromodulation to Boost the Efficacy of Motivational Interviewing
Status at last check: Not yet recruiting · NCT07787572

Cannabis Use Disorder — transcranial alternating current stimulation, sham transcranial alternating current stimulation, Motivational interviewing (MI)

ClinicalTrials.gov registration NCT07787572 · first posted Aug 26, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Supporting Treatment for Opioids and Recovery Capital (STORC) - R61 Phase
Status at last check: Recruiting · NCT07787039

Opioid Use Disorder — STORC

ClinicalTrials.gov registration NCT07787039 · first posted Aug 26, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Accelerated Neuromodulation Therapy and Neurocomputational Biomarkers in Individuals at Clinical High Risk for Psychosis
Status at last check: Recruiting · NCT07786714

Clinical High Risk for Psychosis (CHR), Psychotic Disorders, Prodromal Symptoms — Active Intermittent Theta Burst Stimulation (BEAM-F3 Targeting), Sham Comparator: Sham iTBS

ClinicalTrials.gov registration NCT07786714 · first posted Aug 26, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety Disorder
Status at last check: Recruiting · NCT07786454

Generalized Anxiety Disorder — SEP-363856

ClinicalTrials.gov registration NCT07786454 · first posted Aug 26, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted August 25, 2026
Registration
Adjunctive Probiotic Therapy in Major Depressive Disorder (ProMOOD)
Status at last check: Not yet recruiting · NCT07786285

Depression / Major Depressive Disorder — OMNi-BiOTiC® STRESS Repair, Matched Placebo Powder for Oral Solution

ClinicalTrials.gov registration NCT07786285 · first posted Aug 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Individualized (fMRI-guided) TMS Intervention for Post-Traumatic Stress Disorder (PTSD)
Status at last check: Not yet recruiting · NCT07785908

PTSD, Post Traumatic Stress Disorder (PTSD) — Active Transcranial Magnetic Stimulation (TMS), Sham Transcranial Magnetic Stimulation (TMS)

ClinicalTrials.gov registration NCT07785908 · first posted Aug 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Multicenter Real-World Study Evaluating the Efficacy and Safety of Shugan Jieyu Capsules in the Treatment of Depression
Status at last check: Not yet recruiting · NCT07785284

Outpatients or Inpatients With Depression — Shugan Jieyu Capsules

ClinicalTrials.gov registration NCT07785284 · first posted Aug 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Chemokine Receptors on CD8+ T Cells in Patients With Bipolar Disorder
Status at last check: Not yet recruiting · NCT07785167

Bipolar Affective Disorders — CD8+ T-Cell Gene Expression Analysis

ClinicalTrials.gov registration NCT07785167 · first posted Aug 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Single Day of Ultra-accelerated TMS With a Single Dose of NRX-101
Status at last check: Recruiting · NCT07785102

Major Depression — TMS, NRX-101

ClinicalTrials.gov registration NCT07785102 · first posted Aug 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Immersive Gamified Virtual Reality-Based Training for Children With Attention Deficit Hyperactivity Disorder
Status at last check: Not yet recruiting · NCT07784933

ADHD, Social Skills — Immersive gamified virtual reality-based training (iGameVRT), Traditional social skills training

ClinicalTrials.gov registration NCT07784933 · first posted Aug 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
THRIVE: A Recovery-Focused Suicide Prevention Intervention in Crisis Stabilization Centers
Status at last check: Not yet recruiting · NCT07784634

Suicide — Toward Hope, Recovery, Interpersonal Growth, Values, and Engagement (THRIVE), Center Care as Usual

ClinicalTrials.gov registration NCT07784634 · first posted Aug 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Evaluating the Efficacy of Central Executive Training (CET) For Young Children With ADHD
Status at last check: Recruiting · NCT07784348

ADHD — Central executive training, Behavioral parent training

ClinicalTrials.gov registration NCT07784348 · first posted Aug 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Early Detection of Perinatal Depression With Wearable Technology
Status at last check: Not yet recruiting · NCT07784244

Perinatal Depression — Oura Ring (Photoplethysmography-based wearable ring), EmbracePlus Watch (Electrodermal activity wristband sensor)

ClinicalTrials.gov registration NCT07784244 · first posted Aug 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Precision Closed-loop Brain-Computer Interface Neuromodulation for Treatment-Resistant Depression
Status at last check: Not yet recruiting · NCT07783906

Treatment-Resistant Major Depressive Disorder, Major Depressive Disorder — Closed-loop Deep Brain Stimulation (DBS), Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)

ClinicalTrials.gov registration NCT07783906 · first posted Aug 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Identifying Biomarkers of Response to Digital Interventions for Mood Disorders
Status at last check: Enrolling by invitation · NCT07783633

Depression / Major Depressive Disorder, Bipolar Disorder (BD) — Online Cognitive Behavioural Therapy

ClinicalTrials.gov registration NCT07783633 · first posted Aug 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Varenicline as a Treatment for Cannabis Use Disorder
Status at last check: Not yet recruiting · NCT07783555

Cannabis Abuse — Varenicline (Chantix), Placebo

ClinicalTrials.gov registration NCT07783555 · first posted Aug 25, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted August 24, 2026
Registration
Grappling With Trauma: Brazilian Jiu-Jitsu for First Responders
Status at last check: Recruiting · NCT07783516

Post-traumatic Stress Disorder (PTSD), Trauma and Stress Related Disorders, Occupational Stress, Emotional Regulation Difficulties, Anger Problems, Relational Problems, Irritability — Brazilian Jiu-Jitsu Program

ClinicalTrials.gov registration NCT07783516 · first posted Aug 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Suicide Safety Planning
Status at last check: Not yet recruiting · NCT07783490

Suicide Prevention, Suicide Safety Planning, Suicidal Ideation, Suicide Attempt — Local Care Continuity, Centralized Care Navigation

ClinicalTrials.gov registration NCT07783490 · first posted Aug 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia
Status at last check: Active, not recruiting · NCT07783373

Schizophrenia — xanomeline-trospium chloride, Oral antipsychotics

ClinicalTrials.gov registration NCT07783373 · first posted Aug 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Written Exposure in Substance Treatment (WEST 3.0): Randomized Controlled Trial
Status at last check: Not yet recruiting · NCT07782268

Posttraumatic Stress Disorder (PTSD), Substance Use Disorder (SUD) — Written Exposure Therapy, Treatment as Usual

ClinicalTrials.gov registration NCT07782268 · first posted Aug 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Psychoeducation-Supported Breathing and Relaxation for Earthquake Survivors
Status at last check: Completed · NCT07781904

Post-Traumatic Stress Symptoms, Poor Sleep Quality — Psychoeducation-Supported Breathing and Relaxation Program

ClinicalTrials.gov registration NCT07781904 · first posted Aug 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Improving Quality of Informal Care for People With Schizophrenia
Status at last check: Not yet recruiting · NCT07781748

Schizophrenia — Dyadic Multicomponent Intervention (DMI), Dyadic Benefit-Finding Intervention (DBFI)

ClinicalTrials.gov registration NCT07781748 · first posted Aug 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Study of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant Monotherapy
Status at last check: Not yet recruiting · NCT07781293

Major Depressive Disorder (MDD), Major Depressive Disorder With Psychotic Features — Lurasidone, Placebo, Background Antidepressant Therapy

ClinicalTrials.gov registration NCT07781293 · first posted Aug 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Supported Online Self-Help for Veterans With Depression in Primary Care
Status at last check: Not yet recruiting · NCT07781228

Depression — Enhanced Usual Care (EUC), Supported Online Self-help for Depression (SOS-Depression)

ClinicalTrials.gov registration NCT07781228 · first posted Aug 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effectiveness of a Board Game Intervention on Cognitive and Functional Outcomes in Older Adults With Schizophrenia
Status at last check: Not yet recruiting · NCT07781007

Schizophrenia — Scaffolding-Based Board Game Intervention

ClinicalTrials.gov registration NCT07781007 · first posted Aug 24, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted August 21, 2026
Registration
Effect of Adapted Physical Activity on Emotion Regulation in People With Depressive Disorders
Status at last check: Completed · NCT07780695

Depressive Disorder — Classical Adapted Physical Activity Program, Adapted Physical Activity Program

ClinicalTrials.gov registration NCT07780695 · first posted Aug 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
TRTME: Improving Outpatient Initiation of Medication for Opioid Use Disorder Following Hospitalization
Status at last check: Enrolling by invitation · NCT07780097

Opioid Use Disorder, Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe — TRTME

ClinicalTrials.gov registration NCT07780097 · first posted Aug 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Stratified Care Intervention for Suicidal Ideation, Depression, and Non-Suicidal Self-Injury in Adolescents (Reframe-IT+ & CARIBOU)
Status at last check: Active, not recruiting · NCT07780084

Depression in Adolescence, Suicidal Ideation, Non Suicidal Self Injury — Reframe-IT and CARIBOU

ClinicalTrials.gov registration NCT07780084 · first posted Aug 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The Medically Tailored Groceries and Mental Health Study
Status at last check: Recruiting · NCT07779707

Depression / Major Depressive Disorder, Food Insecurity — Medically Tailored, Home-delivered Groceries, Active Comparison Group: Monthly Grocery Gift Card

ClinicalTrials.gov registration NCT07779707 · first posted Aug 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Maintenance Individualized Neuromodulation and Depression-detection Via Sensors for Early Treatment
Status at last check: Not yet recruiting · NCT07779330

Depression Disorder — Individualized resting-state functional connectivity-guided iTBS, Symptom-titrated algorithm-based longitudinal ECT (STABLE) algorithm

ClinicalTrials.gov registration NCT07779330 · first posted Aug 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
DecNef for Auditory Verbal Hallucinations (AVH) in Schizophrenia
Status at last check: Not yet recruiting · NCT07779226

Schizophrenia Disorder, Schizoaffecitve Disorder — Decoded Neurofeedback

ClinicalTrials.gov registration NCT07779226 · first posted Aug 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Utility of a Mindfulness App for Outpatients Awaiting Appointments for Mental Health Interventions
Status at last check: Active, not recruiting · NCT07778680

Depression Anxiety Disorder, Anxiety and Depression — Mobile App - AmDTx (New name DawnDTx), Placebo App

ClinicalTrials.gov registration NCT07778680 · first posted Aug 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Personalized Addiction Treatment enHancement
Status at last check: Recruiting · NCT07778394

Opioid Use Disorder, mHealth, Peer Support — Vira Platform, Treatment-As-Usual

ClinicalTrials.gov registration NCT07778394 · first posted Aug 21, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted August 20, 2026
Registration
ONE-P TMS Military Veterans
Status at last check: Not yet recruiting · NCT07777380

PTSD - Post Traumatic Stress Disorder — D-Cycloserine (DCS), Placebo, Intermittent Theta Burst Stimulation (iTBS)

ClinicalTrials.gov registration NCT07777380 · first posted Aug 20, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The Effect of 5-hydroxytryptophan on ADHD Traits and Eye Movements
Status at last check: Recruiting · NCT07777328

Attention Deficit and Hyperactivity Disorder (ADHD), Attention Deficit Hyperactivity Disorder in Adults, Attention Deficits — 5-hydroxytryptophan (food supplement) 200mg, 5-hydroxytryptophan (food supplement) 300mg, Placebo

ClinicalTrials.gov registration NCT07777328 · first posted Aug 20, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Group Dialectical Behaviour Therapy (DBT) Skills Training for First Episode Psychosis
Status at last check: Not yet recruiting · NCT07777315

Psychosis — group DBT

ClinicalTrials.gov registration NCT07777315 · first posted Aug 20, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
EMDR Grief Protocol for Traumatic Grief After Earthquake-Related Loss
Status at last check: Completed · NCT07776769

Traumatic Grief, Post Traumatic Stress Disorder PTSD, Emotional Processing — EMDR Grief Protocol

ClinicalTrials.gov registration NCT07776769 · first posted Aug 20, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Substance Use in Pregnancy - Optimizing Retention in Treatment by Maximizing Opportunities for Management
Status at last check: Not yet recruiting · NCT07776457

Pregnancy, Substance Use Disorder (SUD) — Contingency Management, Social Drivers of Health Screening

ClinicalTrials.gov registration NCT07776457 · first posted Aug 20, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Remote Group Cognitive Behavioral Skills Training for Mexican University Students With Anxiety or Depression
Status at last check: Not yet recruiting · NCT07776236

Depression and Anxiety Symptoms — Remote group cognitive behavioral skills training, Mood monitoring web application

ClinicalTrials.gov registration NCT07776236 · first posted Aug 20, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Closed-loop TBS Targeting rPO for the Core Clinical Features of Methamphetamine Use Disorder
Status at last check: Active, not recruiting · NCT07775807

Methamphetamine Use Disorder, Substance Use Disorder, Cue-reactivity, Craving — Closed-loop Theta-Burst Stimulation (TBS) Targeting rPO

ClinicalTrials.gov registration NCT07775807 · first posted Aug 20, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Home-Based Wearable rTMS Therapy for Moderate to Severe Depression
Status at last check: Not yet recruiting · NCT07775586

Major Depressive Disorder — rTMS-Tiny Treatment, Sham Stimulation

ClinicalTrials.gov registration NCT07775586 · first posted Aug 20, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Status at last check: Recruiting · NCT07775300

Depressive Disorder, Major — Brenipatide, Placebo

ClinicalTrials.gov registration NCT07775300 · first posted Aug 20, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted August 19, 2026
Registration
Psilocybin for Methamphetamine Use Disorder
Status at last check: Not yet recruiting · NCT07774702

Methamphetamine Use Disorder — Psilocybin (single oral capsule administered at one of two dose levels, Dose A or Dose B; specific doses withheld during conduct)., Manualized cognitive behavioral therapy platform (2 preparation + 2 integration sessions).

ClinicalTrials.gov registration NCT07774702 · first posted Aug 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Treatment With Repetitive Transcranial Magnetic Stimulation in Peripartal Depression
Status at last check: Recruiting · NCT07774559

Depression During Pregnancy, Postpartum Depression (PPD), Peripartum Depression — Repetitive transcranial magnetic stimulation, Sham repetitive transcranial magnetic stimulation

ClinicalTrials.gov registration NCT07774559 · first posted Aug 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Anxiety Skills Study
Status at last check: Recruiting · NCT07774481

Anxiety, Anxiety Acute, Anxiety Chronic, Anxiety and Mood Disorders, Social Anxiety Disorder, Panic Disorder (With or Without Agoraphobia), Generalized Anxiety Disorder, Obsessive-Compulsive Disorder, Specific Phobia — Cognitive therapy, Behavioral therapy, Mindfulness-based…

ClinicalTrials.gov registration NCT07774481 · first posted Aug 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
ONE-P TMS First Responders
Status at last check: Not yet recruiting · NCT07773935

PTSD - Post Traumatic Stress Disorder — D-Cycloserine (DCS), Placebo, Intermittent Theta Burst Stimulation (iTBS)

ClinicalTrials.gov registration NCT07773935 · first posted Aug 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
An Open-Label Study to Assess the Long-Term Safety of Solriamfetol in Children and Adolescents With ADHD
Status at last check: Enrolling by invitation · NCT07773883

ADHD — Solriamfetol

ClinicalTrials.gov registration NCT07773883 · first posted Aug 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Efficacy and Safety of Temporal Interference Stimulation in Treatment-Resistant Schizophrenia: An Exploratory Study.
Status at last check: Not yet recruiting · NCT07773831

Treatment-resistant Schizophrenia — Temporal Interference Stimulation

ClinicalTrials.gov registration NCT07773831 · first posted Aug 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Imaging Mitochondrial Complex-I in Cocaine Use Disorder: a [F-18]BCPP-EF PET Study
Status at last check: Recruiting · NCT07773649

Cocaine Use Disorder, Healthy Controls Group - Age and Sex-matched — [F-18]BCPP-EF

ClinicalTrials.gov registration NCT07773649 · first posted Aug 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
CODEPAD-III (Collaborative Outcomes of DEpression and Pain Associated With Delivery-III)
Status at last check: Not yet recruiting · NCT07773259

Depression, Postpartum, Pain, Mental Health — Collaborative Psychological Model (CPM), Intervention common to both arms, Telephone-based support (Control)

ClinicalTrials.gov registration NCT07773259 · first posted Aug 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
Status at last check: Recruiting · NCT07772960

Alcohol Use Disorder (AUD), Obesity (BMI Equal to or >30) — Placebo, Semaglutide 1.0 mg, Semaglutide 2.0 mg

ClinicalTrials.gov registration NCT07772960 · first posted Aug 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Study to Evaluate BMS-986511 in Adults With Major Depressive Disorder
Status at last check: Not yet recruiting · NCT07772531

Major Depressive Disorder — BMS-986511, Placebo

ClinicalTrials.gov registration NCT07772531 · first posted Aug 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Therapy for Social Anxiety Disorder
Status at last check: Recruiting · NCT07772401

Social Anxiety Disorder, Social Fear — taVNS, sham-taVNS

ClinicalTrials.gov registration NCT07772401 · first posted Aug 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 3)
Status at last check: Not yet recruiting · NCT07772349

Schizophrenia — Active rTMS, Strong Cognitive Training, Sham rTMS

ClinicalTrials.gov registration NCT07772349 · first posted Aug 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Short-Term Psychodynamic Group Therapy for Problematic Pornography Use
Status at last check: Completed · NCT07772193

Addiction — Short-Term Psychodynamic Group Therapy

ClinicalTrials.gov registration NCT07772193 · first posted Aug 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Evaluation of a Modularized Cognitive Behavioral Group Therapy Programme for Young Adults (CHANGE-Study)
Status at last check: Not yet recruiting · NCT07772180

Psychiatric Disorder — CHANGE - modularized group psychotherapy

ClinicalTrials.gov registration NCT07772180 · first posted Aug 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Identifying Multidimensional Signatures of Gastric Interoception in Functional Dyspepsia
Status at last check: Recruiting · NCT07772167

Functional Dyspepsia, Anorexia Nervosa — Functional magnetic resonance imaging (fMRI)

ClinicalTrials.gov registration NCT07772167 · first posted Aug 19, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted August 18, 2026
Registration
The Efficacy of a Pharmacological Treatment (Reboxetine Plus Ritalin) Versus Dog-Assisted Therapy in PTSD
Status at last check: Recruiting · NCT07771530

PTSD, Posttraumatic Stress Disorder — methylphenidate (Ritalin®), Reboxetine, Placebo

ClinicalTrials.gov registration NCT07771530 · first posted Aug 18, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Role of Kynurenine Pathway and Its Metabolites in Depressive Disorders, Major Depressive Disorder is Suspected to Have the Greatest Burden by 2030,Kynurenine Pathway is Major Route Through Which the Essential Amino Acid Tryptophan is Metabolised and Activated in Time of Stress and Immune Activation.
Status at last check: Not yet recruiting · NCT07771517

Major Depressive Disorder (MDD)

ClinicalTrials.gov registration NCT07771517 · first posted Aug 18, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The SPARK-PMDD Study
Status at last check: Not yet recruiting · NCT07771426

Premenstrual Dysphoric Disorder, PMDD, Premenstrual Dysphoric Disorder ( PMDD), Premenstrual Dysphoric Disorder (PMDD)

ClinicalTrials.gov registration NCT07771426 · first posted Aug 18, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effect of a Telehealth Intervention on Depressive Symptoms Among Caregivers of Patients With Cerebral Palsy Receiving Home Care
Status at last check: Completed · NCT07771413

Depression — Behavioral Treatment

ClinicalTrials.gov registration NCT07771413 · first posted Aug 18, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Digital Mental Health for Asian Americans
Status at last check: Recruiting · NCT07771322

Mental Health, Cultural Adaptation, Psychotherapy, Mood Disorders, Culturally Responsive Care, Asian, Digital Health Intervention — Culturally-attuned digital tools

ClinicalTrials.gov registration NCT07771322 · first posted Aug 18, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Continuous Theta Burst Stimulation for Generalized Anxiety Disorder
Status at last check: Recruiting · NCT07770919

Generalized Anxiety Disorder — Continuous Theta Burst Stimulation of the Right Posterior Parietal Cortex, Continuous Theta Burst Stimulation of the Right Dorsolateral Prefrontal Cortex

ClinicalTrials.gov registration NCT07770919 · first posted Aug 18, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Deep Transcranial Magnetic Stimulation for Tobacco Cessation in Adults With Opioid Use Disorder
Status at last check: Not yet recruiting · NCT07770555

Opioid Use Disorder, Tobacco Use Disorder — Deep TMS System With H4 Coil

ClinicalTrials.gov registration NCT07770555 · first posted Aug 18, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome
Status at last check: Not yet recruiting · NCT07770282

Schizophrenia Disorder, Metabolic Syndrome, Antipsychotic-induced Weight Gain, Cardiovascular Risk, Insulin Resistance — Semaglutide + TAU, Placebo + TAU

ClinicalTrials.gov registration NCT07770282 · first posted Aug 18, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Imagery Rescripting for Traumatic Panic Attack Memories
Status at last check: Completed · NCT07769996

Panic Disorder — Imagery Rescripting

ClinicalTrials.gov registration NCT07769996 · first posted Aug 18, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Basal Stimulation Therapy in Adults With Schizophrenia Requiring Institutional Care
Status at last check: Not yet recruiting · NCT07769749

SCHIZOPHRENIA 1 (Disorder) — physiotherapy, 2 x a week for 6 weeks, basal therapy, 2 x a week for 6 weeks, Standard therapy group

ClinicalTrials.gov registration NCT07769749 · first posted Aug 18, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted August 17, 2026
Registration
The Effect of a Psychiatric Nursing Approach Based on the Tidal Model on Psychological Resilience and Self-Compassion Levels in Patients Diagnosed With Anxiety Disorder
Status at last check: Completed · NCT07768995

Anxiety Disorders, Psychiatric Nursing, Nursing Models, Psychological Resilience, Self-Compassion, Telehealth, Patient-Centered Care, Mental Health Recovery — Online Psychiatric Nursing Approach Based on the Tidal Model

ClinicalTrials.gov registration NCT07768995 · first posted Aug 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Electrophysiologic Mechanisms of Ketamine Antidepressant Response
Status at last check: Not yet recruiting · NCT07768618

Epilepsy, Depressive Symptoms — Ketamine

ClinicalTrials.gov registration NCT07768618 · first posted Aug 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effectiveness of Cognitive Behavioral Intervention for Trauma in Schools (CBITS): A Study With Pakistani Adolescents
Status at last check: Recruiting · NCT07768540

Post Traumatic Stress Symptoms, Psychological Distress, Trauma Exposure — cognitive behavioral intervention for trauma in schools

ClinicalTrials.gov registration NCT07768540 · first posted Aug 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Accelerated Versus Standard Intermittent Theta Burst Stimulation for Major Depressive Disorder
Status at last check: Recruiting · NCT07768397

Major Depressive Disorder — Accelerated Intermittent Theta Burst Stimulation, Standard Intermittent Theta Burst Stimulation

ClinicalTrials.gov registration NCT07768397 · first posted Aug 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The Effectiveness of Online Group Dialectical Behavioral Therapy on Bulimia Nervosa
Status at last check: Completed · NCT07768319

Bulimia Nervosa — Online Group Dialectical Behavioral Therapy, Face-to-face Group Dialectical Behavioral Therapy

ClinicalTrials.gov registration NCT07768319 · first posted Aug 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The Leuven Longitudinal Late-Life Depression Study
Status at last check: Enrolling by invitation · NCT07768098

Late Life Depression (LLD)

ClinicalTrials.gov registration NCT07768098 · first posted Aug 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Real-time Opioid Study
Status at last check: Recruiting · NCT07768007

Substance Use Disorder (SUD) — real-time functional magnetic resonance imaging (rt-fMRI) neurofeedback

ClinicalTrials.gov registration NCT07768007 · first posted Aug 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
Status at last check: Recruiting · NCT07767903

Generalized Anxiety Disorder — SEP-363856, Placebo

ClinicalTrials.gov registration NCT07767903 · first posted Aug 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Efficacy of Cognitive Behavioural Therapy for Insomnia and Bright Light Therapy in Adolescents With ADHD, Insomnia, and Evening Chronotype
Status at last check: Not yet recruiting · NCT07767617

Insomnia, ADHD, Eveningness, Chronotype, Treatment Effectiveness — CBT-I with Bright Light Group, CBT-I with Placebo Light Group

ClinicalTrials.gov registration NCT07767617 · first posted Aug 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Effectiveness of the MindBridge Mobile Health Module for Young Adults at Risk of Suicide
Status at last check: Not yet recruiting · NCT07767604

Suicidal Ideation — MindBridge Mobile Health Intervention, Attention-Matched General Well-Being Program

ClinicalTrials.gov registration NCT07767604 · first posted Aug 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Xingqi Daozhi Decoction for Antipsychotic-Induced Constipation
Status at last check: Not yet recruiting · NCT07767526

Schizophrenia, Antipsychotic Drug — Xingqi Daozhi Decoction, Placebo Group

ClinicalTrials.gov registration NCT07767526 · first posted Aug 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Eye Movement Intervention With Different Memory Reactivation Procedures for Intrusive Traumatic Memories
Status at last check: Recruiting · NCT07767396

Post-traumatic Stress Disorder (PTSD), Intrusive Memories of Traumatic Event(s) — Unconscious Trauma Reactivation plus Eye Movements, Active Trauma Memory Reactivation plus Eye Movements, Neutral Memory Reactivation plus Eye Movements

ClinicalTrials.gov registration NCT07767396 · first posted Aug 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Project MOVE Bipolar
Status at last check: Completed · NCT07767032

Bipolar Disorder (BD) — BA, SHE, HE

ClinicalTrials.gov registration NCT07767032 · first posted Aug 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
EEG and Actigraphy Biomarkers of Written Exposure Therapy for Posttraumatic Stress Disorder
Status at last check: Not yet recruiting · NCT07766798

Posttraumatic Stress Disorder (PTSD) — Written Exposure Therapy, Neutral Writing Condition

ClinicalTrials.gov registration NCT07766798 · first posted Aug 17, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted August 14, 2026
Registration
Mapping the Neural Circuits of Depression and Anxiety Using Personalized, Accelerated TMS and Deep Phenotyping
Status at last check: Not yet recruiting · NCT07766291

Depression Disorder — Individualized connectome-guided accelerated iTBS

ClinicalTrials.gov registration NCT07766291 · first posted Aug 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
NEST: A Group Intervention for Parents With Complex PTSD
Status at last check: Recruiting · NCT07766265

Complex Post-Traumatic Stress Disorder — Trauma-Informed Parenting Group Intervention

ClinicalTrials.gov registration NCT07766265 · first posted Aug 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression
Status at last check: Recruiting · NCT07766161

Postpartum Depression (PPD) — Light therapy

ClinicalTrials.gov registration NCT07766161 · first posted Aug 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
MDMA-AT for PTSD in Young Adults With Childhood Trauma
Status at last check: Not yet recruiting · NCT07765693

Posttraumatic Stress Disorder (PTSD) — MDMA assisted psychotherapy

ClinicalTrials.gov registration NCT07765693 · first posted Aug 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Augmenting Parent Management Training for Child Temper Outbursts Using a Digital Tool
Status at last check: Recruiting · NCT07764536

Disruptive Behavior Disorders, Conduct Disorder, Oppositional Defiant Disorder, Attention-deficit/Hyperactivity Disorder — Psychotherapy

ClinicalTrials.gov registration NCT07764536 · first posted Aug 14, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted August 13, 2026
Registration
Multimodal Cohort Study of Generalized Anxiety Disorder
Status at last check: Not yet recruiting · NCT07764211

Generalized Anxiety Disorder (GAD)

ClinicalTrials.gov registration NCT07764211 · first posted Aug 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
The Effects and Neural Mechanisms of Vitamin D and Iron-Immune Homeostasis on Inhibitory Control in Obsessive-Compulsive Disorder
Status at last check: Enrolling by invitation · NCT07763977

Obsessive Compulsive Disorder (OCD) — Calcitriol and Iron Supplements

ClinicalTrials.gov registration NCT07763977 · first posted Aug 13, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
First posted August 12, 2026
Registration
Study of rTMS in Maintenance in Treatment Resistant Depression
Status at last check: Not yet recruiting · NCT07760168

Treatment Resistant Depression (TRD) — Transcranial Magnetic Stimulation, quetiapine

ClinicalTrials.gov registration NCT07760168 · first posted Aug 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in Schizophrenia
Status at last check: Recruiting · NCT07759895

Schizoaffecitve Disorder, Schizophrenia and Schizoaffective Disorder, Schizophrenia and Predominant Negative Symptoms — Deferiprone (DFP), N-Acetyl Cysteine (NAC)

ClinicalTrials.gov registration NCT07759895 · first posted Aug 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
Screening & TReatment fOr Perinatal WomeN With PTSD in Substance Use Care SettinGs in Arkansas (STRONG Moms)
Status at last check: Recruiting · NCT07759882

Written Exposure Therapy — Written Exposure Therapy (WET)

ClinicalTrials.gov registration NCT07759882 · first posted Aug 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia
Status at last check: Not yet recruiting · NCT07759869

SCHIZOPHRENIA 1 (Disorder) — HS-10380

ClinicalTrials.gov registration NCT07759869 · first posted Aug 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
Status at last check: Recruiting · NCT07759154

Attention-deficit/Hyperactivity Disorder, Emotional Dysregulation — Centanafadine XR

ClinicalTrials.gov registration NCT07759154 · first posted Aug 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov
Registration
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
Status at last check: Recruiting · NCT07759128

Generalized Anxiety Disorder — SEP-363856, Placebo

ClinicalTrials.gov registration NCT07759128 · first posted Aug 12, 2026

Status is as reported by ClinicalTrials.gov at the last verified check (Nov 17, 2026), not a real-time status.

A registration is a sponsor’s listing of a study on ClinicalTrials.gov. It is not a regulatory action and does not show that a trial has results or that a treatment works.

View on ClinicalTrials.gov